Intracellular trafficking of AIP56, a bacterial AB toxin trageting NF - кB by Liliana Marisa Gonçalves Pereira
 
 
 
 
 
 
 
 
 
 
 
Intracellular trafficking of AIP56,  
a bacterial AB toxin targeting NF-B 
 
 
 
 
 
 
 
 
 
 
 
2014
LILIANA MARISA GONÇALVES PEREIRA 
TESE DE DOUTORAMENTO APRESENTADA 
AO INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZAR  
DA UNIVERSIDADE DO PORTO EM 
CIÊNCIAS BIOMÉDICAS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liliana M. G. Pereira  
 
 
 
 
 
 
 
 
Intracellular trafficking of AIP56,  
a bacterial AB toxin targeting NF-B 
 
 
 
                
 
 
 
                 
 
Tese de Candidatura ao grau de Doutor 
em Ciências Biomédicas submetida ao 
Instituto de Ciências Biomédicas Abel 
Salazar da Universidade do Porto. 
 
Orientador – Doutor Nuno Miguel Simões 
dos Santos 
Categoria – Investigador auxiliar 
Afiliação – Instituto de Biologia Molecular 
e Celular 
 
Co-orientador - Doutora Ana Maria Silva 
do Vale 
Categoria – Investigadora auxiliar 
Afiliação – Instituto de Biologia Molecular 
e Celular 
 
 
 
 
 
 
De acordo com o disposto no Decreto-Lei nº 74/2006 de 24 de Março, esclarece-se 
serem da nossa responsabilidade a execução das experiências que estiveram na origem 
dos resultados apresentados, assim como a sua interpretação, discussão e redação.  
Trabalho desenvolvido durante este doutoramento resultou na publicação de dois artigos 
científicos e uma patente: 
 
Pereira LM, Pinto RD, Silva DS, Moreira AR, Beitzinger C, Oliveira P, Sampaio P, Benz R, Azevedo 
JE, dos Santos NM, do Vale A (2014) Intracellular trafficking of AIP56, an NF‐B cleaving toxin from 
Photobacterium damselae piscicida. [accepted for publication in Infection and Immunity] 
 
Silva DS, Pereira LM, Moreira AR, Ferreira‐da‐Silva F, Brito RM, Faria TQ, Zornetta I, Montecucco 
C, Oliveira P, Azevedo  JE, Pereira PJ, Macedo‐Ribeiro  S, do Vale A, dos  Santos NM  (2013)  The 
apoptogenic toxin AIP56 is a metalloprotease A‐B toxin that cleaves NF‐kappab p65. PLoS Pathog 
9: e1003128 
dos Santos NM, do Vale A, Pereira LM, Silva DS, Azevedo JE , Pereira PJ, Macedo‐Ribeiro S (2014) 
UK  Intellectual Property Office patent   WO2014109658A2  (peptides; use of AIP56  for  targeting 
NF‐B and as a delivery system) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Durante este longo caminho contei com a ajuda e apoio de muitos, aos quais estou 
eternamente grata. O meu sincero Obrigada, a todos os que contribuíram para a 
realização deste trabalho. Obrigada por nunca deixarem de acreditar em mim e 
por me fazerem acreditar que “Sabemos muito mais do que julgamos,  
podemos muito mais do que imaginamos” ( José Saramago). 
 
Liliana Marisa 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Funding 
 
The author was supported by national funds through a grant from Fundação para a 
Ciência e a Tecnologia (SFRH/BD/43501/2008). 
 
The work was funded by FEDER through Programa Operacional Factores de 
Competitividade – COMPETE, and by national funds through Fundação para a Ciência e 
a Tecnologia - FCT under the projects FCOMP-01-0124-FEDER-009501 
(PTDC/CVT/099544/2008) and FCOMP-01-0124-FEDER-009036 (PTDC/BIA-
PRO/101111/2008).  
 
 
           
                
                    
 
 
 
 
 
 
 
 
 
 
UNIÃO EUROPEIA
FEDER 
Fundo Europeu de 
Desenvolvimento Regional 
  
 
 
IX 
 
TABLE OF CONTENTS  
 
LIST OF ABBREVIATIONS ............................................................................................................. XIII 
ABSTRACT .................................................................................................................................... XVII 
RESUMO  ........................................................................................................................................ XXI 
 
CHAPTER I - INTRODUCTION ..........................................................................................................1 
A. Bacterial protein toxins  ...............................................................................................................3 
1. Overview ..................................................................................................................................3 
2. Main types of bacterial protein toxins  .....................................................................................3 
2.1. Effectors delivery through injection  ...........................................................................4 
2.2. Exotoxins  ...................................................................................................................5 
2.2.1. Exotoxins acting at cell surface  ....................................................................5 
2.2.2. Exotoxins with cytosolic targets  ...................................................................7 
3. AB toxins  .................................................................................................................................8 
3.1. Overview  ....................................................................................................................8 
3.2. Molecular organization  ..............................................................................................9 
3.2.1. Single polypeptide  ........................................................................................9 
3.2.2. Oligomeric complexes (AB5, A2B5 and AB7/8)  .............................................10 
3.3. Application of bacterial AB toxins .............................................................................11 
 
B. Intoxication pathways of bacterial AB toxins  .........................................................................14 
1. General concepts on endocytosis  ........................................................................................14 
1.1. Clathrin-dependent endocytosis  ..............................................................................15 
1.2. Clathrin-independent endocytosis  ...........................................................................16 
2. Endocytosis of AB toxins  ......................................................................................................17 
3. Intracellular intoxication pathways  ........................................................................................20 
3.1. Endosomal pathway (short-journey)  .......................................................................21 
3.1.1. Diphtheria toxin  ..........................................................................................23 
3.1.2. Anthrax toxin  ..............................................................................................26 
3.2. Retrograde pathway (the long journey)  ...................................................................28 
3.2.1. Cholera toxin ...............................................................................................29 
3.2.2. Shiga toxin  .................................................................................................32 
 
C. AIP56  ...........................................................................................................................................36 
1. Role in Photobacterium damselae piscicida virulence  .........................................................36 
2. AIP56, an AB toxin that cleaves NF-B p65  ........................................................................ 39      
 
X 
 
CHAPTER II - AIMS OF THE STUDY  ............................................................................................ 43 
CHAPTER III - MATERIAL AND METHODS  ................................................................................. 47 
1. Experimental animals and cells  ........................................................................................... 49 
1.1. Ethics statement  ..................................................................................................... 49 
1.2. Experimental animals  ............................................................................................. 49 
1.2.1. Experimental fish  ....................................................................................... 49 
1.2.2. Experimental mice  ..................................................................................... 49 
1.3. Cells  ........................................................................................................................ 49 
1.3.1. Sea bass peritoneal leukocytes (sbPL)  ..................................................... 49 
1.3.2. Mouse bone marrow derived macrophages (mBMDM)  ............................ 50 
1.3.3. Cell lines  .................................................................................................... 50 
2. Recombinant proteins  .......................................................................................................... 51 
2.1. Production and purification of recombinant proteins expressed in E. coli  .............. 52 
2.2. Cell-free expression of 35S-labeled sbp65Rel  ........................................................ 52 
2.3. Protein quantification  .............................................................................................. 53 
3. Fluorescent labelling of AIP56  ............................................................................................. 53 
4. In vitro analysis of AIP56 catalytic activity  ........................................................................... 53 
5. In vitro analysis of AIP56 pH induced conformational changes  .......................................... 54 
5.1. Tryptophan and TNS fluorescence  ......................................................................... 54 
6. Black lipid bilayer experiments  ............................................................................................ 55 
7. pH-induced translocation across the cell membrane ........................................................... 55 
8. Intoxication assays: NF-B p65 cleavage read-out  ............................................................. 56 
9. Analysis of cellular morphology  ........................................................................................... 56 
      10. Viability assay: conversion of resazurin to resorufin   .......................................................... 57 
      11. Detection of apoptosis  ......................................................................................................... 57 
11.1. Caspase-3 activity  ................................................................................................ 57 
11.2. TUNEL assay  ....................................................................................................... 58 
      12. Competition assay  ............................................................................................................... 58 
      13. Detection of the intracellular AIP56  ..................................................................................... 58 
13.1. Western blotting  .................................................................................................... 58 
13.2. Fluorescence microscopy  ..................................................................................... 58 
      14. Recycling assay  ................................................................................................................... 59 
      15. Inhibition of endocytosis and trafficking ............................................................................... 60 
15.1. Inhibitors  ............................................................................................................... 60 
15.2. Lag-time experiments  ........................................................................................... 60 
      16. Phagocytosis assay  ............................................................................................................. 60 
      17. Fluorescence microscopy  .................................................................................................... 60 
17.1. Immunofluorescence  ............................................................................................ 60 
17.2. Transferrin experiments ........................................................................................ 63 
17.3. Acridine Orange  .................................................................................................... 63 
XI 
 
      18. SDS-PAGE and Western blotting  .........................................................................................63 
      19. Statistical analysis  ................................................................................................................64 
 
CHAPTER IV - RESULTS  ................................................................................................................65 
1. Interaction of AIP56 with mammalian cells  ...........................................................................67 
1.1. AIP56 cleaves NF-B p65 in different cell lines but does not induce apoptosis  .....67 
1.2. AIP56 induces depletion of NF-B p65 and apoptosis in mBMDM  .........................68 
1.3. Apoptosis of mBMDM induced by AIP56 occurs in the absence of TNF-α or  
       TLR4 signaling  ........................................................................................................71 
2. AIP56 endocytic uptake  ........................................................................................................72 
2.1. AIP56 is rapidly endocytosed in vesicle-like structures  ..........................................72 
2.2. AIP56 intoxication in mBMDM involves interaction of the C-terminal region  
       of the toxin with cell surface components  ...............................................................75 
2.3. AIP56 endocytosis and toxicity require dynamin and clathrin  .................................77 
2.4. Microtubules and actin dynamics are dispensable for intoxication by AIP56  .........79 
3. AIP56 intracellular pathway  ..................................................................................................82 
3.1. Upon endocytosis, AIP56 localizes in early endosomes and then is routed  
        to the recycling endocytic compartment  .................................................................82 
3.2. Shortly after endocytosis, a pool of AIP56 is recycled back to the  
       extracellular medium through a mechanism requiring PI3K activity but  
       independent on endosome acidification  ..................................................................84 
4. Translocation of AIP56 into the cytosol  ................................................................................88 
4.1. Endosome acidification is required for arrival of AIP56 into the cytosol  .................88 
4.2. Time-course of AIP56 translocation  ........................................................................91 
4.3. At acidic pH, AIP56 undergoes reversible conformational changes and  
       interacts with artificial lipid bilayer membranes  .......................................................93 
4.4. Extracellular acidification triggers translocation of cell surface-bound AIP56  
       into the cytosol  ........................................................................................................95 
 
CHAPTER V- DISCUSSION  ............................................................................................................97 
1. AIP56 cleaves NF-B p65 and induces apoptosis in mBMDM  ............................................99 
2. AIP56 undergoes receptor mediated endocytosis in a clathrin-dependent mechanism  ... 102 
3. AIP56 is a “short-trip” toxin that follows the endocytic recycling route  .............................. 103 
4. Future perspectives  ........................................................................................................... 106 
 
CHAPTER VI - CONCLUDING REMARKS  .................................................................................. 109 
 
CHAPTER VII - REFERENCES  .................................................................................................... 113

XIII 
 
LIST OF ABBREVIATIONS 
 
ADP  adenosine diphosphate 
AIP56   apoptosis inducing protein of 56 kDa  
ANTXR1  anthrax toxin receptor 1 
ANTXR2 anthrax toxin receptor 2 
APCs  antigen presenting cells  
AP2  clathrin adaptor protein 2  
Arf  ADP-ribosylation factor   
ATP  adenosine triphosphate 
BoNT  botulinum neurotoxins  
cAMP  cyclic adenosine monophosphate  
CDCs  cholesterol dependent cytolysins  
CGTs  clostridial glucosylating toxins  
COPI  coat protein complex I  
CT  cholera toxin  
DT  diphtheria toxin  
EF  edema factor  
EF-2  elongation factor 2  
ER  endoplasmic reticulum  
ERAD  ER-associated protein degradation  
GTP  guanosine-5'-triphosphate  
GDP  guanosine 5′-diphosphate 
HB-EGF heparin-binding epidermal growth factor 
Hsp90  heat-shock protein 90  
Hsc70  heat shock cognate 71 kDa protein 
IKK  IB kinase  
IBs  inhibitors of NF-B  
XIV 
 
JNK  c-Jun N-terminal kinase  
LBPA  lysophosphatidic acid  
LF  lethal factor  
LPS  lypopolysaccharide 
LRP6  lipoprotein-receptor-related protein 6  
LT  heat-labile enterotoxins  
MAPK  mitogen activated protein kinase  
mBMDM mouse bone marrow derived macrophages 
MG132 Z-Leu-Leu-Leu-CHO 
MHC-II  major histocompatibility complex class II  
NF-B  nuclear factor-κappa B  
PA  protective antigen  
PAMPs pathogen-associated molecular patterns  
PCR  polymerase chain reaction 
PDI  protein disulphide isomerase  
PE  Pseudomonas exotoxin A  
PFTs  pore-forming toxins  
Phdp  Photobacterium damselae piscicida 
PK  protein kinase  
PMSF  phenylmethylsulfonyl fluoride 
PRRs  pattern-recognition receptors  
PT  pertussis toxin  
Rab  rabenosyn 
RHD  Rel homology domain  
RIPs  receptor interacting proteins 
ROS  reactive oxygen species  
SAgs  Superantigen toxins  
sbPBS  sea bass phosphate saline buffer 
XV 
 
sbPL  sea bass peritoneal leukocytes 
SNARE soluble N-ethylmaleimide-sensitive factor activating protein receptor  
STs  heat-stable toxins  
Stx  Shiga toxin  
TCR  T-cell receptor  
TeNT  tetanus neurotoxin  
TLRs  toll-like receptors  
TNF  tumour necrosis factor  
TNFRs  TNF-receptors  
TRAF  TNF-receptor associated factor 
TRAIL  TNF-related apoptosis-inducing ligand 
V-ATPase vacuolar adenosine triphosphatase pump  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XVI 
 
 
 
XVII 
 
ABSTRACT 
 
Bacterial toxins comprise a large and diverse family of molecules recognized as 
primary virulence factor(s) of a variety of pathogenic bacteria. Studies on bacterial AB 
toxins contributed not only to clarify their role in infection but revealed also their potential 
as tools to study cellular processes and also as therapeutic agents.   
The AIP56 (Apoptosis Inducing Protein of 56 kDa) toxin is a major virulence factor of 
Photobacterium damselae piscicida (Phdp), a Gram-negative bacterium that infects 
economically important fish species and is considered one of the most relevant pathogens 
in mariculture. In infected fish, AIP56 spreads systemically triggering apoptosis of 
macrophages and neutrophils, leading to the impairment of the host phagocytic defense 
and favoring Phdp survival and dissemination. This process of apoptosis culminates in 
post-apoptotic secondary necrosis with the release of the phagocyte’s cytotoxic contents, 
contributing to the genesis of the infection-associated necrotic lesions. Structurally, AIP56 
is an AB-type toxin composed by two domains linked by a disulphide bridge, with the A 
domain displaying the catalytic activity and the B domain responsible for the 
binding/translocation of the toxin. Recently, we have reported that AIP56 is a 
metalloprotease that cleaves NF-B p65 at the Rel homology domain. NF-B is an 
evolutionarily conserved transcription factor that regulates the expression of inflammatory 
and anti-apoptotic genes and plays a key role in host responses to microbial pathogen 
invasion. The proteolytic activity of AIP56 against NF-B results in the removal of crucial 
residues involved in DNA interaction, compromising the NF-B transcriptional activity. 
Despite the knowledge about the toxic effects of AIP56, its structure and intracellular 
target, nothing was known about the susceptibility of different types of cells to AIP56 
neither about the mechanisms involved in toxin uptake and intracellular trafficking. The 
studies included in this thesis aimed at clarifying the details of the interaction of AIP56 
with target cells and at identifying the intracellular pathways followed by the toxin during 
intoxication.  
Bacterial AB toxins, such as AIP56, have cytoplasmic targets and therefore must 
cross biological membranes to reach the intracellular milieu. To enter the cells, they act as 
opportunistic ligands, exploiting existing receptors and diverse mechanisms of 
endocytosis and intracellular trafficking. After receptor-mediated endocytosis some toxins, 
like diphtheria or anthrax toxin, can take the short journey/endosomal pathway and 
translocate from the endosomes through a pH-dependent mechanism while others, like 
Shiga or cholera toxins, can follow the long journey/retrograde pathway and travel to the 
endoplasmic reticulum from where the translocation occurs. 
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In the work herein presented, we show that, although Phdp is not able to infect 
mammals, AIP56 is able to enter and cleave p65 in different mammalian cell lines. We 
also show that, similarly to what was previously reported for sea bass leukocytes, mouse 
bone marrow derived macrophages undergo NF-B p65 depletion and apoptosis in 
response to AIP56. Using both sea bass peritoneal leukocytes and mouse bone marrow 
derived macrophages, we disclosed key steps involved in the entry and intracellular 
trafficking of AIP56. Fluorescence microscopy and western-blotting analysis showed that 
AIP56 is rapidly endocytosed and competition assays revealed that, similarly to what was 
reported for sea bass peritoneal leukocytes, intoxication of mouse bone marrow derived 
macrophages involves interaction of AIP56 C-terminal region with cell surface 
components, suggesting the existence of a conserved receptor. Pharmacological 
inhibition of clathrin-dependent endocytosis regulators revealed that, as in the case of 
diphtheria toxin, AIP56 endocytosis occurs mainly through a clathrin-dependent process 
not requiring functional actin dynamics.  
Data obtained in this study indicate that, alongside with diphtheria, anthrax and 
clostridial neurotoxins, AIP56 is a “short-trip” toxin that reaches the cytosol after 
translocation from endosomes using an acidic-pH dependent mechanism. Indeed, we 
found that pharmacological inhibitors that prevent endosome acidification inhibited AIP56-
mediated p65 cleavage and that an acidic pulse was sufficient to trigger translocation of 
cell-surface bound AIP56 across the cytoplasmic membrane into the cytosol. In 
agreement with these findings, AIP56 became more hydrophobic at pH ≤ 5.5 and was 
able to interact with artificial lipid bilayer membranes only at acidic pH.  
Usually, for “short-trip” AB toxins, a minor pool reaches the cytosol by translocating 
from endosomes whereas the rest is routed to lysosomes for degradation. In this work, 
using biochemical approaches and confocal microscopy we found that part of 
endocytosed AIP56 follows the endocytic recycling route and is recycled into the 
extracellular medium by a mechanism requiring PI3K activity but independent on 
endosome acidification.  
The here reported results show that AIP56 cleaves NF-B not only in fish but also in 
mammalian cells and disclose important aspects of AIP56 trafficking, revealing that these 
are conserved between fish and mammalian cells. Since there are several (so far 
uncharacterized) AIP56 full-length homologues in different bacterial species, expanding 
the knowledge on AIP56 intoxication mechanism, not only adds to the understanding of 
Phdp pathogenesis but may also shed light on the pathogenesis of other bacteria 
producing AIP56-like toxins. Apart from its intrinsic biologic interest, the evidences 
supporting that a significant pool of endocytosed AIP56 follows the recycling pathway and 
is released into the extracellular medium suggest a novel intracellular route amongst the 
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ones already established for bacterial AB toxins. This makes AIP56 an attractive tool for 
studying a poorly understood intracellular route. Moreover, it is well known that 
uncontrolled activation of NF-B is associated with several human pathologies, including 
inflammatory diseases and cancers, and thus the observation that AIP56 acts on 
mammalian cells confers considerable biotechnological potential to the toxin. Altogether, 
the data presented in this thesis not only contribute to a better understanding of AIP56-
associated pathogenicity but also open doors to the use of AIP56 as a 
biotechnological/therapeutic tool specifically targeting NF-B. 
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RESUMO 
 
As toxinas bacterianas constituem uma família ampla e diversificada de moléculas 
que inclui elementos considerados factores de virulência chave de várias bactérias 
patogénicas. Os estudos das toxinas bacterianas demonstraram a sua elevada 
importância não só como factores cruciais para o estabelecimento de várias infeções, 
mas também como ferramentas para o estudo de processos celulares eucarióticos e 
como agentes terapêuticos.  
A AIP56 (Apoptosis Inducing Protein of 56 kDa) é uma toxina que desempenha um 
papel central na virulência da Photobacterium damselae piscicida (Phdp), uma bactéria 
Gram-negativa que infecta várias espécies de peixes marinhos, sendo considerado um 
dos patogéneos mais relevantes em maricultura. Nos peixes infectados, a AIP56 
dissemina-se de forma sistémica e induz apoptose de macrófagos e neutrófilos, 
comprometendo a defesa fagocítica do hospedeiro e contribuindo para a sobrevivência e 
disseminação da bactéria. O processo de apoptose culmina em necrose secundária, com 
libertação de moléculas citotóxicas que contribuem para a génese das lesões necróticas 
características da infeção por Phdp. Estruturalmente, AIP56 é uma toxina do tipo AB, 
composta por dois domínios unidos entre si por uma ponte dissulfureto, em que o 
domínio A é responsável pela actividade catalítica e o domínio B pela 
ligação/translocação da toxina. Recentemente, mostramos que a AIP56 é uma 
metaloprotease que corta a subunidade p65 do NF-B no domínio Rel. O NF-B é um 
factor de transcrição conservado evolutivamente que controla a expressão de genes pró-
inflamatórios e anti-apoptóticos e desempenha um papel importante nas respostas dos 
hospedeiros à invasão por agentes patogénicos microbianos. A proteólise do p65 levada 
a cabo pela AIP56 remove resíduos cruciais envolvidos na interacção do NF-B com o 
DNA, comprometendo a sua actividade transcricional.  
Embora sejam já conhecidos alguns detalhes da estrutura da AIP56 e tenha sido 
identificado um alvo intracelular da toxina, os detalhes da interação da AIP56 com 
diferentes tipos celulares e os mecanismos envolvidos na entrada e tráfico no interior das 
células permanecem por esclarecer. Com este estudo, pretendeu-se clarificar 
mecanismos envolvidos na interação da AIP56 com diferentes células e identificar as vias 
intracelulares seguidas durante a intoxicação.  
As toxinas do tipo AB, como a AIP56, actuam em alvos intracelulares e, por 
conseguinte, precisam de atravessar a membrana celular para alcançar o citosol. Para 
entrar nas células, estas toxinas agem como ligantes oportunistas explorando receptores 
e diversos mecanismos de endocitose e tráfego intracelular existentes na célula alvo. 
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Após endocitose mediada por receptor, algumas toxinas, como a da difteria ou antrax, 
seguem a via endosomal e translocam a partir dos endossomas por meio de um 
mecanismo dependente do pH, enquanto outras, como a toxina Shiga ou a toxina da 
cólera, seguem a via retrógrada até ao ER, de onde ocorre a translocação. 
Embora a Phdp não seja capaz de infectar células de mamífero, trabalhos 
desenvolvidos no âmbito desta dissertação permitiram identificar vários tipos celulares de 
mamíferos susceptíveis à AIP56, mostrando que a toxina tem a capacidade de entrar e 
cortar o p65 em diferentes linhas celulares. No entanto, apenas em macrófagos de 
ratinho derivados da medula óssea (mBMDM) ocorreu depleção do p65 e apoptose em 
resposta à intoxicação, efeitos anteriormente descritos apenas em leucócitos peritoneais 
de robalo (sbPL), um hospedeiro natural da Phdp. Usando sbPL e mBMDM, clarificamos 
mecanismos importantes envolvidos na entrada e tráfico intracelular da AIP56. Usando 
microscopia de fluorescência e análise por western-blotting verificamos que a toxina é 
rapidamente endocitada. Ensaios de competição sugerem a existência de um receptor 
conservado para a AIP56 porque, tal como em sbPL, a entrada da AIP56 em mBMDM 
envolve a interacção da região C-terminal da toxina com elementos localizados à 
superfície da célula alvo. A inibição farmacológica de reguladores da endocitose 
dependente da clatrina revelou que, tal como no caso da toxina da difteria, AIP56 é 
endocitada maioritariamente por uma via dependente da clatrina mas independente da 
actina. 
Em estudos que visaram esclarecer os mecanismos de translocação da AIP56, 
verificámos que compostos que impedem a acidificação endossomal inibem a chegada 
da toxina ao citosol. Verificámos ainda que um choque acídico é suficiente para 
desencadear a translocação da toxina que se encontra ligada à superfície da membrana 
celular das células alvo directamente para o citoplasma. Em consonância com estas 
observações, mostrámos que a pH ≤ 5.5 a hidrofobicidade da toxina aumenta e esta 
torna-se capaz de interagir com membranas bi-lipídicas artificiais. Em conjunto, os dados 
obtidos no âmbito desta dissertação indicam que a AIP56 é uma toxina do tipo “short-trip” 
que chega ao citosol atravessando a membrana dos endossomas primários por um 
mecanismo dependente do pH.  
No caso das toxinas “short-trip”, está descrito que apenas um pequeno número de 
moléculas internalizadas atinge o citosol, sendo a grande maioria encaminhada para 
degradação nos lisossomas. No caso da AIP56, estudos de microscopia confocal e 
ensaios bioquímicos, mostraram que uma proporção significativa da toxina internalizada é 
reciclada e libertada novamente no compartimento extracelular, através de um 
mecanismo dependente da actividade da enzima fosfatidilinositol-3-cinase (PI3K) mas 
independente da acidificação dos endossomas.  
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Os dados aqui reportados mostram que a AIP56 corta a subunidade p65 do NF-B 
não só em células de peixe mas também em células de mamífero e revelam aspectos 
importantes do tráfico da AIP56, mostrando que estes são conservados entre células de 
peixe e de mamífero. Uma vez que existem várias proteínas homólogas à AIP56 (até 
agora não caracterizadas) em diferentes bactérias, o reforço do conhecimento sobre os 
mecanismos de intoxicação da AIP56 não só contribuirá para aumentar a compreensão 
sobre o papel desta toxina no contexto da infecção pela Phdp mas poderá também 
esclarecer a patogénese de outras bactérias que produzem toxinas idênticas à AIP56. 
Para além do interesse biológico intrínseco, os resultados que mostram que a AIP56 
segue a via endocítica de reciclagem revelam uma nova via de tráfico intracelular para 
toxinas AB. Isto faz com que a toxina possa ser uma potencial ferramenta para estudo de 
uma via intracelular pouco caracterizada. Para além disso, é sabido que a activação 
descontrolada do NF-B está associada a diversas patologias humanas, incluindo as 
doenças inflamatórias e cancros e, portanto, a observação de que AIP56 actua em 
células de mamíferos confere considerável potencial biotecnológico à toxina. Em 
conjunto, os dados apresentados nesta tese não só contribuem para uma melhor 
compreensão da patogenicidade associada à AIP56, como também abrem portas ao uso 
da AIP56 como uma ferramenta biotecnológica/terapêutica tendo como alvo o NF-B.  
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A. Bacterial protein toxins 
1. Overview 
The term “bacterial toxin” was used for the first time in 1888 at Pasteur Institute when 
Roux and Yersin discovered diphtheria toxin in sterile filtrates of Corynebacterium 
diphtheriae (Roux & Yersin, 1888). Two years later, Knud Faber, in Denmark, and 
Tizzonni and Cattani, in Italy, found the tetanus toxin, secreted by Clostridium tetani (Alouf 
& Popoff, 2006). In 1896 Van Ermengem identified botulinum toxin as a toxin secreted by 
the bacterium Clostridium botulinum (Alouf & Popoff, 2006). Since then, many studies 
allowed the identification of several bacterial toxins with different structures and modes of 
action, revealing that together they constitute a large family with very diverse members 
(Lemichez & Barbieri, 2013). 
Nowadays, more than hundred years later, the interest in studying toxins remains 
high for a number of reasons. First, because they are recognized as the primary virulence 
factor of a variety of pathogenic bacteria and have the capacity to induce many of the 
symptoms characteristic of the pathology. And second, because studies on bacterial 
protein toxins have provided remarkable insight not only into fundamental aspects of 
host/pathogen interactions but also into the basic biology of eukaryotic cells and have 
revealed the potential biomedical applications of bacterial toxins. 
 
2. Main types of bacterial protein toxins 
Bacterial toxins are often classified into several functional groups based on their 
structures and modes of action. They can be delivered into host cells by injection, using 
an injection apparatus build up by the bacteria (e.g. type III secretion system), or they can 
be secreted by the bacterium into the surrounding milieu (e.g. exotoxins). In this case, 
they may intoxicate host cells on the neighborhood or distantly from the bacterial 
pathogen, either by acting directly on host cells plasma membrane or by delivering toxic 
enzymatic components into the cytosol after entering by receptor-mediated endocytosis.  
 
CHAPTER I - INTRODUCTION 
 
4 
 
 
Figure 1.1. The four major classes of bacterial protein toxins. Bacterial toxins can: (A) and (B) act on the target cell 
surface to irreparable damage the cell membrane or alter normal cellular signal transduction; (C) exhibit enzymatic activity 
once the molecule has gained access to the cytoplasm of the sensitive cell by endocytosis; (D) inject the catalytic domain 
into the host cell using an injection apparatus of the bacterial pathogen. Whereas in classe (D) the bacterial pathogen needs 
to be in contact with host cell in order to exert toxicity, in the classe (A) (B) and (C) the toxins often act distantly from the 
bacterial pathogen. (From Lemichez & Barbieri, 2013) 
 
2.1.  Effectors delivered through injection 
Whereas a high variety of bacterial toxins act distantly from the bacterial pathogen, a 
group of toxins are synthesized within the bacterium and are delivered directly into the 
host cell by an injection apparatus of the producing microorganism. Included in this group 
are the type III secreted cytotoxins/effectors widespread among Gram-negative bacteria 
which are injected directly into the cytoplasm of eukaryotic cells by type III secretion 
systems (T3SS) (Cornelis, 2006; Galan & Wolf-Watz, 2006; Hayes et al, 2010; Izore et al, 
2011; Marlovits & Stebbins, 2010; Worrall et al, 2011). These are needle-like, membrane-
anchored, multi-component complexes present in pathogenic bacteria, characterized by 
affecting the physiology of the host cell by delivering of a large amount of molecules in a 
short period of time (Lemichez & Barbieri, 2013). The structure of the T3SS apparatus 
(Figure 1.2) itself can display notable similarities amongst different bacterial species, 
although the nature of translocated effectors is widely different (Blocker et al, 2003a; 
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Galan & Wolf-Watz, 2006). Some authors considered these injected effectors distinct from 
bacterial toxins because while bacterial toxins usually have a single biochemical activity 
and target specific components of the host cell, effector proteins exert their specific 
function in concert with the activities of multiple other bacterial effectors delivered by the 
same machine (Galán, 2009).  
 
 
Figure 1.2. Type III secretion system. Schematic representation of a type III secretion system (T3SS). The T3SS 
apparatus has a part anchored in the bacterial membrane, formed by several ring structures that span the inner and outer 
membranes, and an extracellular part that is the needle (purple protrusion). The needle is thought to engage a bacterial 
pore-forming complex in the host cell membrane that allows the arrival of the bacterial effectors into the host cell cytosol. 
(From http://carbon.bio.ku.edu/research.html) 
 
2.2.  Exotoxins 
 
2.2.1. Exotoxins  acting at cell surface 
Exotoxins acting at cell surface can display its toxicity by interfering with signal 
transduction pathways, by displaying enzymatic activities towards membrane compounds 
or by forming pores (Popoff, 2005). 
Superatigens (SAgs) produced by a variety of bacteria, including Sthapylococcus 
aureus, Streptococcus sp., Mycoplasma arthritidis and Yersinia pseudotuberculosis are 
examples of bacterial toxins acting at cell surface by corrupting signal transduction 
pathways (McCormick et al, 2001; Yoshino et al, 1994). SAgs stimulate the interaction of 
peptide-independent MHC II with T cell receptor at the surface of antigen-presenting cells 
(Figure 1.3A). These hijacks T-cell antigen recognition (Henkel et al, 2010) leading to a 
non-specific activation of the immune response that culminates in a powerful inflammatory 
response (Fraser & Proft, 2008; Muller-Alouf et al, 2001).  
Also as examples of toxins that can display their toxic program at the cell membrane 
are bacterial hyaluronidases, collagenases, and phospholipases that enzymatically alter 
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the extracellular matrix or the plasma membrane of eukaryotic cells. These include the α-
toxin of Clostridium perfringens, which has phospholipase C activity (Songer, 1997); 
Streptococcus pyogenes streptokinase, which can hydrolyze plasminogen to plasmin and 
dissolve clots (Lottenberg et al, 1994); and the clostridial collagenases, which can 
degrade collagen (Harrington, 1996).  
 
 
 
Figure 1.3. Exotoxins acting at the cell surface. (A) Schematic representation of T-cell activation by SAg. Sags stimulate 
T cells by cross-linking major histocompatibility complex (MHC) class II antigens and T-cell receptors (TCR). (Adapted from 
http://biosiva.50webs.org/antigens.htm). (B) Pore-forming toxins. Schematic representation of pore formation induced by an 
exotoxin. PFT: pore forming toxin. (Adapted from http://vdg.epfl.ch/PoreFormingToxins). 
 
Pore forming toxins (PFTs) are characterized by forming pores of different size and 
molecular selectivity in the membranes of bacteria, plants and mammals that result in loss 
of membrane integrity corrupting cell signaling, and changes in the concentration of ions 
in the target cell cytosol that leads to ion imbalance (Bischofberger et al, 2009; 
Bischofberger et al, 2012; Iacovache et al, 2008). While pathogenic bacteria produce 
PFTs to affect their hosts in order to promote colonization and spread (Aboulaich et al, 
2004) some bacteria can produce PFTs to kill other bacteria. As example, some 
Escherichia coli species produce pore-forming colicins to kill related bacteria (Lakey et al, 
1994). PFTs are secreted as monomeric proteins that, after binding to the cell surface via 
specific receptors, assemble into oligomeric structures which undergo a conformational 
change that generates hydrophobic patches. This allows spontaneous insertion into the 
lipid bilayer that culminates in membrane permeabilization and release of cytosolic ions 
(Figure 1.3B) (Bischofberger et al, 2012). Based on the multimeric structure involved in 
membrane insertion, PFTs are classified in α-PFTs or β-PFTs (Henkel et al, 2010). α-
PFTs, such as colicins, insert into the membrane as an α-helix while β-PFTs like the 
cholesterol-dependent cytolisins, primarily produced by Gram-positive bacteria (Park et al, 
2004; Rosado et al, 2008; Rossjohn et al, 2007) insert into the membrane as β-sheets.  
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2.2.2. Exotoxins with cytosolic targets 
To be successful, intracellular acting toxins must access their substrates inside target 
cells. Usually, these toxins are internalized by receptor-mediated endocytosis before 
reaching the cytosol from intracellular compartments (Lauvrak et al, 2004; Montecucco & 
Papini, 1995).  
Toxins that are internalized by receptor-mediated endocytosis and act at the cytosol 
of host cells are called AB toxins (Lemichez & Barbieri, 2013) and will be discussed in 
detail below (Section 3). According to the nature of the target and the type of modification, 
these toxins cause a dramatic alteration of cellular functions such as protein synthesis, 
cell homeostasis, cell cycle progression, vesicular traffic, actin cytoskeletal 
rearrangements, and signaling pathways (Table 1) (Henkel et al, 2010; Lemichez & 
Barbieri, 2013; Popoff, 2005).  
 
Table 1. Examples of bacterial AB toxins that enzymatically modify cytosolic targets 
Toxin Enzymatic activity Cellular target Effect Reference
Toxins targeting actin cytoskeleton components
Clostridium 
botulinum C2 toxin 
ADP-ribosyl 
transferase Actin Depolymerization 
(Aktories et al, 
1986) 
Clostridum 
perfringens iota toxin 
ADP-ribosyl 
transferase Actin Depolymerization (Aktories, 2011) 
Photorhabdus 
luminescens Tc 
(TccC3-subunit) 
ADP-ribosyl 
transferase Actin Actin clustering (Lang et al, 2010) 
Clostridium difficile 
toxins A and B Glucosyltransferase Rho proteins Actin depolymerization (Just et al, 1995) 
Escherichia coli 
CNF1 Deamidase 
Rac1, RhoA, Cdc42 
(Q61 or Q63) Actin polymerization 
(Lemonnier et al, 
2007) 
Toxins targeting SNARE machinery 
Clostridium tetani 
TeNT Zinc metalloprotease VAMP / synaptobrevin 
Neurotransmission 
inhibition (Hill et al, 2007) 
Clostridium 
botulinum, 
BoNT A, E 
Zinc metalloprotease SNAP25 Neurotransmission inhibition (Hill et al, 2007) 
Clostridium 
botulinum,  
BoNT B, D, F, G 
Zinc metalloprotease VAMP / synaptobrevin Neurotransmission inhibition (Hill et al, 2007) 
Clostridium 
botulinum, BoNT C Zinc metalloprotease SNAP25, syntaxin 
Neurotransmission 
inhibition (Hill et al, 2007) 
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Table 1. Continued 
Toxin Enzymatic activity Cellular target Effect Reference 
Toxins targeting cell translational machinery
Corynebacterium 
Diphtheriae  
 DT 
ADP- ribosyl 
transferase 
EF2 (diphthamide-
715) Translation inhibition (Murphy, 2011) 
Pseudomonas 
aeruginosa  
exotoxin A 
ADP- ribosyl 
transferase 
EF2 (diphthamide-
715) Translation inhibition (Murphy, 2011) 
Shigella dysenteriae 
Stx N-glycosylase 
 
28S ribosomal RNA 
 
Translation inhibition (Johannes & Romer, 2010) 
Toxins targeting cAMP, MAP kinase and NF-B signaling components 
Vibrio cholera CT 
 
ADP- ribosyl 
transferase 
Heterotrimeric G-
protein (Gαs ) cAMP induction (Aktories, 2011) 
Bordetella pertussis     
Ptx 
ADP- ribosyl 
transferase 
Heterotrimeric G-
protein (Gαs ) cAMP induction (Aktories, 2011) 
Bacillus anthracis ET Adenylate cyclase cAMP modulated proteins cAMP production (Leppla, 1982) 
Bacillus anthracis LT Zinc metalloprotease MAP kinase kinases (except MEK5) MAP Kinase signaling 
(Collier & Young, 
2003) 
Photobacterium 
damselae piscicida, 
AIP56 
Zinc metalloprotease NF-B p65 NF- p65 depletion (Silva et al, 2013) 
CNF, cytotoxic necrotizing factor; DT, diphtheria toxin; Stx, Shiga toxin; TeNT, tetanus toxin; BoNT, botulinum neurotoxin; 
CT, cholera toxin; Ptx, pertussis toxin; ET, edema toxin; LT, lethal toxin. (Adapted from Lemichez & Barbieri, 2013). 
 
3. AB toxins 
 
3.1.  Overview 
 
AB toxins can be single proteins or oligomeric proteins complexes organized into 
distinct domains and are characterized by an overall similar structural and functional 
architecture (Figure 1.4). Nevertheless, concerning the molecular organization, the AB 
toxin family includes members with different structural arrangements (Figure 1.4), adapted 
to the specific requirements of the intoxication pathway (Montecucco & Papini, 1995).  
Usually, AB toxins are synthesized and secreted by the pathogen as inactive 
molecules that are activated through proteolytic cleavage performed by either a host (e.g. 
cholera toxin, ricin, clostridial neurotoxins) or a pathogen protease (e.g. Shiga toxin and 
Pseudomonas exotoxin A) at a region between two cysteine residues. In the case of 
diphtheria toxin, it can result from the action of bacterial proteases or occur at the host cell 
surface mediated by a furin or furin-like protease (Gill & Dinius, 1971; Tsuneoka et al, 
1993).  
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Figure 1.4.  Structural organization of AB toxins. AB toxins are composed by two domains, the A domain (A) responsible 
for the catalytic activity and the B domain (B) responsible for binding and delivery of the A domain into cytosol, usually linked 
by a disulfide bond (S-S). In general, proteolytic cleavage (open arrows) of the toxin is required for activity. Such cleavage 
can occurs in the region between the A and B domains, in the A domain or in the B domain (open arrows). 
 
3.2.  Molecular organization 
 
3.2.1. Single polypeptide 
 
In single polypeptide AB toxins, including diphtheria toxin, Pseudomonas aeruginosa 
exotoxin A, tetanus neurotoxin (TeNT) and botulinum neurotoxins (BoNT/A-G), the A and 
B domains are contiguous (Collier, 2001; Turton et al, 2002; Weldon & Pastan, 2011; Wolf 
& Elsasser-Beile, 2009), until proteolytic cleavage. The cleavage results in a di-chain toxin 
molecule with the A moiety and the B moiety linked by a disulfide bond (Ahnert-Hilger et 
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al, 1990; Chaudhary et al, 1990; Collier, 2001; Corboy & Draper, 1997; DasGupta, 1971; 
Fryling et al, 1992; Gill & Dinius, 1971; Krieglstein et al, 1991; Tsuneoka et al, 1993; 
Weller et al, 1989). Upon encountering reducing conditions the catalytic domain is 
released. Whereas most AB toxins secreted as single polypeptides are cleaved by 
proteases of the eukaryotic cell (e.g. furin) or secreted by the pathogen, some have the 
capacity of auto-proteolytic processing (Aktories, 2007; Shen, 2010). These toxins, in 
addition to the characteristic domains of AB toxins, have an autocatalytic/self-cutting 
cysteine protease domain in the N-terminal region responsible for toxin processing. 
Accordingly, it has been proposed that in these toxins the AB model could be extended to 
an ABCD model whereas A represents the biological activity, B the binding, C the cutting 
and D the delivery domain (Jank & Aktories, 2008). Among the ABCD toxins are the 
Clostridium dificille toxin A and B, the hemorrhagic and lethal toxins from Clostridium 
sordelli and the α-toxin from Clostridium novyi (Aktories, 2007; Shen, 2010).  
 
3.2.2. Oligomeric complexes (AB5, A2B5 and AB7/8) 
 
Cholera toxin (Ctx), the closely related heat labile enterotoxins (LT), pertussis toxin 
(Ptx) and Shiga toxin (Stx) are examples of AB5 toxins (Merritt & Hol, 1995). In the case of 
AB5 toxins, discrete genes encode the A and B fragments that assemble as non-covalent 
complexes in which the A fragment (the catalytic domain) rests upon a donut-shaped 
pentamer of B fragments (the receptor-binding domain) (Beddoe et al, 2010). The 
proteolytic cleavage occurs in the A moiety resulting in two fragments, A1 and A2, linked 
by a disulfide bond (Booth et al, 1984; Garred et al, 1995b; Grant et al, 1994; Krueger et 
al, 1991). The A2 domain consists of an α-helix that penetrates into the central pore of the 
pentameric B-domain, tethering the A- and B-domains together through non-covalent 
interactions (Fraser et al, 1994; Sixma et al, 1993a; van den Akker et al, 1996) while the 
A1 domain contains the enzymatic activity and is translocated into cytosol after reduction 
of the disulﬁde linkage.  
Recently, an unprecedented chimeric A2B5 toxin secreted by Salmonella enterica 
serovar Typhi (S. Typhi) has been described and proposed to constitute the founding 
member of the A2B5 organization (Song et al, 2013). This toxin was named typhoid toxin 
and is organized by two covalently linked A domains non-covalently associated to a 
pentameric B domain (Figure 1.4). The A domains, CdtB and PltA, are homologues of the 
A domain of cytolethal distending toxin and pertussis, respectively, and its single B 
domain, PltB, is homologous to one of the components of the hetero-pentameric B domain 
of pertussis toxin. Crystal structure of the chimeric A2B5 toxin showed that, similarly to the 
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B domains of AB5 toxins, the PltB oligomer is arranged as a pentamer but, in contrast to 
AB5 toxins instead of one A domain has two domains (CdtB and PltA). The disulphide 
bound linking the two A domains seems to be essential for the integrity of the holotoxin. 
Furthermore, this ensures that CdtB and PltA are delivered simultaneously to the same 
target cell and upon reduction of the disulphide bond (most likely by reductases of the 
endoplasmic reticulum) PltA and CdtB would be freed from one another allowing them to 
translocate into the cytosol and reach their place of action (Song et al, 2013). 
For AB7/8 toxins, including anthrax toxin (Collier & Young, 2003; Young & Collier, 
2007) and C2 toxin (Aktories & Barth, 2004a; Aktories & Barth, 2004b), different genes 
encode the A and B domains, which are released as separate polypeptides that interact at 
the surface of the host cell. AB7/8 toxins are so termed because its B domain (the receptor-
binding domain) is composed by seven or eight subunits that form a ring-shaped 
heptamer or octamer (Barth et al, 2004). The B domain is activated at cell surface by 
proteolytic cleavage (serum proteases or furin proteases) and assembles into a 
heptameric/octameric complex that recruits the A domain (Blank, 2006; Sun, 2012a). 
Usually the B domain oligomerizes to form a pore that binds with high affinity host cell 
receptors and the enzymatic A subunit, allowing endocytosis of the complex and 
delivering of the A subunit into the cytosol (e.g. C2 toxin (Aktories & Barth, 2004a)) or into 
the lumen of the intraluminal vesicles of endosomal carrier vesicles (e.g. anthrax toxin 
(Abrami et al, 2013; Abrami et al, 2004)). 
 
3.3.  Application of bacterial AB toxins 
 
In agreement with the key role of bacterial toxins in the establishment and 
development of the infections induced by several bacterial pathogens, inactivated toxin-
based vaccines have been successfully used to protect from toxin-induced diseases. 
Accordingly, vaccines based on inactivated bacterial toxins (toxoid vaccines) are routinely 
used to promote antitoxin immunity for the treatment and prevention of bacterial infections 
(Holmgren et al, 2005; Holmgren et al, 1977; Hu et al, 2013; Karczewski et al, 2014; 
Kitchin, 2011; Mortimer, 1978), including vaccines against tetanus, diphtheria and 
pertussis that integrate the obligatory Portuguese immunization program.   
Bacterial protein toxins have provided remarkable insight not only into fundamental 
aspects of host/pathogen interactions but also into basic mechanisms of eukaryotic cells 
such as: receptor endocytosis, vesicular trafficking, translocation through intracellular 
membranes, and regulation and function of cellular targets (Table 2).  
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Moreover, AB toxins have diverse characteristics that make them promising tools for 
diagnosis and treatment of different diseases, including cancer and inflammatory diseases 
(Lemichez & Barbieri, 2013; Odumosu et al, 2010; Sandvig et al, 2010): (i) they can 
interact with the cell machinery of diverse cell types and thus, are useful to treat different 
diseases; (ii) they have very high toxicity, i.e. small amounts are sufficient to intoxicate the 
target cells (Yamaizumi et al, 1978); (iii) they are very stable enzymes, with few inhibitors, 
and can survive temperature extremes and proteolytic degradation, allowing them to 
remain active long enough to display toxicity; (iv) and they are easily produced in E. coli 
(Fitzgerald, 1996; Johannes & Decaudin, 2005). Another important feature is their 
modular structure and corresponding mechanisms of action that make them suitable to 
modifications that can redirect their potent cytotoxicity from disease to a therapeutic 
function. 
 
Table 2. Mechanisms of basic biology revealed by studies of protein toxins. Adapted from Sandvig & van Deurs, 2005. 
Date Mechanism revealed 
1979 Demonstration of the recycling of endocytosed material through studies with plant toxin ricin (Sandvig & 
Olsnes, 1979). 
1980 Studies with diphtheria toxin revealed the direct penetration of a protein across the eukaryotic cell 
membrane in response to low pH (Draper & Simon, 1980; Sandvig & Olsnes, 1980). 
1985-1987 Evidence for clathrin-independent endocytosis through studies with plant toxin ricin (Moya et al, 1985; 
Sandvig et al, 1987). 
1986 Studies with ricin showed that conjugates of a particular ligand (e.g. ricin) with different probes can 
influence the intracellular destiny of the ligand (van Deurs et al, 1986). 
1992 Studies with Shiga toxin revealed a retrograde transport all the way from the cell surface to the Golgi 
apparatus, the ER and the nuclear envelope (Sandvig et al, 1992). 
1999 Studies using a GPI-anchored diphtheria toxin receptor demonstrated that GPI-anchored proteins could be 
endocytosed by clathrin- and caveolin-independent endocytosis (Skretting et al, 1999). 
 
In some circumstances, the toxins are used in their native form. Successful examples 
of the use of holotoxins is the  use of the powerful botulinum neurotoxin type A (BoNT/A) 
in disorders related to muscle hyperactivity, including  eye movement abnormalities, 
cervical and laryngeal dystonia, writer’s cramp, hemifacial spasm, tremors, and tics 
(Averbuch-Heller & Leigh, 1997; Kessler & Benecke, 1997; Wheeler, 1997), and also in 
cosmetic treatments to reduce deep wrinkles caused by the contraction of facial muscles 
(Carter & Seiff, 1997). Another example is Shiga toxin. Shiga toxin binds to the cell 
surface glycosphingolipid Gb3, which is overexpressed in various cancer cells (Distler et 
al, 2009; Johannes & Decaudin, 2005; Kovbasnjuk et al, 2005) leading to the suggestion 
that the toxin could be used in its native form for diagnosis of cancer cells (LaCasse et al, 
1999; LaCasse et al, 1996; Lingwood et al, 1998; Murray et al, 1985; Taga et al, 1995). 
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However, due to the possible toxicity of the holotoxins, in most instances, toxins need to 
be modified for therapeutic proposes. A good example is the use of the catalytic domain of 
toxins, like Pseudomonas exotoxin A (PE) and diphtheria toxin (DT) (Doherty et al, 2006; 
Duvic & Talpur, 2008; Pastan et al, 2006; Pastan et al, 2007; Potala et al, 2008; Shapira & 
Benhar, 2010; Weldon & Pastan, 2011; Wolf & Elsasser-Beile, 2009; Wong et al, 2007) as 
the cell-killing component of immunotoxins (Li et al, 2013). Immunotoxins (IT; Figure 1.5) 
are proteins constructed by replacing the toxin’s natural binding domain by an antibody or 
malignant cell-binding ligand that redirects cell killing activity to malignant cells 
(Brinkmann, 1996; Li et al, 2013). After binding of the antibody to a target cell antigen, the 
IT is internalized, processed and delivered into the cytosol, where it induces cell death 
(FitzGerald et al, 2004; Kreitman, 1999; Kreitman, 2009; Pastan et al, 2007). 
Immunotoxins have been used in treatment of hematologic malignancies and solid tumors 
and have demonstrated potent clinical efficacy (FitzGerald et al, 2004; Johannes & 
Decaudin, 2005; Kreitman, 1999; Kreitman, 2009; Li et al, 2013; Pastan et al, 2007; 
Sandvig et al, 2010; Sandvig & van Deurs, 2000). 
 
 
Figure 1.5. Application of bacterial toxins in therapeutics. Immunotoxins (IT) therapy using the catalytic domain of 
an AB toxin.  IT are composed by a cell recognition (binding) domain that selectively targets malignant cells, which 
concentrates the toxin on the surface of the target cell, usually linked by a disulphide bridge, to the enzyme active and 
translocating domains of a bacterial AB toxin (B domain). The translocation domain enables the toxin to cross a membrane 
to reach the cytosol and the catalytic domain is responsible for cell death. (From Blank, 2006). 
 
Despite their use in immunotoxins, toxins can also be used as tools to induce an 
immune response. In this case, the domain responsible for binding and internalizing of the 
toxin, the B domain, is used as a vector to deliver desired cargos into cell. Indeed, the B 
subunit of Shiga toxin (Haicheur et al, 2003; Haicheur et al, 2000; Lee et al, 1998; 
Sandvig et al, 2010; Sandvig & van Deurs, 2000; Smith et al, 2002), cholera toxin 
(Czerkinsky et al, 1996; Eriksson & Holmgren, 2002; Porgador et al, 1998; Sun et al, 
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1994; Sun et al, 2000), E.coli heat-labile toxin (Loregian et al, 1999; Marcello et al, 1994) 
and Pseudomonas exotoxin A (Donnelly et al, 1993) have been used as vectors to deliver 
antigen epitopes for presentation to MHC I, triggering an immune response (Haicheur et 
al, 2003; Haicheur et al, 2000; Lee et al, 1998; Smith et al, 2002).  
 
 
Figure 1.6. Application of bacterial toxins in therapeutics. The binding domain of an AB toxin (B domain) used as 
vector. The toxin B domains are used to deliver heterologous cargo into target cells. Method used to treat human cancers, 
infectious diseases and autoimmune diseases. (From Blank, 2006). 
 
 
B. Intoxication pathways of bacterial AB toxins 
1. General concepts on endocytosis 
The plasma membrane of a cell is not just a simple physical barrier that separates the 
cytoplasm from the outer world but constitutes one of the most complex components of 
the cell that can defend it against the invasion of microbial pathogens (Sun, 2012a).  
Endocytosis, the internalization of plasma membrane components, extracellular 
ligands and soluble molecules, is a key process in all eukaryotic cells. It has a 
fundamental role in a diversity of cellular processes, ranging from nutrient uptake to 
maintenance of cellular homeostasis, generation of cell polarity, synaptic vesicle recycling, 
regulation of cell-surface expression of signaling receptors, remodeling of the plasma 
membrane, antigen presentation and cell migration (Doherty & McMahon, 2009). To 
efficiently coordinate such processes, endocytic pathways must possess a high variability 
in terms of regulation, specificity for different cargoes, and ultimate destination within cells. 
Indeed it is now evident that there are several mechanisms of endocytosis differentially 
regulated but that may operate in parallel (Doherty & McMahon, 2009; Kumari et al, 
2010). Despite the variety of endocytosis pathways these can be classically divided into 
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clathrin-dependent endocytosis or clathrin-independent endocytosis (Doherty & McMahon, 
2009). 
 
 
Figure 1.7. Different endocytic pathways and small molecules that can inhibit these pathways. Endocytic pathways 
dependent on dynamin can be inhibit by a potent cell-permeable inhibitor of dynamin (dynasore) (Kirchhausen et al, 2008; 
Macia et al, 2006); clathrin-mediated  endocytosis can be inhibit by preventing  the   uncoating   of   clathrin   (Pitstop)  
(Harper et al, 2013) or by altering the distribution of clathrin and AP-2 preventing formation of clathrin-coated pits at the 
plasma membrane  (chlorpromazine) (Wang et al, 1993). Actin filaments are involved in formation of plasma membrane 
ruffles important for macropinocytosis, therefore macropinocytosis can be inhibited by break-down of actin filaments 
(cytochalasin D – cyto D) (Ohmori & Toyama, 1992; Sampath & Pollard, 1991). (From Harper et al, 2013). 
 
1.1.  Clathrin-dependent endocytosis 
The most well-characterized endocytic pathway is the clathrin-mediated endocytosis. 
Because, in many cell types, it is the major pathway for receptor-dependent endocytosis it 
was incorrectly used for several years as synonymous of receptor-mediated endocytosis. 
This mechanism of endocytosis is dependent on adaptor proteins and proceeds through a 
series of well-defined morphological alterations and intermediates (McMahon & Boucrot, 
2011). It involves cargo recognition by a specific receptor at the plasma membrane and 
coat assembly, followed by concentration in clathrin-coated pits that undergo progressive 
invagination and after scission form clathrin-coated vesicles (Roth & Porter, 1964; Schmid 
& McMahon, 2007). During this process, soluble clathrin is recruited from the cytoplasm to 
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the plasma membrane and the clathrin triskelia assemble into a polygonal lattice at the 
plasma membrane to form coated pits (Bonifacino & Lippincott-Schwartz, 2003; 
Kirchhausen, 2000). Clathrin interacts in a coordinated fashion with a diversity of adaptor 
and accessory proteins that coordinate clathrin polymerization into curved lattices 
stabilizing the deformation of the attached membrane (Doherty & McMahon, 2009; Ehrlich 
et al, 2004; Kirchhausen, 1999; Schmid et al, 2006). Clathrin-coat nucleation at plasma 
membrane and stabilization of the clathrin-coated pit requires cargo acquisition via 
subunits of adaptor protein 2 (AP2) and of various AP2-binding partners (Edeling et al, 
2006; Kelly et al, 2008). The process of invagination is promoted by BAR  (Bin 
Amphiphysin  Rvs)  domain-containing  proteins, such  as  endophilin  and  amphiphysin,  
and  is  further  facilitated  by  epsin (e.g. Eps15) (Abrami et al, 2003) and  inherent 
curvature properties of assembled clathrin structures (Doherty & McMahon, 2009). Finally, 
the pinching off of the endocytic vesicles from the plasma membrane, that irreversibly 
releases the clathrin-coated vesicle into the interior of the cell, is promoted by the large 
GTPase dynamin (Baba et al, 1995; Bashkirov et al, 2008; Damke et al, 1994; Praefcke & 
McMahon, 2004; Pucadyil & Schmid, 2008; Roux & Antonny, 2008; Schmid et al, 1998; 
Sever et al, 2000). After released into cell, clathrin-coated vesicles are uncoated and fuse 
with early endosomes.  
 
1.2.  Clathrin-independent endocytosis 
Clathrin-independent endocytosis is less characterized but equally important. During 
several years it has been thought that clathrin-dependent endocytosis was the only 
existing endocytic mechanism. Interestingly the first description on the existence of non-
clathrin dependent endocytosis was through pioneering studies on cellular uptake of AB 
toxins (Moya et al, 1985; Sandvig & Moskaug, 1987; Sandvig et al, 2008; Sandvig & van 
Deurs, 1990). Nowadays it is clear that a cell can have several endocytic mechanisms 
that are independent on clathrin. In contrast to clathrin-dependent endocytosis, these 
mechanisms of endocytosis do not use known coat complexes for cargo recruitment and 
budding of transport intermediates. Instead they might exploit the constituents of the 
plasma membrane to their own benefit (Hansen & Nichols, 2009; Le Roy & Wrana, 2005; 
Mayor & Pagano, 2007; Nichols & Lippincott-Schwartz, 2001; Sandvig et al, 2011; 
Sandvig et al, 2008). 
Clathrin-independent endocytic pathways are responsible for internalization of either 
large particles or small solutes and includes phagocytosis, caveolae-mediated uptake, 
macropinocytosis and constitutive non-clathrin uptake. Phagocytosis, usually restricted to 
phagocytes, is the process involved in uptake of large particles that typically occurs after a 
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phagocytic stimulus (Flannagan et al, 2012). The non-clathrin pathways underlying the 
uptake of smaller cargoes include caveolae, macropinosomes or a little-understood 
constitutive process of plasma membrane internalization such as CLIC/GEEC-type 
(clathrin-independent carriers/GPI-enriched early endosomal compartments) endocytosis 
(Kirkham & Parton, 2005; Mayor & Pagano, 2007), the putative flotillin-associated 
endocytic structures (Frick et al, 2007), circular dorsal ruffles (Orth & McNiven, 2006), and 
entosis (Overholtzer et al, 2007). It is known that a diverse array of molecular machinery 
is involved in these pathways, including dynamin and actin (Damke et al, 1994; Lamaze et 
al, 2001; Pelkmans et al, 2002; Tse et al, 2003), however questions about the 
organization of markers for non-clathrin pathways within the plasma membrane and how 
interactions with ligands and the cellular matrix can modulate these endocytic pathways 
are still not clear. 
So far, the most commonly reported and understood non clathrin-coated plasma 
membrane buds are known as caveolae (for “little caves”) (Doherty & McMahon, 2009). 
Caveolae are small invaginated plasma membrane domains, with a defined and 
characteristic flask-shaped morphology (Stan, 2002), enriched in cholesterol and 
glycosphingolypids (Hailstones et al, 1998; Parton et al, 1994; Parton & Simons, 2007; 
Pelkmans et al, 2001; Rodal et al, 1999; Rothberg et al, 1990), exclusively taking place at 
microdomains of the plasma membrane denoted as lipid rafts (Nabi & Le, 2003). They are 
characterized by the abundant presence of the integral membrane protein caveolin 1 
responsible for caveolar biogenesis (Rothberg et al, 1992). Cargoes internalized by 
caveolae are delivered to neutral pH caveosomes (Nichols, 2003; Pelkmans & Helenius, 
2002). 
 
2. Endocytosis of AB toxins 
The first barrier encountered by bacterial AB toxins on host cells is the plasma 
membrane and to overcome this barrier they exploit mechanisms of endocytosis as 
portals of entry into host cells. The cells have not developed specific receptors for toxins 
and therefore these act as opportunistic ligands by using existing receptors, which can be 
proteins, glycoproteins, glycolipids or another compound, but in a lipid environment 
(Blank, 2006; Geny & Popoff, 2006). In the entry process of an AB toxin, the B domain 
recognizes one or more plasma membrane receptors and assists the movement of the A 
domain across the membrane. Cells lacking specific receptors are generally resistant to 
intoxication (Blank, 2006) highlighting the relevance of toxin-receptor complexes in the 
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intoxication process. If, or how, different receptors/endocytosis regulate sorting of the 
toxins into defined intracellular pathways is still not clear.  
Bacterial AB toxins can exploit different endocytotic mechanisms and can use 
exclusively one or more than one endocytic pathway to enter the cells. While diphtheria 
toxin, clostridial glucosylating toxins (CGTs) and anthrax toxin are thought to 
predominantly use clathrin-dependent endocytosis mechanisms, other toxins, including 
Shiga, cholera and tetanus toxins enter cells by one of several alternative clathrin-
independent endocytic pathways. In the case of Shiga and cholera toxins it seems that 
endocytosis can occur either through clathrin-dependent or independent pathways.  
Diphtheria toxin binds to a transmembrane protein that serves as precursor for 
heparin-binding epidermal growth factor (HB-EGF) (Collier, 2001; Naglich et al, 1992) and 
is internalized, in different cell types, via clathrin-mediated endocytosis (Lemichez et al, 
1997; Skretting et al, 1999) dependent on clathrin adaptor protein 2 (AP2) but 
independent on actin (Abrami et al, 2010). Accordingly, treatments that remove the 
clathrin-coated pits (Moya et al, 1985) and pharmacological inhibition of dynamin 
(Papatheodorou et al, 2010) or expression of a dominant-negative mutant dynamin K44A, 
protect against diphtheria toxin (Simpson et al, 1998). CGTs are internalized by receptor 
mediated endocytosis, although far less is known about the specific binding structures for 
most clostridial glucosyltransferases. Nevertheless, it is known that this toxin family is 
internalized by a dynamin dependent mechanism governed by clathrin (Kushnaryov & 
Sedmak, 1989; Papatheodorou et al, 2010).  
In the case of anthrax toxin the process of endocytosis is more complex. Anthrax 
toxin is a tripartite toxin composed by two enzymatic subunits, the calmodulin-dependent 
adenylate cyclase edema factor (EF), and the zinc-dependent metalloprotease lethal 
factor (LF), which require the third subunit, the protective antigen (PA), to interact with 
cells. PA is an 83 kDa protein, organized into four domains, essentially composed of 
hydrophilic β-strands, that binds to cells via one of two receptors: tumor endothelial 
marker 8 (TEM8, also called ANTXR1) and capillary morphogenesis 2 (CMG2, also called 
ANTXR2) (Abrami et al, 2005; Scobie & Young, 2005; van der Goot & Young, 2009; 
Young & Collier, 2007). A coreceptor, the cell surface protein lipoprotein-receptor-related 
protein 6 (LRP6), seems to be also involved in PA-binding as well as toxin internalization 
(Wei et al, 2006; Young & Collier, 2007). After binding to its receptor (Figure 1.8), PA is 
proteolytically activated (Singh et al, 1989) by members of the furin family of 
transmembrane proteases, which cleave the 20kDa N-terminal domain of PA83 (Collier & 
Young, 2003; Klimpel et al, 1992). The resulting PA monomers (63 kDa, PA63) self-
associates into a heptameric (PA7mer) ring-like structure and form a pre-pore structure 
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(Abrami et al, 2000; Lacy et al, 2004; Nassi et al, 2002; Petosa et al, 1997) capable of 
binding a combination of three molecules of EF and/or LF (Mogridge et al, 2002; Pimental 
et al, 2004), via homologous N-terminal domains (Bragg & Robertson, 1989; Quinn et al, 
1991). The heptamerization of PA is promoted by its concentration in lipid rafts domains at 
cell membrane and is accelerated by the presence of EF and/or LF (Abrami et al, 2005; 
Wigelsworth et al, 2004). Following lipid-raft association (a pre-requisite for efficient 
endocytosis) (Abrami et al, 2003; van der Goot & Young, 2009), endocytosis of the 
anthrax toxin-receptor complexes occurs through a mechanism that requires clathrin and 
the large GTPase dynamin (Abrami et al, 2003; Boll et al, 2004), but not the caveolar 
proteins caveolin-1 (Abrami et al, 2003). Nevertheless, anthrax endocytosis occurs via a 
non-canonical clathrin-dependent route that depends on β-arrestins and the 
heterotetrameric adaptor complex AP-1 but not on the more conventional adaptor 
complex AP-2. In contrast to diphtheria toxin, anthrax endocytosis is strongly actin 
dependent (Abrami et al, 2010).  
 
 
 
Figure 1.8. Schematic representation of anthrax toxin endocytosis. As represented in the figure, TEM8-1 is pre-
organized at the cell surface by the cortical actin cytoskeleton while CMG2 is not. After binding to cell surface receptor, 
PA83 is cleaved by furin originating PA63. PA63 heptamerizes forming a pre-pore complex that can bind LF and/or EF and 
trigger raft association of the toxin–receptor complex which facilitates the interaction with partner proteins. Within rafts, β-
arrestin mediates the recruitment of cellular E3 ligase Cbl that ubiquitinates a conserved receptor lysine residue (Lys352 in 
TEM8-1 and Lys350 in CMG2) (Abrami et al, 2006; Young & Collier, 2007), modifies the cytoplasmic tails of the receptor, 
thus allowing the interaction with proteins of the endocytic machinery harboring Ub-interacting domains. The clathrin-
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dependent endocytic machinery is thus recruited, the heterotetrameric adaptor AP-1 and finally clathrin, and the toxin–
receptor complex is internalized in clathrin-coated pits (CCP). The pinch off of the CCP-containing toxin requires both actin 
and dynamin. (From Abrami et al, 2010). 
Shiga toxin binds to the neutral glycosphingolipid Gb3 by a quite complex mechanism 
(Sandvig et al, 2009; Windschiegl et al, 2009) and can be then endocytosed by different 
pathways (Khine & Lingwood, 1994; Lingwood, 1999; Nichols & Lippincott-Schwartz, 
2001; Sandvig et al, 2009; Sandvig et al, 2002; Sandvig & van Deurs, 2000). The 
composition of the Shiga receptor, the Gb3 species, are thought to be essential for sorting 
of the toxin (Bergan et al, 2012; Lingwood et al, 2010; Sandvig et al, 2013). Different 
evidences point to a clathrin-dependent endocytosis: shortly after incubation at 37ºC the 
toxin-receptor complex has been found in clathrin-coated pits (Sandvig et al, 1989) and 
conditions that interfere with clathrin-dependent endocytosis (Sandvig et al, 2002; Sandvig 
& van Deurs, 1996; Nichols et al, 2001; Lauvrak et al, 2004) have been shown to inhibit 
Shiga toxicity and uptake. However, there is a large variability in the sensitivity of cells to 
Shiga toxin that corroborates the hypothesis that a certain fraction might be endocytosed 
by other pathways as well. According to this, when clathrin expression was down-
modulated the toxin still entered cells efficiently (Lauvrak et al, 2004; Saint-Pol et al, 
2004). Also, Shiga toxin has the ability to induce tubular structures at the plasma 
membrane, originated from caveolae and dependent on plasma membrane cholesterol, 
actin and dynamin for pinching off, that can contribute for a minor part of the toxin that is 
endocytosed (Hansen et al, 2009; Romer et al, 2007).  
Cholera toxin B domain binds to the glycosphingolipid GM1 receptor found in 
membrane microdomains on the plasma membrane, named lipid rafts (Fujinaga et al, 
2003). Each B domain monomer has a binding site for GM1, making it able to bind up to 
five GM1 molecules at once. After receptor binding, the toxin can enter the cell by several 
endocytic mechanisms including clathrin-dependent and independent pathways. Amongst 
the clathrin-independent pathways cholera toxin can take advantage of lipid  raft/caveolae  
mediated  endocytic pathway, ADP-ribosylation  factor  6  (Arf6)-associated endocytic 
pathway, as well as caveolae and dynamin-independent pathways (Bharati & Ganguly, 
2011; Hansen et al, 2005; Massol et al, 2004; Orlandi & Fishman, 1998; Torgersen et al, 
2001; Wernick et al, 2010). However, it is not clear whether all the different types of 
uptake mediate Golgi transport and cholera toxicity. 
As discussed above, bacterial toxins can take advantage of several existing receptors 
and endocytic mechanisms to be internalized and arrive to their target to exert toxicity.  
 
3. Intracellular intoxication pathways 
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Independently on how bacterial toxins are endocytosed, they generally first end up in 
early endosomes (Gould & Lippincott-Schwartz, 2009; Jovic et al, 2010), a complex 
compartment composed by a mosaic of proteins and lipid domains and with tubular and 
multivesicular elements (Huotari & Helenius, 2011).  
Usually, upon endocytosis bacterial AB toxins follow one of the two classical 
intracellular trafficking pathways (Figure 1.9) for traveling to translocation portals where 
they cross the membrane barrier into cytosol. With exception of Pseudomonas exotoxin A, 
which can take advantage of the two intracellular routes to arrive into cytosol (Box 1), AB 
toxins can either translocate from endosomes in response to low pH or take the long way 
round and traffic all the way to the Golgi apparatus and the endoplasmic reticulum (ER) 
from where translocation into cytosol occurs (Blank, 2006; Sandvig & van Deurs, 2005; 
Watson & Spooner, 2006).  
 
 
Figure 1.9. Classical intracellular trafficking routes of AB toxins. AB toxins bind to host cell receptors through their B 
domains and are endocytosed. The A domain can be translocated from endosomes to cytosol in response to low pH (a) or 
can travel retrogradely to the ER before reaching the cytosol (b). (From Falnes & Sandvig, 2000). 
 
3.1.  Endosomal pathway (short journey) 
Several toxins, including diphtheria toxin (Moskaug et al, 1988; Olsnes et al, 1990), 
clostridial neurotoxins (Turton et al, 2002), the large clostridial toxins (Jank & Aktories, 
2008; Pruitt & Lacy, 2012), anthrax toxin (Young & Collier, 2007) and C2 toxin (Barth, 
2004; Barth et al, 2000; Blocker et al, 2003b) take the endosomal pathway, also referred 
as short journey, taking advantage of the acidic endosomal pH (resulting from the activity 
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of the vacuolar ATPase proton pump) to translocate the A domain into the cytosol. 
Because they take the short journey to arrive into their target are commonly named “short-
trip” toxins.  
Basically, after receptor mediated endocytosis, “short-trip” toxins are embedded in 
endocytic vesicles that fuse with endosomes from where translocation of the A domain 
takes place through a pH dependent mechanism. In the case of diphtheria toxin 
(Montecucco et al, 1985; Sandvig & Olsnes, 1980; Sandvig & Olsnes, 1981), anthrax toxin 
(Milne & Collier, 1993), CNF1 (Falnes & Sandvig, 2000), Costridium difficile toxin B 
(Qa'Dan et al, 2000) and clostridial neurotoxins (Blocker et al, 2003b; Puhar et al, 2004), 
among others, acidic endosomal pH triggers a proteolytic processing and/or 
conformational change that results on partial unfolding of the protein with exposure of 
hydrophobic areas. Then, the translocation region of the B domain interacts with the 
endosomal membrane, forms a cation-selective pore and mediates the translocation of 
the A domain into cytosol. Consistent with this, most of the toxins that translocate from 
endosomes share the property of forming ion channels in lipid bilayers at low pH 
(Bachmeyer et al, 2001; Bann, 2012; Blaustein et al, 1987; Blocker et al, 2003b; Chenal et 
al, 2002; Galloux et al, 2008; Genisyuerek et al, 2011; Giesemann et al, 2006; Hoch et al, 
1985; Qa'Dan et al, 2000; Shone et al, 1987; Silverman et al, 1994b), both in artificial 
membranes (Barth et al, 2001; Donovan et al, 1981; Finkelstein, 1994; Kagan et al, 1981; 
Lang et al, 2008; Schmid et al, 1994) and living cells (Barth et al, 2001; Blocker et al, 
2003b; Li & Shi, 2006; Madshus et al, 1994; Milne & Collier, 1993; Olsnes et al, 1990; 
Papini et al, 1988; Sandvig & Olsnes, 1988). Another characteristic of toxins that 
translocate from endosomes in response to low pH, is that surface-bound toxin can 
directly translocate from the plasma membrane by exposing cells to low pH, mimicking 
what occurs at endosomes (Draper & Simon, 1980; Sandvig & Olsnes, 1980; Sandvig & 
van Deurs, 2005). Consistent with this, inhibitors that interfere with endosome acidification 
(Figure 1.10) can inhibit translocation of several “short-trip” toxins (Friedlander, 1986; 
Kaiser et al, 2011; Kim & Groman, 1965; Leppla et al, 1980; Menard et al, 1996; Sandvig 
& Olsnes, 1980; Sandvig et al, 1984; Umata et al, 1990; Williamson & Neale, 1994). 
During the translocation process or after reaching the cytosol, the disulfide bond linking 
the A and B domain is reduced (Papini et al, 1993) and the A domain is released into the 
cytosol leaving the B subunit behind. Once in the cytosol, usually with participation of 
cytosolic factors, the A domain refolds and renatures into a catalytically active enzyme. 
The translocation of “short-trip” toxins into cytosol can occur either from early or 
late endosomes. To illustrate this variety, an example of a toxin that translocates from 
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early endosomes, diphtheria toxin, and of a toxin that translocates from late endosomes, 
anthrax toxin, is detailed below.  
 
Figure 1.10. Compounds that inhibit endosome acidification. Bafilomycin A1 and concanamycin A are highly specific V-
ATPases inhibitors which bind to the c-subunit of the membrane V0 complex, blocking proton pump (Drose et al, 1993; 
Huotari & Helenius, 2011; Huss & Wieczorek, 2009; Toei et al, 2010); chloroquine is a weak base that in its unprotonated 
form is permeable, but after accumulation in acidic organelles it traps protons and becomes membrane impermeable 
resulting in a subsequent increase of the pH (Ohkuma & Poole, 1978); nigericin and monensin are acidic ionophores that 
exchange protons for potassium ions (Ohkuma & Poole, 1978). 
 
3.1.1. Diphtheria toxin 
Diphtheria toxin (DT) is the best characterized example of a “short-trip” toxin that 
translocates from early endosomes. As described earlier, DT is composed by three 
functional and structural regions: an N-terminal enzymatic domain, corresponding to the A 
domain; a transmembrane/translocation domain in the middle, involved in translocation of 
the catalytic domain into cytosol, and a C-terminal receptor-binding domain, both 
comprising the B domain. The A and B domain are linked by a disulfide bridge with a furin-
sensitive loop which nicking and reducing is a prerequisite for toxicity (Collier, 1975; 
Collier, 2001; Papini et al, 1993).   
After binding to the cell surface receptor by its C-terminal domain, DT is 
endocytosed by a clathrin dependent mechanism and transported to early endosomes 
where the translocation of the catalytic domain into the cytosol occurs (Lemichez et al, 
1997). Toxin that does not translocate follows the degradative pathway to lysosomes 
where degradation takes place (Geny & Popoff, 2006; Lemichez et al, 1997) (Figure 1.11). 
The endosomal acidic pH plays a crucial role in DT toxicity. Indeed, under endosomal 
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acidic conditions DT undergoes a dynamic unfolding (Boquet et al, 1976; Ladokhin, 2013; 
Leka et al, 2014; Murphy, 2011) that leads to insertion of the B domain into the membrane 
and formation of a transmembrane ion channel (Donovan et al, 1981; Falnes & Sandvig, 
2000; Kagan et al, 1981; Olsnes et al, 1990; Papini et al, 1988; Sandvig & Olsnes, 1988; 
Silverman et al, 1994a), which is an essential prerequisite step for the translocation of DT 
catalytic domain (Murphy, 2011). The use of v-ATPase inhibitors confirmed that pore 
forming activity was associated with the action of the v-ATPase pump in the endosomal 
vesicle membrane (Bowman et al, 1988; Murphy, 2011). 
 
 
 
Figure 1.11. Intracellular trafficking of diphtheria toxin (DT). After receptor-mediated endocytosis in clathrin coated-
vesicles (1), DT reaches early endosomes (2), from where the catalytic A domain (DTA) is translocated through a pH-
dependent mechanism. Translocation can be inhibited by the V-ATPase proton pump inhibitor bafilomycin A1 (Baf A1) (3). 
The remaining protein follows the degradative pathway to lysosomes, where degradation of the toxin occurs, in a 
microtubule dependent way that can be inhibited by nocodazole (a compound that disrupts microtubules) (4) (5). During the 
course to the degradative destination some DTA can also be translocated from intermediates between early and late 
endosomes, the ECV (4). (From Lemichez et al, 1997). 
 
In what concerns the translocation process, two different hypotheses came out. In 
vitro studies, using artificial lipid membranes in the absence of other proteins 
(Hayashibara & London, 2005; Murphy, 2011; Oh et al, 1999; Ren et al, 1999), led to a 
model in which delivery of the A-domain is achieved through  the  chaperone-like  activity  
of  the translocation domain (T-domain) where it would act as a transmembrane 
chaperone that forms a pore and binds to the hydrophobic A chain surface maintaining it 
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in an unfolded state during translocation (Chenal et al, 2002; Hammond et al, 2002; 
Ladokhin et al, 2004; Ren et al, 1999). Later, the crystal structure of DT (Choe et al, 1992) 
allowed analyzing in more detail the functional activity of each DT domain and the re-
interpretation of earlier findings. Among other evidences, studies based in the 
translocation domain have shown that while pore formed by the two strongly hydrophobic 
TH8-TH9 α-helices is important for the catalytic domain delivery into cytosol, it is not in 
itself sufficient (Cabiaux et al, 1993; Cabiaux et al, 1994; Hu et al, 1998; Mindell et al, 
1994; O'Keefe et al, 1992; Silverman et al, 1994b; vanderSpek et al, 1994). Later on, it 
was demonstrated that transmembrane helix 1 (TH1) of the T-domain possesses a 
potential entry motif, designated T1 (Murphy, 2011; Ratts et al, 2005), and that KXKXX 
COPI complex binding motifs in TH1 are essential for catalytic domain delivery to the 
cytosol (Madshus, 1994; Ratts et al, 2005; Trujillo et al, 2010). Additionally, some host cell 
factors (Lemichez et al, 1997; Ratts et al, 2003), like β-COP from the COPI complex 
(Cabiaux et al, 1993) along with ATP (Sandvig & Olsnes, 1982) have been suggested to 
be involved in the translocation process.  
 
 
Figure 1.12. Translocation mechanism of diphtheria toxin (DT). (Adapted from Geny & Popoff, 2006). 
 
It is now evident that the mechanism of DT translocation into cell cytosol is 
facilitated by target cell proteins, all acting in a systematic and ordered fashion in the 
delivery process. So a current accepted hypothesis for DT catalytic A domain (DTA) 
translocation (Figure 1.12) proposes that: once in the early endosome, DT undergoes pH-
induced conformational changes that result in the exposure of buried hydrophobic regions 
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that will facilitate the interaction with the hydrophobic membrane. The transmembrane α–
helices, TH8-TH9 and TH5-TH7,  from the translocation domain, insert into the endosomal  
vesicle  membrane  resulting  in  the  formation  of  a transmembrane  pore. Membrane 
lipids seem to play a role in the T-domain structural change that allow the insertion of such 
helices into the membrane (Ladokhin, 2013). KXKXX motifs of TH1 emerge on the 
cytosolic side of the vesicle membrane, COPI complex binds to these sequences and 
facilitate the translocation of the unfolded catalytic A domain. During the translocation 
process, the interchain disulfide bridge is reduced, possibly by cytoplasmic thioredoxin 
reductase, and the catalytic A domain is released in the cytosol. At neutral cytosolic pH 
with the help of the cytoplasmic chaperone heat-shock protein 90 (Hsp90) (and possibly 
Hsc70) the catalytic A domain refolds generating its ADP-ribosyltransferase active form. 
Finally the catalytic A domain catalyzes the NAD+-dependent ADP-ribosylation of 
elongation factor 2 (EF2) and inhibits cellular protein synthesis (Collier, 1967) that 
culminates in cell death by apoptosis (Kochi & Collier, 1993; Murphy, 2011). 
 
3.1.2. Anthrax toxin 
The entry of anthrax toxin into the cell cytosol is a little bit more complex than that 
of DT. As previously mentioned (Section 2), anthrax toxin is a tripartite toxin composed by 
two enzymatic subunits, the calmodulin-dependent adenylate cyclase edema factor (EF), 
and the zinc-dependent metalloprotease lethal factor (LF), which require the third subunit, 
the protective antigen (PA), to interact with cells. The receptor-anthrax toxin complex is 
endocytosed within a lipid raft environment into clathrin-coated vesicles (Abrami et al, 
2010; Abrami et al, 2006; Abrami et al, 2003; Boll et al, 2004), migrates to the intraluminal 
vesicles and from there to late endosomes. As occurs with DT, several evidences indicate 
that low endosomal pH plays a crucial role in the translocation process of anthrax toxin 
(Abrami et al, 2005; Kochi et al, 1994; Puhar & Montecucco, 2007; Wang et al, 1996; 
Wang et al, 1997; Wigelsworth et al, 2004; Young & Collier, 2007): at low pH, PA 
dissociates from the receptor and pre-pore suffers conformational changes leading to its 
insertion into the membrane and formation of a functional pore; acidic pH, also triggers 
conformational changes on EF and LF that result in partial unfolding of these subunits with 
exposure of hydrophobic regions that allow their translocation through the PA pore; 
compounds that inhibit endosome acidification also inhibit EF and LF translocation 
(Friedlander, 1986; Guidi-Rontani et al, 2000). In what concerns the compartment from 
where translocation occurs, available data are contradictory. While some evidences point 
to the hypothesis that part of the toxin can translocate from early endosomes (Dal Molin et 
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al, 2006), many evidences corroborate the hypothesis that translocation of EF and LF 
occurs from late endosomes (Abrami et al, 2004; Abrami et al, 2005). It  seems  that  the  
two  enzymatic  domains  of  anthrax  toxin  can exit  from endosomal compartments at 
various stages of the endocytic route, depending on the specific receptor to which PA is 
bound (Rainey et al, 2005), more likely and preferentially from late endosomes after 
multivesicular bodies (MVB) back-fusion (Abrami et al, 2004; Abrami et al, 2005; Puhar & 
Montecucco, 2007; Thoren & Krantz, 2011). Consistent with this, toxin delivery is inhibited 
by: (i) disruption of late endosomes function through expression of a dominant-negative 
form of Rab5; (ii) a lysophosphatidic acid (LBPA)-specific antibody that inhibit formation of 
late endosomes; (iii) knocking-down ALIX, a protein involved in multivesicular body 
biogenesis; (iv) the microtubule depolymerizing drug nocodazole (Abrami et al, 2004; 
Young & Collier, 2007). Based on these data, Abrami and colleagues (Abrami et al, 2004; 
Abrami et al, 2005) proposed a model for anthrax catalytic domains translocation (Figure 
1.13) where they defend that although the pore formation occurs preferentially in the 
intraluminal vesicles, the translocation of EF and LF occurs mainly from late endosomes. 
According to this model, upon endocytosis, the toxin-receptor complex is delivered to 
early endosomes. Once in the early endosomes, the low pH triggers the membrane 
insertion of PA and the partial unfolding of EF and LF. PA inserts into the membrane of 
intraluminal vesicles rather than the limiting membrane of early endosomes forming a pore 
through a mechanism possibly regulated by the toxin-receptor complex and that helps to 
maintain the membrane integrity of endosomes. Instead of translocation into cytosol, in 
this case EF and/or LF translocate into the lumen of the intraluminal vesicles (topological 
equivalent to the cytoplasm (Gruenberg & Stenmark, 2004; Murk et al, 2003; van der Goot 
& Gruenberg, 2006)) where refolding takes place (Abrami et al, 2004). Translocation 
through the PA pore is driven by a proton gradient (Krantz et al, 2006) with PA pore 
playing a crucial role by blocking protons passage, and thus maintaining the pH gradient 
that drives translocation (Collier, 2009; Krantz et al, 2005). Additionally, cofactors from the 
host cell seem to also play a role in the translocation process. Similarly to DT, LF has T1-
like motifs with multiple coatomer I complex binding motifs that require COPI complex for 
efficient translocation (Tamayo et al, 2008). Furthermore, the cytoplasmic chaperone 
heat-shock protein 90 and cyclophilin have been shown to play a role in the cytosolic 
delivery of the anthrax related fusion protein LFnDTA (Dmochewitz et al, 2010). After 
translocation, EF and/or LF are packaged into endosomal carrier vesicles (ECV) and 
transported to late endosomes. Finally, intraluminal vesicles undergo back-fusion with the 
limiting membrane of late endosomes and EF and LF translocate into the cytosol. While 
LF is fully translocated to the cytosol in the perinuclear region, EF translocation is only 
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partial once it remains bound to a membrane fraction of the endosome (Guidi-Rontani et 
al, 2000; Zornetta et al, 2010). EF is biologically active in its membrane-bound form (Dal 
Molin et al, 2006; Guidi-Rontani et al, 2000), only requiring the exposure of its ATP and 
calmodulin binding domains to the cytosol (Labruyere et al, 1990; Ladant et al, 1989).  
It is noteworthy that by being isolated in the lumen of intraluminal vesicles, EF and 
LF are protected from proteases and degradation in contrast to PA that is degraded. 
Recently, Abrami and colleagues (Abrami et al, 2013) showed that a major advantage of 
this delivery route is the protection/preservation of the toxin for a long time (up to a week) 
allowing it to be exocytosed and infect naïve cells. 
 
 
 
Figure 1.13. Intracellular trafficking of anthrax toxin. (Adapted from Young & Collier, 2007). 
 
3.2.  Retrograde pathway (the long journey) 
After endocytosis, endosomes are an obligatory through station for AB toxins. 
However, while toxins like diphtheria toxin, anthrax, clostridial neurotoxins, among others, 
translocate from endosomes in a pH-dependent manner, others, such as Shiga and 
cholera toxins do not depend on endosomal acidic pH for intoxication of cells. Rather, 
after endocytosis, they escape the lysosomal degradative pathway by being transported, 
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either from early or recycling endosomes, to the trans-Golgi network (TGN) and from the 
Golgi retrogradely to the endoplasmic reticulum (ER). In the ER the catalytic A domain is 
liberated from the holotoxin by reduction of the disulfide bond and translocated to the 
cytosol (Geny & Popoff, 2006; Sandvig et al, 2013; Sandvig & van Deurs, 2005).  
The ER is where folding and assembly of secretory and transmembrane proteins 
occur assisted by numerous molecular chaperones, principally calnexin/calreticulin and 
BiP/Grp94 (Gregers et al, 2013). To maintain ER homeostasis, misfolded proteins have to 
be degraded. This is achieved by retro-translocation through the Sec61 translocon to the 
cytosol for ubiquitinylation and degradation by the proteasome – the ER associated 
degradation (ERAD). It is believed that protein toxins that follow the retrograde pathway 
disguise themselves as misfolded proteins and take advantage of this cellular system to 
arrive into the cytosol (Bergan et al, 2012; Bharati & Ganguly, 2011; Blank, 2006; Cho et 
al, 2012; Gregers et al, 2013; Hazes & Read, 1997; Sandvig et al, 2009; Sandvig et al, 
1993; Sandvig et al, 2002; Sandvig et al, 2013; Sandvig et al, 2004; Sandvig et al, 2010; 
Sandvig & van Deurs, 2005; Sokolowska et al, 2011; Spooner & Lord, 2012). Once in the 
cytosol, in contrast to ER substrates destined for proteasomal destruction, these toxins 
escape degradation, undergo folding to a catalytic conformation and inactivate their 
cytosolic targets (Johannes & Romer, 2010). Most of them inhibit protein synthesis in an 
enzymatic manner (May et al, 2013) with the exception of cholera toxin which increases 
the level of cAMP by ADP-ribosylation of adenylate cyclase (Spangler, 1992).  
Similarly to the toxins that translocate from endosomes, some of the bacterial 
toxins retrogradely transported need to be proteolytically cleaved and activated by furin 
(Garred et al, 1995b; Sandvig et al, 2013). Because furin is expressed in most cells and 
tissues (Halban & Irminger, 1994) and seems to be localized primarily in the trans-Golgi 
network (TGN) (Bosshart et al, 1994; Molloy et al, 1994) but cycles between TGN, 
endosomes and cell surface (Bosshart et al, 1994; Klimpel et al, 1992; Tsuneoka et al, 
1993), furin-cleavage can occur either at the plasma membrane, in the endosomes or in 
the Golgi apparatus (Bonifacino & Rojas, 2006; Mallet & Maxfield, 1999).  
The translocation from ER is common to all retro-translocated toxins but the exact 
mechanism of arriving into ER and translocation seems to be cell-type and toxin 
dependent. In fact, retrograde transport of toxins through the Golgi to the ER can occur by 
more than one mechanism. To illustrate this variability, a detailed description of cholera 
and Shiga toxin retrograde pathway is provided below. 
 
3.2.1. Cholera toxin 
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Cholera toxin (CT) is an example of a bacterial toxin that travels retrogradely 
(Sandvig et al, 1996) and translocates from ER into the cytosol. CT binds to the 
ganglioside GM1 at the plasma membrane via its B-domain, is endocytosed and travels 
from early or recycling endosomes through the trans-Golgi network (TGN) into the ER 
(Cho et al, 2012; Lencer & Saslowsky, 2005; Wernick et al, 2010), in a pathway regulated 
by a combination of cellular lipid (Chinnapen et al, 2012; Glebov et al, 2006; Wolf et al, 
2002) and protein components (Badizadegan et al, 2004; Geiger et al, 2013; Saslowsky et 
al, 2010). An alternative pathway where CT could be directly sorted from early endosomes 
to ER without intersecting the TGN has also been described (Saslowsky et al, 2010).  
The Golgi complex has a central position in the secretory pathway playing a crucial 
role in the regulation of cargo transport from the ER to the Golgi complex (anterograde 
pathway) and also from the Golgi into the ER (retrograde pathway) (Cancino et al, 2013; 
Cancino & Luini, 2013). A key player in this Golgi control system is the KDEL receptor. 
Usually, cargos carry components that can be then sensed by the KDEL receptor 
(KDELR) in the Golgi complex that results in the activation of this receptor and initiates 
signalling pathways that can activate anterograde and retrograde trafficking (Cancino et 
al, 2013). The presence of the retrograde targeting signal KDEL sequence in the catalytic 
domain of CT (Sixma et al, 1993b) leads to the suggestion that this toxin would exploit the 
coat protein I (COPI; responsible for retrograde transport of KDEL receptors) and KDEL 
receptor-dependent pathway to go from the Golgi complex to the ER. Surprisingly it was 
found that mutation or removal of the KDEL motif from the catalytic domain of CT does not 
inhibit the access of the toxin to the ER (Lencer et al, 1995; Fujinaga et al, 2003). 
Furthermore, the B domain of CT, which does not possess a KDEL motif, is able to traffic 
retrogradely to ER (Bharati & Ganguly, 2011; Fujinaga et al, 2003). These observations 
indicated that a KDEL signal was not mandatory for CT retrograde transport (Bharati & 
Ganguly, 2011; Feng et al, 2004; Lencer et al, 1995), suggesting that COPI-mediated 
retrograde traffic from Golgi to ER was not required (Lencer et al, 1995). Nevertheless, 
mutation in the KDEL motif of CT results in a delay in intoxication leading to the 
hypothesis that the KDEL motif present in the catalytic domain of CT may be used to 
enhance toxicity (Lencer et al, 1995).  
During the intracellular route to ER (Figure 1.14), the catalytic domain of CT is 
proteolytically activated by a host cell protease (Lencer et al, 1997) originating two A 
domain peptides, CTA1 and CTA2, linked by a disulfide bridge. Once in the ER the 
disulfide bridge is reduced by oxidoreductases and the enzymatically active portion of the 
A domain, CTA1, is dissociated from the remaining toxin followed by unfolding assisted by 
ER lumenal chaperones, protein disulfide isomerase (PDI) and flavoenzyme Ero1p (Cho 
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et al, 2012; Tsai & Rapoport, 2002; Tsai et al, 2001). Unfolded CTA1 is stabilized in a 
competent state for retro-translocation by the ER luminal chaperone Hsp40 and 
ERdj3/HEDJ   complex  (Massey et al, 2011)   along    with   the   Hsp70   chaperone   Bip  
 
 
Figure 1.14. Intracellular trafficking of cholera toxin. (1) After binding to the ganglioside GM1, cholera tocin (CT) is 
endocytosed by various endocytic routes. (2) All the endocytic pathways end up in the early/sorting endosomes (EE/SE) 
from where sorting occurs to the TGN (3a), to the recycling endosomes (3b) or to late endosomes (not shown). (4) From the 
Golgi, the toxin is transported to the ER where the dissociation of the A domain from the B domain occurs with the aid of 
PDI and Erop1p. (5) The A-chain is then unfolded by the ERdj3/HEDJ complex along with BiP, where it is translocated 
across the ER membrane into the cytosol with the aid of TorsinA, gp78/Hrd1 and Derlin-1. (6) Once in the cytosol, the A-
chain rapidly refolds in an Hsp90-dependent manner where its catalytic activity stimulates adenylate cyclase (AC) resulting 
in an intracellular increase of cAMP (7). (From Cho et al, 2012). 
 
(Nishikawa et al, 2005; Shen & Hendershot, 2005; Winkeler et al, 2003). Further, CTA1 is 
target to the ER membrane for retro-translocation into cytosol through a still unknow 
protein-conducting channel. Some evidences point to retro-translocation through the 
Sec61 translocon (Schmitz et al, 2000), involved in the ERAD pathway (responsible for 
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transfer of degradation substrates from the ER to proteasome (Pilon et al, 1997; Wiertz et 
al, 1996)), but other translocation channels could be involved, with greatest evidence for 
the protein complex centered on the E3 ubiquitin ligases HRD1 and gp78 (Bernardi et al, 
2010). It is known that many ERAD substrates are pulled from the ER membrane by the 
cytosolic AAA-ATPase p97 (Jarosch et al, 2002; Ye et al, 2001). However, in the case of 
CT it seems that another ER luminal AAA-ATPase, Torsin A (Kothe et al, 2005; Nery et al, 
2011) may be involved. Unlike retro-translocated ERAD substrates that once in the 
cytosol are destined for the proteasome to degradation, CTA1 rapidly refolds in its 
catalytic active form and evades the degradative fate (Rodighiero et al, 2002). Refolding 
of CTA1 is mediated in part by the small GTPase ADP-ribosylation factor 6 (Arf6) 
(Ampapathi et al, 2008; Cho et al, 2012; Teter et al, 2006), the cytosolic chaperone Hsp90 
and Hsc70 (Spooner et al, 2008; Taylor et al, 2010). Finally, the refolded catalytic active 
CTA1 activates adenylate cyclase by ADP-ribosylation of the heterotrimeric protein G-
protein, with increase of the intracellular cAMP that causes an excessive secretion of fluid 
and electrolytes culminating in the massive diarrhea that typifies cholera disease 
(Spangler, 1992; Wernick et al, 2010). 
 
3.2.2. Shiga toxin 
Shiga toxin (Stx) is another example of a toxin that follows the retrograde pathway 
to gain access to cytosol (Sandvig et al, 1992). After binding strictly to the neutral 
glycosphingolipid Gb3 through its pentameric B domain, Stx is endocytosed either by 
clathrin-dependent or independent mechanisms (Sandvig et al, 2013). The toxin then 
travels from early or recycling endosomes (Lieu & Gleeson, 2010; Mallard et al, 1998; 
McKenzie et al, 2012) to the TGN network (McKenzie et al, 2009) in a dynamin (Lauvrak 
et al, 2004) and cholesterol (Falguieres et al, 2001) dependent way, and from the Golgi to 
the ER from where it translocates to the cytosol (Figure 1.15). Interestingly, Stx is able to 
stimulate its own transport into Golgi (Lauvrak et al, 2006) by: (i) recruiting clathrin at the 
cell surface (Utskarpen et al, 2010; Walchli et al, 2009); (ii) increasing microtubules 
assembly (Hehnly et al, 2006), necessary for the retrograde transport to the Golgi 
complex (Chen et al, 2005; Itin et al, 1999; Murshid & Presley, 2004; Yoshino et al, 2005); 
(iii) activation of Protein kinase C delta isoenzyme (Torgersen et al, 2007) and Mitogen-
activated protein kinase p38 (Walchli et al, 2008); (iv) releasing cytoplasmic 
phospholipase A2 from an Annexin A1 complex (Tcatchoff et al, 2012).  
It is currently accepted that the endosomal acidic pH is not a prerequisite for 
translocation of toxins that follow the retrograde pathway. Accordingly, although a recent 
study showed that different compounds that increase endosomal pH protect against Stx 
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(Dyve Lingelem et al, 2012) the effect was not due to the endosomal pH as such, but to 
other factors that play a role in interfering with the transport of Stx, with the proton pump 
activity playing a role in the efficient endosome to Golgi transport (Dyve Lingelem et al, 
2012).  
 
Figure 1.15. Intracellular trafficking of Shiga toxin. Upon endocytosis, Shiga toxin reaches early endosomes. Here the 
toxin undergoes retrograde sorting to trans-Golgi network (TGN) bypassing the late endosomes/lysosomes in a retromer-
dependent manner. Finally, the toxin reaches the endoplasmic reticulum (ER) from where it takes advantage of the ERAD 
machinery to translocate into cytosol. Y-shapes correspond to the transferrin receptor protein (TfR) that concentrates in 
recycling tubules in the early endosome and recycles back to the plasma membrane. (From Johannes & Romer, 2010). 
 
Contrarily to cholera toxin, Stx does not have a KDEL sequence and, not 
surprisingly, is sorted from Golgi to ER in a COPI-independent way through a Rab6- 
(Bassik et al, 2013; Girod et al, 1999; Jackson et al, 1999; White et al, 1999) and ARF1-
dependent route (Moreau et al, 2011). Intriguingly, Bassik et al. (Bassik et al, 2013) 
showed recently that knockdown of COPI protect cells against Stx. Nevertheless, it is not 
clear if the knockdown of COPI interferes only with the complex or if it results in secondary 
changes of the Golgi apparatus (Sandvig et al, 2013). Similarly to cholera, during the 
endocytic route to ER, Stx is activated by furin cleavage. Furin cleaves the A domain of 
the toxin resulting in two A fragments, A1- (containing catalytic activity) and A2-fragments, 
linked by a disulfide bridge (Garred et al, 1995a; Garred et al, 1995b). After arrival in the 
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ER, two processing steps required for an efficient translocation of A1-fragment into cytosol 
take place: the A1-fragment is released from A2-fragment plus B domain by reduction of 
the disulfide bridge (Garred et al, 1995b; Lee et al, 2010; Sandvig et al, 2013) and the A1-
fragment unfolds by a chaperone-mediated mechanism. The dissociation mechanism 
seems to be similar to the one described for cholera toxin with the ER lumenal chaperone 
protein disulfide isomerase (PDI) playing an important role (Cho et al, 2012; Fagerquist & 
Sultan, 2010; Lord et al, 2003; Spooner et al, 2004). Also similar to cholera toxin, 
ERdj3/HEDJ and BiP have been shown to be involved in stabilizing the unfolded A1-
fragment and later targeting it to the retro-translocation channels (Cho et al, 2012; 
Falguieres & Johannes, 2006; Yu & Haslam, 2005). The unfolded A1-fragment is probably 
targeted to the ER membrane, where retro-translocation occurs, presumably through the 
protein-conducting channel Sec61p (Cho et al, 2012; Sandvig & van Deurs, 2002a; 
Sandvig & van Deurs, 2002b; Yu & Haslam, 2005). Although the involved molecular 
details remain to be explored (Spooner & Lord, 2012). Finally in the cytosol, A1-fragment 
inhibits protein synthesis by removing one single adenine from the 28S RNA of the 60S 
subunit of the ribosome (Bergan et al, 2012), and may induce signaling leading to 
apoptosis (Cherla et al, 2003; Lee et al, 2008; Tesh, 2010). 
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Box 1. Cytotoxic pathways of Pseudomonas exotoxin A 
Exotoxin A from Pseudomonas aeruginosa is produced as a single polypeptide chain composed of domain I, domain II and 
domain III, responsible for receptor binding, translocation and catalytic activity, respectively (Allured et al, 1986; Pastan et 
al, 1992). The first essential step in the cytotoxic pathway of Pseudomonas exotoxin A (PE) is the binding of PE domain I to 
the CD91 receptor, also called alpha2-macroglobulin receptor/low density lipoprotein receptor related protein (α2MR/LRP) 
on the host cell membrane. Then, PE enters the cells (Kounnas et al, 1992) and after endocytosis, exposure to low 
endosomal pH leads to receptor dissociation and conformational changes within PE structure (Idziorek et al, 1990; Ogata et 
al, 1992; Sandvig & Moskaug, 1987; Wolf & Elsasser-Beile, 2009). From here two different situations have been 
documented (Morlon-Guyot et al, 2009) for arrival of PE into cytosol: 
(I) On the one side, the pH induced conformational changes mediates insertion of domain II (translocation domain) into the 
endosome membrane and the entire toxin translocate from endosomes into cytosol (Morlon-Guyot et al, 2009). Different 
data involved acidic pH in the PE translocation: (i) drugs that inhibit endosome acidification, as the weak bases ammonium 
chloride, methylamine and chloroquine and the inhibitor of the vacuolar proton-pump ATPase bafilomycin A1 protect cells 
from PE cytotoxicity (Beaumelle et al, 1993; Beaumelle et al, 1992; Clague et al, 1994; Morris & Saelinger, 1986; Olsnes & 
Sandvig, 1988; Pastan et al, 1992; Taupiac et al, 1996); (ii) cells unable to show endosomal acidification are resistant to PE 
(Robbins et al, 1984); (iii) acidic pH promotes PE insertion into model membranes (Jiang & London, 1990). Interestingly, 
contrarily to what has been described for toxins that translocate from endosomes through endosome-cytosol pH gradient, 
like in the case of diphtheria toxin, PE is not able to translocate directly from the plasma membrane when exposed to an 
acidic media (Olsnes & Sandvig, 1988; Taupiac et al, 1996). In the case of PE, the acidic endosomal pH is only a 
prerequisite for translocation (Jiang & London, 1990; Mere et al, 2005) but the energy for translocation of the full-length PE 
is directly driven by ATP hydrolysis (Taupiac et al, 1996). 
(II) On the other side, after reaching the endosomal compartment, PE can travel retrogadely to the ER through two different 
pathways (Smith et al, 2006; Wolf & Elsasser-Beile, 2009). Most of the PE is internalized by clathrin-coated pits but, 
alternatively, it can bind to CD91 receptor and associate with detergent-resistant microdomains (DRM) to be endocytosed 
via caveosomes. Once in the acidic endosomal compartment, the toxin undergoes conformational changes and can be 
proteolytically processed by furin within an exposed loop of the translocation domain (Ogata et al, 1992). This results in a N-
terminal fragment of 28 kDa and a 37 kDa C-terminal fragment (most of domain II and the entire enzymatic domain III) 
(Ogata et al, 1990; Wedekind et al, 2001). After reduction of the disulfide bridge, possibly by protein disulfide isomerases 
(PDI) or PDI-like enzyme (McKee & FitzGerald, 1999), the 37 kDa C-terminal fragment is released and travels via late 
endosomes and a Rab9-dependent route to the trans-Golgi network (TGN) (PE endocytosed via clathrin) or can pass 
directly from the EE to the TGN in a pathway independent of the small GTPase Rab9 (PE endocytosed via caveosomes). 
The 37 kDa C-terminal fragment is then transported to the ER via its C-terminal KDEL-like sequence REDL (PE 
endocytosed via clathrin) (Jackson et al, 1999; Kreitman & Pastan, 1995) or in a lipid-dependent sorting pathway, controlled 
by Rab6  (PE endocytosed via caveosomes) (Smith et al, 2006; White et al, 1999). Despite the retrograde pathway used, 
the PE fragments in the ER translocate into cytosol using sequences of the translocation domain II (Ogata et al, 1990; 
Theuer et al, 1993) and via the translocon Sec61p (Hazes & Read, 1997; Koopmann et al, 2000; Wolf & Elsasser-Beile, 
2009).  
There is a lack of correlation between the described pathways and PE efficiency and toxicity. However, different lines of 
evidence support the relevance of the retrograde transportation to ER for translocation and toxicity. PE has a carboxyl-
terminal sequence (REDLK) in the C-terminal domain that is similar to ER retrieval motif KDEL and is required for toxicity 
(Chaudhary et al, 1990). Moreover, replacing this carboxyl-terminal sequence (REDLK) by KDEL enhances toxicity 
(Seetharam et al, 1991) and overexpression of lysozyme-KDEL that inhibits KDEL-mediated ER system reduced PE toxicity 
(Jackson et al, 1999). Also, in highly sensitive cells, PE needs to be proteolytically cleaved to express full toxicity (Pastan et 
al, 1992; Taupiac et al, 1996). So far, it seems that, depending on the cell type, PE may enter cells directly from endosomes 
or can be processed and transported retrogradely to the ER before it reaches the cytosol. Nevertheless, further studies are 
needed in order to disclose the intriguingly mechanisms of PE intoxication. 
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C. AIP56 
1.  Role in Photobacterium damselae piscicida virulence 
AIP56 (Apoptosis Inducing Protein of 56 kDa) is a bacterial exotoxin identified by do 
Vale and colleagues (do Vale et al, 2005) as the major virulence factor of Photobacterium 
damselae piscicida (Phdp). 
 Phdp (Trůper & De'clari, 1997) is the causative agent of a bacterial septicaemia 
(known as pseudotuberculosis, photobacteriosis or pasteurellosis, the latter due to the 
previous classification of Phdp in the genus Pasteurella), an important bacterial disease 
affecting different marine fish species worldwide, including sea bass, sole, yellow-tail, gilt-
head seabream and turbot both in wild and in culture (Romalde, 2002; Thune et al, 1993). 
Because of its wide host range, massive mortality, ubiquitous geographical distribution, 
widespread antibiotic resistance and lack of efficient vaccines, Phdp infection is 
recognized as one of the most threatening bacterial diseases in mariculture (Andreoni & 
Magnani, 2014). This disease, in its acute form, has a septicaemic nature with a short 
course and very high mortality (Hawke et al, 1987; Romalde, 2002; Thune et al, 1993).  
Phdp is highly pathogenic, with characteristics of an extracellular pathogen (Lopez-
Doriga et al, 2000; Magariños et al, 1996a; Magariños et al, 1996b; Magariños et al, 
1992b; Noya & Lamas, 1997; Noya et al, 1995b). After entering the host, Phdp proliferates 
and spreads to several organs, including spleen, liver and kidney (Barnes et al, 2005; 
Magariños et al, 1996c; Toranzo et al, 1991). In advanced disease, apoptosing 
macrophages and neutrophils are present in spleen, head kidney, blood and gut lamina 
propria that present exuberant cytopathology (do Vale et al, 2007). It is of note that fish 
head kidney is equivalent to mammalian bone marrow in terms of haematopoietic activity  
and that cells of the fish immune system are mostly located in the head kidney, spleen, 
gut and thymus (Rombout et al, 2005; Scapigliati et al, 2002). Diseased fish often present 
whitish nodules (granulomatous lesions) in several internal organs, including kidney, 
spleen and liver, consisting of bacterial accumulation and apoptotic and necrotic cell 
debris (Figure 1.16). Consequently, the disease has been named to as 
pseudotuberculosis. Despite the severity of the pathology in marine fish species, the 
range of growth temperatures (15-30ºC) and the strict salt requirement (Magariños et al, 
1992a) render Phdp unable to infect fresh water fish and mammals. 
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Figure 1.16. Phathological changes in organs of Phdp infected fish. (A) Macroscopic view of a spleen from a Phdp 
infected sea bass, showing the presence of whitish nodules consisting of bacterial accumulation and apoptotic and necrotic 
cell debris that named the pathology as pseudotuberculosis. (B) Histophatological analysis of head kidney from Phdp 
infected sole showing that the whitish nodules correspond to areas of cell destruction. In these areas numerous apoptotic 
cells, positive for TUNEL (left panel; red area) and for active caspase-3 (right panel; brownish area), are observed. 
Objective 5x. (From do Vale et al, 2007). 
  
 It has been shown that Phdp-induced apoptotic death of macrophages and 
neutrophils (do Vale et al, 2003) results from the activity of AIP56 (do Vale et al, 2005). 
Indeed, it has been shown that in infected fish, the toxin is systemically distributed (Figure 
1.17) and depletes macrophages and neutrophils by post-apoptotic secondary necrosis 
(do Vale et al, 2007). The death of the phagocytes, which involves both extrinsic and 
intrinsic apoptotic pathways with activation of caspases -8, -9, and -3 and loss of 
mitochondrial membrane potential, translocation of cytochrome C to the cytosol and over-
production of reactive oxygen species (ROS) (Costa-Ramos et al, 2011), inevitably leads 
to a severe depletion in the number of these cells. This results not only in the impairment 
of host phagocytic defense (do Vale et al, 2007; do Vale et al, 2003; do Vale et al, 2005) 
but also affects cytokine production (Nascimento et al, 2007a; Nascimento et al, 2007b), 
further impairing the host immune response. The depletion of the host phagocytes 
together with the dramatic weakening of the host immune responses contributes to the 
establishment of a septicaemia and bacteraemia infection by allowing the rapid spread of 
the bacteria throughout the infected host, with massive extracellular multiplication 
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occurring mainly in spleen and head kidney (do Vale et al, 2007; do Vale et al, 2003). 
Furthermore, the occurrence of a secondary necrotic process in which the apoptosing 
phagocytes lyse and release their cytotoxic contents contributes to the genesis of the 
infection-associated necrotic lesions (do Vale et al, 2007; Silva et al, 2008).  
These observations, together with the fact that (i) AIP56 gene is present in all Phdp 
virulent strains and absent in the non-virulent isolates tested, (ii) AIP56 is the most 
abundant protein of mid-exponential phase virulent Phdp culture supernatants; (iii) 
passive immunization of sea bass with anti-AIP56 antibodies provides significant 
protection against Phdp challenge and, (iv) intraperitoneal injection of AIP56 reproduces 
the pathology of the disease and leads to a dose-dependent lethality (do Vale et al, 2007; 
do Vale et al, 2005), established AIP56 as a key player in the etiopathogenesis of Phdp. 
 
 
 
 
Figure 1.17. During Phdp infection AIP56 is systemically distributed. (A) AIP56 exotoxin is present in the plasma of sea 
bass with advanced Phdp infection. Western blotting analysis using an anti-AIP56 rabbit serum (upper panel) showing the 
presence of AIP56 in the plasma of infected sea bass (each lane corresponds to one animal; MB: moribund fish). Non-
infected fish were used as control. Protein loading was controlled by staining with Ponceau S (lower panel). (B) AIP56 is 
present in apoptosing cells and apoptotic bodies in advanced disease. Spleen from an infected sea bass immunolabeled for 
AIP56 (brownish red). Left panel: magnification of an area of cell destruction; right panel: magnification of blood in a vessel 
of spleen. (Adapted from do Vale et al, 2007). 
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2.  AIP56, an AB toxin that cleaves NF-B p65 
AIP56 is an exotoxin encoded in a high-copy plasmid (pPHDP10 plasmid) present in 
virulent Phdp strains from diverse geographical origins (do Vale et al, 2005). The location 
of the AIP56 gene in a high-copy plasmid is probably the reason why Phdp virulent strains 
are capable of producing large amounts of toxin (Figure 1.16B). 
Protein and nucleotide sequence together with heterologous expression of AIP56 in E. 
coli cells helped to characterize the primary structure of the toxin. AIP56 was first 
annotated as a 513 amino acid  precursor  protein,  including  an  N-terminal  cleavable  
signal  peptide  of  16  amino  acid  residues (GeneBank  Accession  number  DQ066884) 
(do Vale et al, 2005). However,  an  alternative  GTG  start  codon  exists,  21 nucleotides  
ahead  of  the  previously  annotated  ATG  start  codon,  extending  the  signal  peptide  
to  23 amino  acids  and  the  full  length  protein  to  520  amino  acids (Silva, 2010). 
AIP56 has only two cysteine residues (C262 and C298) and a zinc-binding region signature 
HEXXH, typical of most zinc metallopeptidases (Jongeneel et al, 1989).  
Limited proteolysis experiments revealed that AIP56 is composed by two domains 
linked by a disulfide bridge established between its two unique cysteine residues (C262 and 
C298) (Silva et al, 2013). Using constructs corresponding to the N- and C-terminal domains 
of the toxin (AIP561-285 and AIP56286-497, respectively) and chimeric proteins consisting of 
the Bacillus anthracis lethal factor N-terminal region fused to AIP56 N-terminal (LF11-
363.AIP561-261) and C-terminal (LF11-363.AIP56299-497) it was confirmed that AIP56 is an AB-
type toxin, possessing a catalytic A domain at its N-terminal, and a B domain involved in 
binding/internalization into target cells at its C-terminal region (Silva et al, 2013).  
 
 
 
 
 
 
 
 
 
Figure 1.18. Schematic representation of AIP56. AIP56 is structurally composed by two different domains, the catalytic A 
domain and the binding B domain,  linked by a disulfide bridge (SS) between the two unique cysteines residues (C262 and 
C298). After proteolytic cleavage between Phe285 and Phe286 (F286) and under reducing conditions two independent 
domains were originated, with the metalloprotease signature within the catalytic A domain.                                                              
 
It is now recognized that AIP56 is the founding member of a continuously growing 
family of bacterial proteins. Indeed, since it was first described (do Vale et al, 2005), 
M-21 N1 H EIVH165 C262 C298
SS
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several open reading frames coding for AIP56 full-length homologues were identified in 
different organisms, mainly in marine Vibrio species but also in Arsenophonus nasoniae.  
Interestingly, AIP56 seems to have originated from a fusion of two components: one 
related to NleC, which is a type III secreted effector present in several enteric pathogenic 
bacteria (Baruch et al, 2010) associated with human illness and death worldwide (Clarke, 
2001); and another related with a protein of unknown function from Acrythosiphon pisum 
bacteriophage APSE-2 (Degnan et al, 2009). 
Recently, it has been demonstrated that during intoxication of sea bass peritoneal 
leukocytes, the catalytic activity of AIP56 results in the depletion of NF-B p65 (Silva et al, 
2013). Considering that NF-B is an evolutionarily conserved transcription factor that 
regulates the expression of inflammatory and anti-apoptotic genes, playing a key role in 
host responses to microbial pathogen invasion (Box 2) (Gilmore & Wolenski, 2012), 
AIP56-induced NF-B p65 depletion likely explains the disseminated apoptosis observed 
during Phdp infection. Interestingly, similar to what was described for NleC (Baruch et al, 
2010), the cleavage occurs  in the Rel-homology domain at the Cys39-Glu40 peptide bound 
(Silva et al, 2013), key residues of p65 involved in DNA interaction (Chen et al, 1998; 
Garcia-Pineres et al, 2001). Further studies with a mutated version of the toxin 
(AIP56AAIVAA) containing a disrupted putative zinc-binding motif showed that disruption of 
the zinc metalloprotease signature does not induce major structural changes in the toxin 
but abolishes AIP56 apoptogenic activity and p65 cleavage, confirming AIP56 as a zinc 
dependent metalloprotease (Silva et al, 2013).  
It is now known that AIP56 (i) is the major virulence factor of Photobacterium 
damselae piscicida with pathological consequences well studied and documented, (ii) is 
an AB toxin, with an A domain displaying the metalloprotease activity linked by a single 
disulfide bridge to a B domain responsible for the binding/internalization of the toxin and 
(iii) cleaves the cytosolic target NF-B p65 at the Cys39-Glu40 peptide bound. Despite that, 
the interaction of AIP56 with different cell types, the endocytosis mechanisms and the 
intracellular route that the toxin exploits to arrive to its cytosolic target(s) have not been 
explored. 
 
 
 
 
 
 
CHAPTER I - INTRODUCTION 
 
41 
 
Box 2. Nuclear factor-B (NF-B)  
The transcription factor NF-B, first described in 1986 (Sen & Baltimore, 1986), comprises a family of evolutionarily 
conserved transcription factors, , master regulators of immune, inflammatory and antiapoptotic responses (Gilmore & 
Wolenski, 2012; Wolenski et al, 2013). In mammals, the NF-B family is composed by five elements: RelA/p65, RelB, c-Rel, 
p50 (NF-B1), and p52 (NF-B2) (see Figure). Each member contains an N-terminal conserved region known as the Rel 
homology domain (RHD) (Ghosh et al, 1998), which makes contact with DNA and supports subunit dimerization (Hayden & 
Ghosh, 2012). This domain can be divided into three structural regions: (i) the N-terminal domain that contains sequences 
required for dimerization and nuclear localization, (ii) the dimerization domain that mediates the association of NF-B 
subunits to form combinatorial dimmers, and (iii) the nuclear 
localization signal  (Ghosh et al, 2012; Huang et al, 2010; Zheng et 
al, 2011). The C-terminal transactivation domains (TADs) that 
confer the ability to initiate transcription are only present in p65, c-
Rel, and RelB (Hayden & Ghosh, 2012). The p52 and p50 are 
synthesized as large precursors (p100 and p105, respectively) that 
undergo proteolytic processing (Blank et al, 1991; Fan & Maniatis, 
1991; Mellits et al, 1993; Mercurio et al, 1993) and, instead of a C-
terminal TAD, contain a glycine-rich region (GRR), multiple ankyrin 
repeats (ANK) and a death domain (DD) (Ghosh et al, 2012). The 
five different proteins of NF-B family form different combinations 
of homo- or hetero-dimers contributing to the transcriptional 
selectivity of the NF-B response (Oeckinghaus & Ghosh, 2009; 
Smale, 2012). In most unstimulated cells, NF-B is retained 
inactive in the cytoplasm by forming a complex with inhibitors of 
NF-B (IBs). These IBs are characterized by presence of 
multiple ankyrin repeats (ANK) that interact with the Rel-homology 
domain, preventing the translocation of NF-B to the nucleus (Ghosh et al, 2012; Hinz et al, 2012; Oeckinghaus & Ghosh, 
2009). Curiously, the NF-B precursor’s p105 and p100 contain at their C-terminal multiple ankyrin repeats and they can 
also display an IB-like function (Ghosh et al, 2012). There are two NF-B signaling pathways, classical (or canonical) and 
alternative (or non-canonical), which lead to its activation and translocation to the nucleus. In the canonical pathway 
(characteristic of p65/p50 dimmer) the activation of NF-B occurs mainly by inflammatory stimuli including activation of TNF 
receptor-1 (TNFR1), IL-1 receptor and Toll-like receptors (TLRs). Upon stimulation, the IKK (IB kinase) complex (consisting 
of two catalytically active kinases, IKKα and IKKβ and a regulatory subunit IKKγ or NEMO) is activated, which results in 
phosphorylation of IBα (bound to NF-B dimers) leading to its polyubiquitination, subsequent proteosomal degradation and 
nuclear translocation of liberated NF-B dimers (Xiao, 2004). Once at the nucleus, the NF-B dimers bind specific DNA 
sequences (B sites), and promote transcription of target genes (Le Negrate, 2012; Vallabhapurapu & Karin, 2009). By 
contrast with the classical NF-B pathway the non-canonical pathway strictly depends on IKKα phosphorylation and 
activation but is independent of IKKβ and IKKγ. The stimuli is restricted to specific members of the TNF cytokine family 
including B-cell activating factor (BAFF), CD40 ligand, lymphotoxin-β, TNFR2 ligands, among others (Sun, 2012b). This 
pathway leads to activation of p52/RelB dimer through the activation of the NF-B-inducing kinase (NIK) and is based on 
processing of the p52 precursor protein, p100. The processing of p100 is a signal-induced and posttranslational event (Xiao 
et al, 2001) and, because p100 preferentially interacts with RelB (Solan et al, 2002), the processing of p100 not only 
generates p52 but also causes p52/RelB nuclear translocation (Sun, 2011). Due to NF-B important roles in 
the regulation of apoptosis and inflammation as well as innate and adaptive immunity, abnormal activation contributes to the 
pathophysiology of a variety of diseases, from inflammatory and autoimmune diseases to cancer (DiDonato et al, 2012; Li & 
Verma, 2002; Wong & Tergaonkar, 2009). Furthermore, as a consequence of the crucial role of NF-B in immune response, 
many successful pathogens have evolved a variety of mechanisms to subvert NF-B signaling pathway. 
 
 
(From Oeckinghaus & Ghosh, 2009) 
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Previous studies on AIP56 were focused on the elucidation of its toxic effects and 
their contribution to the pathology caused by Photobacterium damselae piscicida (Phdp). 
AIP56 was identified as an exotoxin secreted by virulent strains of Phdp, which acts by 
triggering apoptosis of macrophages and neutrophils, resulting in lysis of these cells by post-
apoptotic secondary necrosis. It has been demonstrated that this leads not only to the 
impairment of host immune defences allowing establishment of a septicemic infection, but 
also to the release of the cytotoxic contents of the phagocytes, causing tissue damage. More 
recently, it has been shown that AIP56 is a zinc-metalloprotease that cleaves NF-B p65, 
compromising the NF-B transcriptional activity. In terms of structural organization, it has 
been reported that AIP56 is an AB toxin, having an N-terminal/A domain responsible for the 
metalloprotease activity connected by a disulfide bridge to a C-terminal/B domain involved in 
binding and internalization of the toxin into cells.    
 Although it is well established that AIP56 is a key virulence factor of Phdp and despite 
the available knowledge on its structural organization, no information is available concerning 
the trafficking of AIP56 in intoxicated cells. Moreover, the activity of AIP56 has been only 
tested in fish cells and nothing was known about the susceptibility of other cells to AIP56.  
 
In this thesis, we aimed at extending the characterization of AIP56 by: 
1. Analysing the susceptibility of mammalian cells to AIP56  
2. Investigating the mechanism involved in AIP56 endocytosis  
3. Identifying the intracellular trafficking routes followed by AIP56 during 
intoxication  
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1. Experimental animals and cells 
1.1. Ethics statement 
This study was carried out in accordance with European and Portuguese legislation for 
the use of animals for scientific purposes (Directive 2010/63/EU; Decreto-Lei 113/2013). The 
work was approved by Direcção-Geral de Alimentação e Veterinária (DGAV), the Portuguese 
authority for animal protection (ref. 004933, 2011-02-22). 
 
1.2. Experimental animals 
1.2.1. Experimental fish 
Sea bass (Dicentrarchus labrax) were purchased from a commercial fish farm and 
housed in a recirculating ozone-treated salt-water (25-30‰) system at 20 ± 2ºC, with a 12 h 
light/dark cycle and fed at a ratio of  2% body weight per day with a commercial pelleted diet. 
Fish were euthanized with 2-phenoxyethanol (Panreac; 5 ml/10 L). Water quality was 
maintained with mechanical and biological filtration and ozone-disinfection. 
 
1.2.2. Experimental mice 
The C57BL/6 wild-type and TNF-α deficient mice were purchased from Charles River 
(Madrid, Spain) and bred and housed at the Instituto de Biologia Molecular e Celular (IBMC) 
animal facility. The mice were fed sterilized food and water ad libitum. TLR4 deficient mice 
were a kindly gift from University of Minho. For the experimental treatments, 4- to 12-week-
old males were used. Mice were euthanized by isofluorane anesthesia followed by cervical 
dislocation.  
 
1.3. Cells 
1.3.1. Sea bass peritoneal leucocytes (sbPL) 
Sea bass peritoneal leucocytes were obtained as described (Costa-Ramos et al, 
2011) from fish weighting between 100 to 200 g. Briefly, 12 to 20 days after stimulation with 
Incomplete Freund’s Adjuvant, the peritoneal cells were collected in L-15 medium adjusted to 
322 mOsm and supplemented with 10% inactivated FBS, 1% penicillin/streptomycin and 20 
U ml-1 heparin (Braun) (supplemented L-15). The peritoneal population of cells consist of 
approximately 70% macrophages and 20% neutrophils with the presence of small numbers 
of eosinophilic granular cells, lymphocytes and erythrocytes (Costa-Ramos et al, 2011). 
Unless otherwise stated, cells were used at a concentration of 2 × 106 cells ml−1 in L-15 
supplemented medium. 
 
CHAPTER III- MATERIAL AND METHODS 
 
50 
 
1.3.2. Mouse bone marrow derived macrophages (mBMDM) 
Macrophages were derived from femurs of 4- to 12-week-old C57BL/6 male mice, 
following a previously established protocol (Gomes et al, 2008). Briefly, femurs were 
removed and flushed with 5 mL of Hanks' balanced salt solution (HBSS). The resulting cell 
suspension was centrifuged and the cells resuspended in supplemented DMEM (DMEM with 
10 mM glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 10%  heat inactivated FBS, 1% 
penicillin/streptomycin and 10% of L929 cell conditioned medium (LCCM) as a source of 
Macrophage Colony Stimulating Factor (M-CSF)). In order to remove fibroblasts, the cells 
were cultured overnight, at 37°C in a humidified chamber in a 7% CO2 atmosphere, on a cell 
culture dish. The non-adherent cells were collected, centrifuged, resuspended in 
supplemented DMEM at a concentration of 4 × 105 cells ml−1 (or 5 × 105 cells ml−1 for the 
recycling experiments), plated in different cell culture plates according to the experiment they 
will be used (Table 1) and incubated again at 37°C in a humidified chamber in a 7% CO2 
atmosphere. Three days later, 10% LCCM/well was added and on the 7th day of culture, the 
medium was renewed. Cells were used at day 10, when they were fully differentiated into 
macrophages. 
 
Table 1.  mBMDM culture conditions 
Experiment Culture plate Cell dilution Volume/well 
Western blotting 24 well 4 × 105 cells ml−1 1 ml 
Caspase-3 24 well 4 × 105 cells ml−1 1 ml 
Resazurin 96 well 4 × 105 cells ml−1 200 µl 
Fluorescence microscopy 
24 well 
(containing LPS-free 
12-mm coverslips) 
4 × 105 cells ml−1 1 ml 
Recycling 24 well 5 × 105 cells ml−1 1 ml 
 
1.3.3. Cell lines 
Cells were propagated and maintained in tissue culture flasks in the respective 
medium (Table 2) at 37°C in a humidified chamber in a 7% CO2 atmosphere. Twenty four 
hours before the experiment cells were seeded in 24-well plates for p65 cleavage and 
morphology analysis or in 96-well plates for viability assays (conversion of resazurin to 
resorufin assay). 
To differentiate THP-1 monocytes in macrophages, THP-1 monocytes were seeded 
in 24-well plates at 4 x 105 cells ml−1 and stimulated for 16-18 hours with 0.1 µg ml-1 phorbol 
12-myristate 13-acetate (PMA, Sigma-Aldrich). Cells were washed with PBS and then 
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incubated in fresh medium without PMA for more 24 hours at 37°C in a humidified chamber 
in a 7% CO2 atmosphere before being used. 
 
Table 2.  Cell lines culture conditions 
Cell line designation Culture medium Culture plate Cell dilution Volume/well
J774A.1 
Reticulum cell sarcoma 
monocyte/macrophage 
BALB/C mice cell line 
DMEM 
+ 
10%FBS 
24 well 
 
 
2x105 cells ml−1 
 
 
 
1 ml 
 
96 well 
 
100 µl 
 
Raw 264.7 
Abelson murine leukemia 
virus induced tumor 
monocyte/macrophage 
BALB/C mice cell line 
DMEM 
+ 
10%FBS 
 
24 well 
 
 
 
2x105 cells ml−1 
 
 
 
1 ml 
 
 
96 well 
 
100 µl 
 
THP-1 
Acute monocytic leukemia 
peripheral blood  
human monocyte 
 
RPMI+10%FBS 
+1%HEPES+0.5%NEAA 
+0.5%EAA+ 0.1% 2-
mercaptoethanol 
 
24 well  
4x105 cells ml−1 
 
1 ml 
 
96 well 
 
100 µl 
 
HeLa 
Cervix adenocarcinoma 
human epithelial cell line 
 
DMEM 
+ 
10%FBS 
 
24 well 
 
 
1x105cells ml−1 
 
1 ml 
 
96 well 
 
100 µl 
Vero 
Kidney epithelial cells 
extracted from an African 
green monkey 
 
DMEM 
+ 
10%FBS 
 
24 well 
 
 
1x105 cells ml−1 
 
 
 
1 ml 
 
96 well 
 
100 µl 
 
CHO 
Epithelial cells extracted 
from Chinese Hamster 
Ovary 
 
DMEM 
+ 
10%FBS 
 
24 well 
 
 
1.2x105 cells ml−1 
 
 
 
1 ml 
 
96 well 
 
100 µl 
 
 
2. Recombinant proteins  
The different proteins used to perform this work are represented in table 3. AIP56 
proteins and chimeric proteins were expressed in E. coli while sbp65Rel was synthesized in 
vitro as 35S-labeled proteins using rabbit reticulocyte lysates. Protective antigen (PA), the 
receptor binding for anthrax lethal factor (LF) (Collier, 2009), was obtained as previously 
described (Tonello et al, 2004) and was kindly provided by Cesare Montecucco (University of 
Padova, Italy). 
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Table 3.  Recombinant proteins used in this study 
Name Description Expression system
 
AIP56 
 
Wild type, full length his-tagged  AIP56 toxin 
 
E. coli 
AIP56AAIVAA 
His-tagged AIP56 metalloprotease mutant corresponding to a 
full-length version of the toxin in which key residues for zinc ion 
coordination and water molecule activation (His165, Glu166, His169 
and His170) were substituted by alanines 
 
E. coli 
AIP561-285C262S His-tagged AIP56 N-terminal truncate (AIP56
1-285) with cysteine 
262 mutated to serine E. coli 
 
AIP56286-497C298S 
 
His-tagged AIP56 C-terminal truncate (AIP56286-497) with cysteine 
298 mutated to serine  E. coli 
LF11-263∙AIP561-261 
LF.AIP56 chimeric protein consisting of the amino-terminus of 
anthrax lethal factor (LF11-263) fused to AIP56 N-terminal region 
(AIP561-261) 
E. coli 
LF11-263∙AIP56299-497 
LF.AIP56 chimeric protein consisting of the amino-terminus of 
anthrax lethal factor (LF11-263) fused to AIP56 C-terminal region 
(AIP56299-497) 
E. coli 
 
sbp65Rel 
 
Sea bass NF-B p65 Rel homology domain (Met1-Arg188) 
 
Rabbit reticulocyte 
 
 
2.1. Production and purification of recombinant proteins expressed in E. coli 
Recombinant AIP56, AIP56AAIVAA, AIP561-285C262S, AIP56286-497C298S, LF11-263.AIP561-261 and 
LF11-263∙AIP56299-497 were produced and purified as previously described (Silva et al, 2013). 
Briefly, AIP56, AIP56286-497C298S, LF11-263.AIP561-261 and LF11-263∙AIP56299-497 were purified from 
the soluble fraction of induced E. coli cells by metal-affinity chromatography. This was 
followed by an anion exchange chromatography in the case of AIP56 or a size exclusion 
chromatography in the case of AIP56286-497C298S. AIP56AAIVAA and AIP561-285C262S were purified 
from inclusion bodies by metal-affinity chromatography under denaturing conditions, 
refolded, and subjected to size exclusion chromatography. To obtain AIP56Myc and 
AIP56V5, pET28aAIP56H+ plasmid (do Vale et al, 2005) was amplified using the forward 
primer AIP56NdeFw1 together with AIP56MycXhoRv1 or AIP56V5XhoRv1.  The PCR 
products were subcloned into pGEM-T Easy vector (Promega) and cloned into the 
pET28a(+) plasmid (Promega), yielding the plasmids pET28aAIP56MycH+ and 
pET28aAIP56V5H+. AIP56Myc and AIP56V5 were expressed in E. coli BL21(DE3) and 
purified following the same protocol used for AIP56 (Silva et al, 2013). 
 
2.2. Cell-free expression of 35S-labeled sbp65Rel 
The coding region (Met1-Arg188) of sea bass p65 Rel domain (sbp65Rel) was amplified by 
PCR from cDNA obtained as described in (Pinto et al, 2012) using primers DLp65Fw1NcoI 
and DLp65Rv4XhoI. For production of 35S-labeled sbp65Rel the reverse primer 
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DLp65Rv2XhoI, that introduces a stop codon before the 6xHis-tag of the pET-28a(+)vector, 
was used instead of DLp65Rv4XhoI, with the purpose of producing a protein without a 6xHis-
tag. PCR products were cloned in pET-28a(+). Untagged sbp65Rel was produced as 35S-
labeled proteins in rabbit reticulocyte lysates by in vitro translation using the TNT T7 Quick 
Coupled transcription/Translation kit (Promega), in the presence of RedivueTM L-[35S] 
methionine (specific activity of N1000 Ci/mmol) following the manufacturer’s instructions. 
 
Table 4. Primers used in this study.  
Primer designation Nucleotide sequence 5′→3′ 
AIP56NdeFw1 CGCCATATGGCATAACCTTCAATGATGGT 
AIP56MycXhoRv1 CGCCTCGAGAAGATCTTCTTCAGAAATAAGTTTCTGTTCATTAATGAATTGTGGCGCGTGGGGAT 
AIP56V5XhoRv1 CGCCTCGAGCGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCTTACCATTAATGAATTGTGGCGCGTGGGGAT 
DLp65Fw1NcoI  CGCCCATGGAAGGTGTGTATGGATGGAGCCTG 
DLp65Rv2XhoI GCGCTCGAGTCACCTGTTGTCATAGATGGGCTGCG 
DLp65Rv4XhoI GCGCTCGAGCCTGTTGTCATAGATGGGCTGCG 
 
2.3. Protein quantification  
Recombinant proteins were quantified by measuring absorbance at 280 nm and using the 
extinction coefficient calculated by the ProtParam tool 
(http://www.expasy.org/tools/protparam.html), using the Edelhoch method (Edelhoch, 1967), 
but with the extinction coefficients for Trp and Tyr determined by Pace et al (Pace et al, 
1995). 
 
3. Fluorescent labelling of AIP56 
AIP56 labelled with Alexa Fluor 488 (Alexa 488-AIP56) was prepared using the Alexa 
Fluor Protein Labelling Kit (A-10235) from Molecular Probes following the manufacturer’s 
instructions. AIP56 labelled with FITC (FITC-AIP56) was prepared using the Fluoreporter 
FITC Protein Labelling Kit (F6434) from Molecular Probes following the manufacturer’s 
instructions. 
 
4. In vitro analysis of AIP56 catalytic activity 
To prove that the inhibitors used in this study do not interfere with AIP56 activity, 
cleavage of AIP56 cytosolic substrate was evaluated in vitro, using in vitro translated 35S-
labeled sbp65Rel synthesized as previously described on section 2.2. 35S-labeled sbp65Rel 
was incubated for 2 h at 22ºC with 100 nM (5.7 µg ml-1) of recombinant AIP56 in the 
presence of the inhibitors at the concentration described on table 5 (also used for the ex vivo 
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assays) in a final volume of 20 µl adjusted with 10 mM Tris-HCl pH 8.0, 150 mM NaCl. The 
reaction was stopped by adding SDS-PAGE sample buffer and p65 cleavage assessed by 
autoradiography. 
 
Table 5. Inhibitors used in this study.  
Inhibitor Supplier Reference Concentration Pre-incubation
Ammonium Chloride  Merck 1011450500 30 mM 
1 h 
Bafilomycin A1 
Sigma 
B1793 10 nM 
Chloroquine diphosphate salt C6628 100 µM 
Chlorpromazine C8138 30 µM 
Concanamycin A C9705 10 nM 
Cytochalasin D C8273 4 µM 
Dynasore D7693 80 µM 
Monensin sodium salt M5273 5 µM 
Nigericin sodium salt  N7143 50 nM 
MG132 Calbiochem CAS 133407-82-6 20 µM 
LY294002 Cell Signaling 9901 10 µM 
Colcemid 
Gibco 
15210-040 0.27 µM 
3 h Nocodazole M1404 30 µM 
Taxol Sigma T1912 20 µM 
 
5. In vitro analysis of AIP56 pH induced conformational changes 
 
5.1. Tryptophan and TNS fluorescence 
Tryptophan and TNS fluorescence at different pH values was analyzed in a PerkinElmer 
LS45 Luminescence Spectrometer with excitation of 270 nm and an emission scan of 310 
nm to 450 nm or excitation of 366 nm and an emission scan of 380 to 500 nm, respectively. 
The following buffers were used: for pH 4.0, 4.5, 5.0, and 5.5, 150 mM NaCl, 100 mM 
ammonium acetate; for pH 6.0 and 6.5, 150 mM NaCl, 100 mM morpholineethanesulfonic 
acid (MOPS); for pH 7.0 and 7.5, 150 mM NaCl, 100 mM HEPES (Qa'Dan et al, 2000). TNS 
was added to each buffer at a final concentration of 150 µM. AIP56Myc was added to a final 
concentration of 1.5 µM (8.7 µg ml−1) in a final volume of 300 µL. Fluorescence 
measurements were done after 15 min incubation at RT. For the pH shift experiments, the 
toxin was incubated with TNS at pH 4.0 for 15 min at RT and the fluorescence recorded. The 
pH was then adjusted to 7.5 by gradual addition of 1 N NaOH and the fluorescence recorded 
again. Since the pH 7.5 was not within the buffering range of ammonium acetate, the pH of 
the sample was checked following the analysis to confirm that the desired pH value was 
maintained. Experiments were repeated at least three times and in each experiment, 
fluorescence intensities were determined by averaging two readings. 
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6. Black lipid bilayer experiments 
The methods used for black lipid bilayer experiments have been previously described in 
detail (Benz et al, 1978). The instrumentation consisted of a Teflon chamber with two 
aqueous compartments connected by a small circular hole, with a surface area of about 0.4 
mm2. Membranes were formed across the hole by painting on a 1% (w/v) solution of 
diphytanoyl phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL) in n-decane. The 
aqueous salt solution (150 mM KCl) was buffered with 2 mM CaCl2 and 10 mM of either 
HEPES (pH 7.4 or pH 7.0), MES (pH 6.5 or pH 6.0) or CH3COOK (pH 5.5, pH 5.0 or pH 4.5) 
added to the cis compartment of the chamber. Reducing conditions were established by 
addition of 1 mM DTT after the membrane had turned black. Approximately 10 µg of protein 
were used for each measurement; purified protein samples mixed 1:1 with cholesterol 
suspension in water were added to the cis compartment of the chamber after the membrane 
had turned black. The membrane current was measured with a pair of Ag/AgCl electrodes 
with salt bridges switched in series with a voltage source and a highly sensitive current 
amplifier (Keithley 427). The amplified signal was recorded by a strip chart recorder. The 
applied membrane potential was 50 mV. All measurements were performed at RT and each 
experiment was repeated at least twice.  
 
7. pH-induced translocation across the cell membrane 
To address if an acidic pulse can drive translocation of cell-bound AIP56 across the cell 
membrane we followed the protocol first described for diphtheria toxin (Barth et al, 2000; 
Draper & Simon, 1980; Sandvig & Olsnes, 1980). Different pH values were obtained by 
adding sufficient H3PO4 to a buffer containing 0.5 mM MgCl2, 0.9 mM CaCl2, 2.7 mM KCl, 
1.5 mM KH2PO4, 3.2 mM Na2HPO4, and 184 mM NaCl for sbPL or 137 mM NaCl for 
mBMDM.  In all experiments, concanamycin A (10 nM final concentration) was maintained 
during the entire assay, including washes, to inhibit normal toxin uptake. 
sbPL were incubated in supplemented L-15 medium (pH 7.4) with 10 µg ml−1 of AIP56 in 
the presence or absence of 10 nM concanamycin A for 30 min on ice, washed twice in 
phosphate buffers at pH 7.0, pH 5.5 or pH 5.0, resuspended and incubated in the different 
buffers for 10 min at RT. Cells were collected by centrifugation, resuspended in 
supplemented L-15 and incubated at 22ºC for 2 h with or without concanamycin A. mBMDM 
monolayers were incubated in supplemented DMEM with 5 µg ml-1 of AIP56 in the presence 
or absence of 10 nM concanamycin A for 30 min on ice. Supernatant was removed and cells 
were incubated at the different pH for 1 h at 37ºC in a humidified chamber in the presence of 
7% CO2.  After 1 h incubation, supernatants were removed, fresh supplemented DMEM was 
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added and cells were incubated for further 2 h at 37ºC with or without concanamycin A. 
Mock-treated cells and cells treated only with toxin were used as controls and NF-B p65 
cleavage was analyzed by western blotting and used as a read-out.  
 
8. Intoxication assays: NF-B p65 cleavage read-out 
sbPL: cells obtained as described in section 1 were pulsed with 10 µg ml-1 of AIP56, 
FITC-AIP56 or Alexa 488-AIP56 for 30 min on ice, washed 3 x with ice-cold sbPBS (PBS 
with osmotic strength adjusted to 322 mOsm) by centrifugation at 500 g for 5 min at 4ºC and 
then transferred to 22ºC. Mock-treated cells were used as control. At the indicated times, 
cells were collected by centrifugation (500 g, 5 min, 4ºC), washed once with sbPBS and 
lysed by addition of SDS-PAGE sample buffer. Cleavage of NF-B p65 was evaluated by 
western blotting, as described in section 18. 
Mammalian cells: cells were incubated with AIP56 or with AIP56AAIVAA at the indicated 
concentration for 30 min on ice, washed twice with PBS to remove unbound toxin, 
resuspended in complete medium without toxin and then transferred to 37ºC for the indicated 
time-intervals. In experiments using chimeric proteins, mBMDM were continuously incubated 
with 0.5 µg ml-1 (8.75 nM) AIP56 or 10 nM of anthrax protective antigen (PA) together with 20 
nM of LF1-254∙AIP561-261 or LF1-254∙AIP56299-497. In all experiments, mock treated cells were 
included as controls. At the indicated times cells were washed once with PBS and 
resuspended in SDS-PAGE sample buffer to further analyze NF-B p65 cleavage by western 
blotting as described in section 18. 
 
9. Analysis of cellular morphology 
sbPL: cellular morphology was assessed by light microscopy morphological analysis of 
cytospin preparations, fixed in 10% formalin in ethanol followed by neutrophils’ peroxidase 
detection using the Antonow’s technique (Afonso et al, 1997; do Vale et al, 2002) and 
staining with hemacolor (Merck). A set of morphological alterations such as occurrence of 
cell rounding and shrinkage, nuclear fragmentation and/or chromatin condensation, cell 
blebbing and formation of apoptotic bodies (Hacker, 2000) was considered. Experiments 
were performed using cells collected from at least 3 individual fish. The percentage of 
apoptotic cells was determined in a blind fashion by scoring a minimum of 350 cells per slide. 
Cytospins preparations were analysed under an Olympus microscope equipped with an X-
cite lamp source (series 120PC) and an Olympus DP72 microscope digital camera. Images 
were acquired using cellSens Dimension software. 
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Mammalian cells: cellular morphology was assessed by morphological evaluation of the 
cell monolayers by phase-contrast microscopy (Olympus CKX41). Morphological alterations 
such as shrinkage and rounding up of the cells, membrane blebbing and detachment of the 
cells were considered. Images were captured using an Olympus sc30 camera and the 
“analySIS getIT” Olympus software. 
 
10.  Viability assay: conversion of resazurin to resorufin 
The indicator dye resazurin can be used to measure the metabolic capacity of the cells - 
indicator of cell viability. Viable cells retain the ability to reduce resazurin into highly 
fluorescent resorufin while nonviable cells rapidly lose metabolic capacity, do not reduce the 
indicator dye, and thus do not generate a fluorescent signal (Magnani & Bettini, 2000; 
Springer et al, 1998; White et al, 1996).  
Mammalian cells were left untreated or incubated with the appropriated recombinant 
protein. At the indicated times 20 µl of resazurin at 1.25 mM (diluted in water) was added per 
well (final concentration 0.125 mM). Cells were again incubated at 37°C to allow them to 
convert resazurin to resorufin, and after 3 h the fluorescent signal was measured on a 
Spectra Max Gemini XS fluorimeter (Molecular Devices) at an excitation wavelength of 560 
nm and an emission wavelength of 590 nm.  
 
11.  Detection of apoptosis 
11.1. Caspase-3 assay 
The activity of caspase-3 in total cell lysates was determined using a commercial 
fluorimetric assay (EnzChek Caspase-3 Assay Kit, Molecular Probes), following the 
manufacturer´s instructions. Briefly, soluble extracts prepared from AIP56 or AIP56AAIVAA 
treated cells were allowed to react with 100 µM Z-DEVD–AMC in 1x reaction buffer for 3 h at 
RT and in the dark. Fluorescence was measured on a Spectra Max Gemini XS fluorimeter 
(Molecular Devices) at an excitation wavelength of 360 nm and an emission wavelength of 
460 nm. In sbPL experiments the results are expressed as relative fluorescent units (RFU). 
In mBMDM, to normalize the results, the protein concentration in each sample was 
determined using the Bio-Rad Protein Assay (Bio-Rad 1-800-424-6723) following the 
recommended procedure for microtiter plates. In some experiments, the results, in relative 
fluorescence units per nanogram of protein (RFU/ng) were converted to fold increase by 
comparing to the values obtained in extracts from mock-treated cells. 
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11.2. TUNEL assay 
The internucleosomal DNA fragmentation was detected by TUNEL staining of DNA 
strand breaks with the In Situ Cell Death Detection Kit, POD (Roche Diganostics) following 
the manufacturer’s instructions. Propidium iodide (PI) at 1 µg ml-1 was used as a nuclei 
counterstain. 
 
12.  Competition assay 
AIP56286-497C298S was tested, in competition experiments, for its ability to inhibit AIP56-
mediated p65 cleavage. The competition assays were performed as previously described 
(Silva et al, 2013). Briefly, cells were pre-incubated for 15 min on ice with 7 µM A domain 
(AIP56286-497C298S) or with 7 µM B domain (AIP56286-497C298S) followed by incubation for further 
15 min on ice with  an 800-fold lower concentration of AIP56 (8.75 nM (0.5 µg ml-1) of AIP56) 
in the presence of the competitors. Cells were washed once with ice cold supplemented 
DMEM and incubated at 37ºC for 2 h. Mock-treated cells and cells only treated with each of 
the proteins were used as control. NF-B p65 cleavage was assessed by western blotting as 
described on section 18. 
 
13.  Detection of the intracellular AIP56 
13.1. Western blotting 
Cells were intoxicated with the appropriated recombinant protein as described in 
intoxication assays section 8. When specified, cells were pre-treated and incubated in the 
presence of MG132, concanamycin A, bafilomycin A1, dynasore, chlorpromazine, 
cytochalasin D or nocodazole at the concentration and pre-incubation time described in table 
5. At different time-points, aliquots were collected and cells were washed twice with ice-cold 
PBS and incubated for 10 min on ice with 500 µg ml-1 (in PBS) of pronase E from 
Streptomyces griseus (P5147, Sigma Aldrich) to digest the extracellular cell-associated toxin. 
Cells treated with the toxin, washed and incubated in PBS without protease were used as 
control. Protease was inactivated with phenylmethylsulfonyl fluoride (PMSF) at a final 
concentration of 250 µg ml-1. Cells were washed in PBS, resuspended in SDS-PAGE sample 
buffer and analyzed by western blotting for detection of AIP56 as described on section 18.  
 
13.2. Fluorescence microscopy 
To monitor AIP56 entry and intracellular behavior by fluorescence microscopy cells were 
incubated with 10 µg ml−1 of Alexa 488-AIP56 or FITC-AIP56 for 30 min on ice, then the 
medium was replaced by supplemented medium without toxin and cells were switched to 
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37ºC for mBMDM or to 22ºC for sbPL. At different time-points, cells were washed three times 
with PBS and fixed with ice-cold 4% paraformaldehyde (w/v in PBS) for 10 min at RT. To 
counterstain the cell limits, cells were permeabilized for 10 min at RT with 0.1% Triton X-100 
in PBS, washed and incubated with blocking buffer (10% FBS in 0.1% Tween in PBS) for 30 
min prior to incubation for 1 h with the F-actin probe Alexa Fluor 594-Phalloidin 5 U ml−1 also 
diluted in blocking buffer. Nuclei were counterstained with 0.2 µg ml−1 DAPI (4', 6-diamidino-
2-phenylindole) and coverslips were mounted on a glass-slide with Vectashield (Vector 
laboratories) and sealed with polish nail. Samples were 3D analyzed on a laser scanning 
confocal microscope (Leica TCS SP5 II running LAS AF 2.6 software - Leica Microsystems, 
Germany) using a 60x/1.40 N.A. oil immersion objective, with a pixel size of 60 nm and a z 
step size of 210 nm. The 3D image stacks were deconvolved with Huygens Professional 
software (SVI, Netherlands) applying the Maximum Likelihood Estimation restoration 
algorithm. Restored images were processed and maximum intensity projected with Fiji 
software (Schindelin et al, 2012). 
 
14.  Recycling assay 
mBMDM were incubated for 30 min on ice in serum-free medium containing 10 µg ml−1 
AIP56V5, transferred to 37ºC for 5 min to allow AIP56 to be endocytosed (pulse) and 
switched to ice again. Cells were washed 3x with ice-cold PBS and the third wash was 
collected and precipitated with trichloroacetic acid (TCA). After washing, cells were incubated 
for 10 min on ice with 125 µg ml−1 pronase E (pronE) in PBS, to remove extracellular toxin. 
Then cells were washed twice with PBS, treated with 250 µg ml−1 PMSF/PBS (1 ml/well) to 
inhibit protease activity and washed 3x with ice-cold PBS followed by washing with 250 
µl/well serum-free medium containing 10 µg ml−1 AIP56286-497C298S .The medium from the last 
wash was collected and precipitated with TCA. Then cells were incubated at 37ºC in a 
humidified chamber with 7% CO2 in serum-free medium containing 10 µg ml−1 AIP56286-
497C298S (to prevent re-entry of recycled full-length AIP56). At different time-intervals, 
supernatant was collected and precipitated with TCA and the corresponding cell monolayer 
was washed twice with PBS and lysed with SDS-PAGE sample buffer. TCA precipitates were 
resuspended in SDS-PAGE sample buffer and the equivalent to 12 wells for supernatant and 
washes and 4 wells for monolayer (pellet) was analyzed by western blotting for detection of 
AIP56V5 using an anti-V5 antibody. Membranes were reprobed with an anti-GAPDH 
antibody (used as cytosolic marker).  
In some experiments, cells were incubated with 10 µM LY294002 or 10 nM of 
concanamycin A for 1 h at 37ºC before pulse with AIP56V5. In this case, the inhibitor was 
maintained during the entire chase. 
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15.  Inhibition of endocytosis and trafficking 
15.1. Inhibitors 
Before the intoxication assay (see section 8) with the appropriated recombinant toxin, 
cells were pre-treated with the inhibitor for 1 h or 3 h (see Table 5) at the appropriated 
temperature. Cells treated with dynasore were incubated in culture medium lacking FBS. 
AIP56 was added to a final concentration of 5 µg ml−1 for mBMDM or 10 µg ml−1 for sbPL and 
cells were switched to 37ºC or 22ºC respectively and incubated for a maximum of 2 h while 
maintaining the inhibitory conditions. Analysis of NF-B p65 cleavage by western-blotting was 
used as a read-out. In sbPL experiments the inhibitory effect of the inhibitors was also 
evaluated by AIP56-induced apoptotic morphological alterations (as described in section 9). 
 
15.2. Lag-time experiments 
Cells were intoxicated with AIP56 as described in section 8 and at the indicated time-
points concanamycin A, at a final concentration of 10 nM, was added to the cells. 
Internalization of the toxin was assessed by evaluating the cleavage of NF-B p65 by 
western blotting as described on section 18. 
 
16. Phagocytosis assay 
Listeria monocytogenes EGD (wild-type NCTC 7973, kindly provided by Didier Cabanes, 
Group of Molecular Microbiology, Instituto de Biologia Molecular e Celular, Universidade do 
Porto, Porto, Portugal) was grown in brain-heart infusion (BHI; Difco) to an optical density at 
600 nm of 0.8, pelleted by centrifugation, washed 3x  and resuspended in warm complete 
DMEM without FBS and antibiotic. mBMDM were incubated with 4 µM cytochalasin D,  80 
µM dynasore or 30 µM chlorpromazine for 1 h at 37ºC or left untreated prior to phagocytosis 
assay. Bacteria were added to untreated or treated mBMDM (5 x 105 cells/well, 24 well-
plates) at a multiplicity of infection of 10 bacteria per cell and incubated for 30 min at 37ºC. 
Monolayers were washed 3x with warm complete DMEM without antibiotic, extracellular 
bacteria were killed with 20 µg ml-1 gentamicin (Lonza) for 1 h at 37ºC, cells washed again 
3x, lysed with 0.1% Triton X-100 and serial dilutions plated in BHI agar. Colony forming units 
(CFU) were determined after 24 h incubation at 37ºC and normalized to CFU in cells treated 
with bacteria in the absence of the inhibitors. Assays were performed in triplicate.  
 
17.  Fluorescence microscopy 
17.1. Immunofluorescence 
For fluorescence microscopy studies, mBMDM cultured on LPS-free 12-mm glass 
coverslips were incubated in supplemented DMEM with 10 µg ml−1 FITC-AIP56 or Alexa 488-
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AIP56 for 30 min on ice. The supernatant was removed, replaced by supplemented medium 
without toxin and cells switched to 37ºC for a maximum of 60 min.  At different time-points, 
cells were washed once with PBS and processed for immunofluorescence. mBMDM 
monolayers were either fixed with ice-cold 4% paraformaldehyde (w/v in PBS) for 10 min at 
RT and permeabilized with 0.1% Triton X-100 in PBS for 10 min at RT (for immunodetection 
of EEA, LAMP-1 and GM130) or fixed with ice-cold methanol for 10 min at RT (for detecting 
GRP78 Bip). Cells were incubated with blocking buffer (10% FBS in 0.1% Tween in PBS 
(PBS-T)) for 30 min prior to the addition of primary antibodies. The primary antibodies  were 
diluted in blocking buffer as described in table 6 and incubated overnight at 4ºC in a 
humidified chamber. After several washes, the secondary antibodies, diluted in blocking 
buffer, were incubated with the cells for 1 h at RT in a humidified chamber. Nuclei were 
counterstained with 0.2 µg ml−1 DAPI and preparations were mounted with Vectashield. 
Samples were 3D analysed on a laser scanning confocal microscope (Leica TCS SP5 II 
running LAS AF 2.6 software - Leica Microsystems, Germany) using a 60x/1.40 N.A. oil 
immersion objective, with a pixel size of 60 nm and a z step size of 210 nm. Each 
fluorochrome was imaged by sequential acquisition in order to avoid crosstalk between 
channels. The 3D image stacks were deconvolved with Huygens Professional software (SVI, 
Netherlands) applying the Maximum Likelihood Estimation restoration algorithm. Restored 
images were processed and maximum intensity projected with Fiji software (Schindelin et al, 
2012). 
To control the effect of microtubule destabilizing agents (nocodazole, colcemid and taxol) 
and the effect of cytochalasin D on actin filaments, cells were incubated with the inhibitors at 
22ºC (sbPL) or at 37ºC (mBMDM) for 3h in the case of microtubules inhibitors or 1 h for 
cytochalasin D. Cells were washed, fixed with ice-cold 4% paraformaldehyde (w/v in PBS)  
for 10 min at RT, washed 3x with PBS, permeabilized with 0.1% Triton-X100 for 10 min at 
RT, washed 3x as above and blocked for 15 min (10% FBS, 0.01% Tween 20 in PBS). Cells 
treated with microtubules destabilizing agents were incubated for 1 h with the primary 
antibody mouse monoclonal anti-α-Tubulin washed as described above and incubated with 
the fluorescence-conjugated secondary antibody Alexa Fluor 488 goat anti-mouse IgG (H+L), 
both diluted in blocking buffer. In the case of cytochalasin D, cells were incubated for 1 h with 
the F-actin probe Alexa Fluor 594-Phalloidin also diluted in blocking buffer. Nuclei were 
counterstained with 0.2 µg ml−1 DAPI and preparations were mounted with Vectashield. 
Slides were analysed under an Olympus microscope equipped with an X-cite lamp source 
(series 120PC) and an Olympus DP72 microscope digital camera. Images were acquired 
using cellSens Dimension software, processed and maximum intensity projected with Fiji 
software (Schindelin et al, 2012). 
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17.2. Transferrin experiments 
For transferrin experiments, mBMDM were incubated in supplemented DMEM without 
FBS with 10 µg ml−1 Alexa 488-AIP56 for 20 min on ice, the supernatant was removed and 
replaced by ice-cold supplemented DMEM with 500 µg ml-1 Alexa 647-Transferrin conjugated 
and incubated for more 10 min on ice. Then cells were switched to 37ºC and incubated for a 
maximum of 60 min. At the time-intervals indicated cells were washed twice with PBS and 
fixed with ice-cold 4% paraformaldehyde (w/v in PBS) for 10 min at RT. Cell were washed 3x 
with PBS and nuclei were counterstained with 0.2 µg ml−1 DAPI and preparations mounted 
with Vectashield. Samples were 3D analysed on a laser scanning confocal microscope 
(Leica TCS SP5 II running LAS AF 2.6 software - Leica Microsystems, Germany) as 
described on step 17.1. 
 
17.3. Acridine Orange 
The efficacy of concanamycin A in inhibiting the endosomal vacuolar ATPase pump was 
confirmed through acridine orange staining. Cells were incubated for 1 h in the presence of 
10 nM concanamycin A or DMSO (vehicle of concanamycin A) and then 0.5 µg ml−1 of 
acridine orange (AO) were added and the cells incubated for further 15 min at 22ºC (sbPL) or 
37ºC (mBMDM). Cells were washed twice with PBS and fixed with ice-cold 4% 
paraformaldehyde (w/v in PBS)  for 10 min at RT. Nuclei were counterstained with 0.2 µg 
ml−1 DAPI and coverslips were mounted with Vectashield prior to  visualization of endosomal 
acidification by AO fluorescence. 
 
18. SDS-PAGE and Western blotting  
SDS-PAGE was performed using the Laemmli discontinuous buffer system (Laemmli, 
1970). Prior to loading, the samples were boiled for 5 min in SDS-PAGE sample buffer (50 
mM Tris-HCl (pH 8.8), 2% SDS, 0.05% bromofenol blue, 10% glycerol, 2 mM EDTA and 100 
mM DTT). For western blotting analysis, the proteins were transferred onto nitrocellulose 
membranes. The efficiency of transfer was controlled by staining with Ponceau S. The 
membranes were blocked for 1 h at RT with 5% skimmed milk in tris-buffered saline (TBS) 
containing 0.1% Tween 20 (TBS-T) followed by incubation for 1 h at RT with the primary 
antibodies diluted in blocking buffer (see table 6).  Immunoreactive bands were detected 
using horseradish peroxidase-linked secondary antibodies (table 6; sheep anti-rabbit HRP-
conjugated or sheep anti-mouse HRP-conjugated) and ECL West Dura Chemiluminescence 
substrate (Pierce biotechnology) or alkaline phosphatase conjugated secondary antibodies 
(table 6; goat anti-rabbit alkaline phosphatase conjugated or goat anti-mouse alkaline 
phosphatase conjugated) and NBT/BCIP (50 µg ml-1 / 50 µg ml-1) (Promega).  
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Blots shown correspond to representative results of at least 3 independent experiments. 
The quantification of the blots was performed by densitometry analysis using Fiji software. 
Loading correction was achieved by dividing the density of AIP56, p65 or cl-p65 band by the 
respective density of Ponceau S. In the case of the recycling assays, the densities of the 
GAPDH bands were used instead of Ponceau S.  
 
19. Statistical analysis 
Statistical analysis of results presented in Figures 4.2, 4.7, 4.8, 4.9, 4.13B, 4.13C, 4.16 
and 4.19 involved performing one-way or two-way ANOVA. Normality of the data was tested 
by the Kolmogorov-Smirnov test; homogeneity of variances was assessed using the Levene 
test; p-values for individual comparisons were calculated using Tukey's Honest Significant 
Difference (HSD) multiple comparisons test. Figures 4.3, 4.6, 4.11B, 4.12B and 4.13A 
present several regression models where the dependent variable is modeled as a function of 
time. In order to obtain these curves, several models were studied (linear, quadratic, inverse 
and logarithmic) and the selected models were based on the quality of the adjustment, in 
particular, the residuals distribution as well as the coefficient of determination R2. The 
analysis of the residuals included the verification of normality as well as the study of extreme 
values. Analyses were performed using the SPSS software and significance was set at 
p<0.05. 
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1. Interaction of AIP56 with mammalian cells 
We have previously shown that AIP56 is a metalloprotease AB toxin that cleaves NF-
B p65 at an evolutionary conserved peptide bond, formed by the Cys39-Glu40 residues, 
located at the N-terminal region of the Rel homology domain. We also showed that 
incubation of sea bass peritoneal leukocytes (sbPL) with the toxin ex vivo results in NF-B 
p65 depletion (Silva et al, 2013). However nothing was known about the interaction of 
AIP56 with different cell types. Furthermore, there was a lack of appropriate and 
established tools (e.g. antibodies, protocols, etc.) available to study AIP56 trafficking in 
fish cells. These led us to search for an alternative model. Although mammals are not 
susceptible to infection by Phdp, likely due to temperature and osmolarity restrictions 
(Magariños et al, 1992), we decided to evaluate the susceptibility of different mammalian 
cells to AIP56. Thus, we tested macrophage (J774A.1, Raw264.7, THP-1) and epithelial 
(HeLa, CHO, Vero) cell lines as well as primary macrophages (mouse bone marrow 
derived macrophages, mBMDM). 
 
1.1. AIP56 cleaves NF-B p65 in different cell lines but does not induce 
apoptosis 
To investigate the susceptibility of different mammalian cell lines to AIP56, cells were 
left untreated or incubated with the toxin and, at different time-points, samples were 
collected for assessment of NF-B p65 cleavage and for morphological and viability 
analysis. Mock-treated cells were used as control and the metalloprotease mutant 
AIP56AAIVAA was included in some experiments, to assess the involvement of the 
metalloprotease activity in AIP56 intoxication. As shown in Figure 4.1A, AIP56 was able to 
enter and cleave NF-B p65 in J774A.1, Raw264.7 and HeLa cells. However, contrarily to 
what was previously reported for sea bass peritoneal leukocytes (Silva et al, 2013), the 
decrease in p65 levels was transient and after 24 h incubation the normal levels of p65 
were fully recovered (Figure 4.1B). Accordingly, phase-contrast microscopy revealed no 
morphological alterations, even after 24 h incubation (Figure 4.1C). In agreement with the 
absence of morphological alterations, no differences in the viability (metabolic capacity) of 
cells treated with AIP56 was observed when compared to cells untreated or treated with 
the catalytically inactive mutant AIP56AAIVAA (Figure 4.1D). The susceptibility to AIP56 was 
found to be cell-type dependent, since no p65 cleavage was observed in THP-1, CHO or 
Vero cell lines (Figure 4.1A). 
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Figure 4.1. AIP56 cleaves NF-B p65 in mammalian cell lines but does not induce apoptosis. (A) Cell lines were left 
untreated or incubated with 10 µg ml-1 AIP56, washed to remove unbound toxin and chased at 37ºC for the indicated time-
points. Cleavage of NF-B p65 was analyzed by western blotting (ECL detection: J774A.1, Raw264.7 and HeLa; 
chromogenic detection: THP-1, CHO and Vero; cl-p65: p65 cleavage fragment). (B) Kinetic analysis of AIP56-induced NF-
B p65 cleavage in J774A.1 cells. Cells were treated as described in A with the indicated concentrations of AIP56. 
Cleavage of NF-B p65 was analyzed by western blotting (chromogenic detection). To control the protein loading, the 
membrane was stained with Ponceau S (bottom panel). The blots shown in A and B are representative of four independent 
experiments. (C) Incubation of different cell lines with AIP56 does not result in morphological alterations. Phase contrast 
microscopy of macrophage (J774A.1 and Raw264.7 cells) and epithelial (HeLa) cell lines incubated with 10 µg ml-1 AIP56 or 
the catalytically inactive mutant AIP56AAIVAA for 24 hours at 37ºC. Images shown are derived from one out of four 
independent experiments. (D) Mammalian cell lines incubated with AIP56 have no alterations in metabolic capacity. Cells 
were incubated with 10 µg ml-1 of AIP56 or AIP56AAIVAA and at the indicated time-points the indicator dye resazurin was 
added. Cells were incubated for more 3 h at 37ºC, and the conversion of resazurin in resorufin measured at an excitation 
wavelength of 560 nm and an emission wavelength of 590 nm. Results are expressed as relative fluorescence units (RFU) 
(mean ± SD, n=4).  
 
 
1.2. AIP56 induces depletion of NF-B p65 and apoptosis in mBMDM 
To access the susceptibility of mBMDM to AIP56, cells were incubated with the toxin 
for a maximum of 24 h and analyzed by phase contrast microscopy for detection of 
morphological alterations and by western blotting for accessing the occurrence of NF-B 
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p65 cleavage. When mBMDM were treated with AIP56, morphological alterations were 
evident from 6-24 h incubation (Figure 4.2A). These alterations were dependent on the 
metalloprotease activity of the toxin, since they did not occur after incubation with the 
AIP56 metalloprotease mutant AIP56AAIVAA (Figure 4.2A). The cellular alterations included 
shrinkage and rounding up of the cells and membrane blebbing, and resulted in the 
detachment of almost all cells after 24 h incubation (Figure 4.2A), suggesting the 
occurrence of an apoptotic death process. Assessment of nuclear DNA fragmentation by 
TdT-mediated dUTP Nick-End Labeling (TUNEL) and fluorimetric measurement of 
caspase-3 activity confirmed that mBMDM exposed to AIP56 were undergoing apoptosis 
(Figure 4.2B and 4.2C). As expected, cells treated with AIP56AAIVAA revealed no signs of 
apoptosis (Figure 4.2B and 4.2C). Western blotting analysis revealed that intoxication of 
mBMDM by recombinant AIP56 resulted in time- and dose-dependent decrease of NF-B 
p65 protein levels leading to a complete depletion at longer incubation times (Figure 
4.2D). Altogether, these results indicate that, similarly to what has been reported in sbPL, 
intoxication of mBMDM by AIP56 results in p65 depletion and apoptosis. 
 
 
Figure 4.2. Intoxication of mBMDM with AIP56 leads to NF-B p65 depletion and apoptosis. (A) Incubation of mBMDM 
with AIP56 results in apoptotic morphological alterations and cell loss. Phase contrast microscopy of mBMDM incubated 
with 5 µg ml-1 of recombinant AIP56 or AIP56AAIVAA for the indicated time-points. Images shown are derived from one out of 
three independent experiments. (B) Incubation of mBMDM with AIP56 results in the appearance of TUNEL-positive and 
condensed nuclei. Cells were incubated with 5 µg ml-1 of recombinant AIP56 or catalytic inactive AIP56AAIVAA for the 
indicated time-points and processed for the detection of DNA fragmentation by TUNEL (green). Nuclei were counterstained 
with propidium iodide (red). Images shown are derived from one out of three independent experiments. (C) Incubation of 
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mBMDM with AIP56 results in caspase-3 activation. Cells were incubated with 5 µg ml-1 recombinant AIP56 or AIP56AAIVAA 
for the indicated time-points and caspase-3 activity determined by fluorimetry using the substrate Z-DEVD-AMC. The 
results, in relative fluorescence units per nanogram of protein were converted to fold increase by comparing to values 
obtained in extracts from mock-treated cells (n=7; the middle bar corresponds to the median and the lower and upper side 
of the boxes, the first and third quartiles; circle and asterisk signal extreme observations). The fold increase in caspase-3 
activity following treatment with AIP56AAIVAA (white bars) is not statistically different from 1 whereas it is significantly different 
from 1 at all time-points following treatment with recombinant AIP56 (dark grey bars) (p-values for 3, 6 and 9 h: 0.018, 
0.008, 0.033, respectively). Statistical analysis involved performing one sample t-test for the hypothesis that the fold 
increase is equal to 1. Extracts from staurosporine-treated cells (light grey bar) were used as a positive control (n=5). (D) 
Incubation of mBMDM with AIP56 results in NF-B p65 depletion. Cells were left untreated or incubated with the indicated 
doses of recombinant AIP56 for 30 min on ice, washed and chased at 37ºC for the indicated times. Cleavage of NF-B p65 
was analyzed by western blotting (chromogenic detection). The graph shows quantification of the blots. Loading correction 
was achieved by dividing the density of p65 band by the respective density of Ponceau S. The results were divided by the 
same constant in order to set to 1 the mean of the control (cells not exposed to recombinant AIP56). Plotted values 
correspond to the estimated means of three independent experiments. Dose and time dependence on intact p65 levels 
were tested by two-way ANOVA (dose main effect p<0.001, time main effect p<0.001 and interaction dose with time 
p<0.001; there was a significant difference of the group “no toxin (dose 0)” with respect to the other groups, Tukey´s HSD 
p<0.001). 
 
The presence of the p65 cleavage fragment (cl-p65) is time-dependent, since it was 
detected in cells up to 1.5 h after intoxication but not in cells subjected to longer 
incubation times (Figure 4.2 D). Similarly, in sbPL, the p65 cleavage fragment was 
detected up to 4 h but was no longer visible after intoxication for 6 h (Figure 4.3). Using 
the proteosomal inhibitor MG132, we found that degradation of the p65-cleavage fragment 
originated by AIP56 depends on proteosomal activity, in agreement to what has been 
reported for the p65 cleavage fragment resulting from the activity of the type III effector 
NleC (Yen et al, 2010). It is possible that the faster degradation of the cleavage fragment 
observed in mBMDM results from an increased activity of the proteasomal machinery in 
mBMDM than in sbPL. 
 
 
 
Figure 4.3. Degradation of the AIP56-generated NF-B p65 cleavage fragment (cl-p65) is dependent on the activity 
of the proteasome.  sbPL were left untreated or incubated with 20 µM of the proteosomal inhibitor MG132 for 1 h, pulsed 
with 10 µg ml-1 of recombinant AIP56 for 30 min on ice, washed to remove unbound toxin, shifted to 22ºC and chased for 
the indicated time-points. Cleavage of NF-B p65 was analyzed by western blotting (chromogenic detection). To control the 
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protein loading, the membrane was stained with Ponceau S (bottom panel). The graph shows the results of the 
quantification of the blots from three independent experiments. Values correspond to density of cl-p65 relative to density of 
Ponceau S of the respective lane. The quadratic regression model represents cl-p65 as a function of time (AIP56 R2=0.941, 
AIP56+MG132 R2=0.958). 
 
1.3. Apoptosis of mBMDM induced by AIP56 occurs in the absence of TNF-α or 
TLR4 signaling 
Depending on the cell type, down-regulation of NF-B p65 per se may not be sufficient 
to induce apoptosis. However it is also known that cells with depletion of NF-B p65 are 
more susceptible to start an apoptotic process in response to different stimuli, including 
TNF-α and TLRs ligands (Beg & Baltimore, 1996; Hsu et al, 2004; Wang et al, 1996).  
 
 
 
 
 
Figure 4.4. AIP56-induced apoptosis in mBMDM occurs in the absence of TNF-α or TLR4 signaling. (A) Phase 
contrast microscopy of mBMDM incubated with 5 µg ml-1 AIP56 or the catalytically inactive mutant AIP56AAIVAA for the 
indicated time-points. Images shown are derived from one out of two independent experiments. (B) Incubation of TNF-α-/- or 
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TLR-4-/- mBMDM with AIP56 results in the activation of the effector caspase-3. Cells were incubated with 5 µg ml-1 
recombinant AIP56 or the catalytically inactive mutant AIP56AAIVAA for the indicated time-points and caspase-3 activity 
determined by fluorimetry using the substrate Z-DEVD-AMC. The results are presented as relative fluorescence units (RFU) 
per nanogram (ng) of protein. The bar graph shows the results of two independent experiments (mean ± SD, n=2). (C) 
Incubation of TNF-α-/- or TLR-4-/- mBMDM with AIP56 results in NF-B p65 depletion. Cells were left untreated or incubated 
with 5 µg ml-1 AIP56 or AIP56AAIVAA for 30 min on ice, washed to remove unbound toxin and chased at 37ºC for the indicated 
time-points. Wild-type (WT) mBMDM were used as control. Cleavage of NF-B p65 was analyzed by western blotting 
(chromogenic detection). The blot shown is representative of two independent experiments.  
 
To determine if TNF-α or TLR-4 signaling were involved in AIP56-induced toxicity, we 
performed the intoxication assays in mBMDM from TNF-α and TLR-4 knockout mice.  As 
shown in Figure 4.4A, similarly to what was observed in wild type cells, morphological 
alterations typical of an apoptotic death process were observed in TNF-α-/- and TLR-4-/- 
macrophages treated with AIP56. The detection of DNA fragmentation by TUNEL (not 
shown) and the detection of caspase-3 activity (Figure 4.4B) confirmed that AIP56 
induces apoptosis in TNF-α-/- and TLR-4-/- cells. In agreement with this observation, 
intoxication of TNF-α-/- or TLR-4-/- macrophages resulted in complete depletion of NF-B 
p65 (Figure 4.4C). However, a slight delay in toxicity was observed in TLR-4-/- 
macrophages when compared to WT or TNF-α-/- cells (Figure 4.4A). While in WT 
macrophages after 12 h incubation the cellular apoptotic morphology is evident, with some 
cells detached, in TLR-4-/- macrophages cellular morphological alterations were only 
slightly evident (Figure 4.4A). Accordingly, in TLR-4-/- cells, the levels of caspase-3 activity 
were found to be lower at 6 h and prolonged to 12 h after infection with AIP56 (Figure 
4.4B). These results indicate that TNF-α or TLR4 signaling are not mandatory for 
intoxication of mBMDM in response to AIP56 but suggest that TLR4 signaling may 
potentiate toxicity. 
 
2. AIP56 endocytic uptake 
2.1. AIP56 is rapidly endocytosed in vesicle-like structures 
The observation that AIP56 cleaves NF-B indicates that the toxin is able to reach the 
cytosol of target cells. To investigate the entry mechanisms used by the toxin we used 
fluorescence microscopy and biochemical approaches. 
In order to perform the fluorescence microscopy studies we labeled AIP56 with 
fluorescein isothiocyanate (FITC) or Alexa Fluor 488. Alexa Fluor 488 dye is spectrally 
similar to fluorescein but more photostable (Panchuk-Voloshina et al, 1999). Furthermore, 
unlike fluorescein, the fluorescence of the Alexa Fluor 488 dye is insensitive to pH 
changes (in the range between pH 4 and 10) (Panchuk-Voloshina et al, 1999). The use of 
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a pH insensitive fluorescent dye is particularly relevant in cellular trafficking experiments, 
since different intracellular compartments have different pH. Although fluorescent labeled 
AIP56 was not as active as unlabeled toxin, it retained the ability to cleave NF-B p65 and 
to induce apoptosis upon addition to cells (Figure 4.5A and B) and, therefore, was used to 
study AIP56 intracellular trafficking. Since similar results were obtained using FITC- or 
Alexa Fluor 488-labeled AIP56 (Figure 4.5C) both proteins were used to perform different 
experiments. 
 
 
Figure 4.5. Fluorescent labeled AIP56 retained toxicity. (A) sbPL were incubated with 10 µg ml-1 of the indicated proteins 
for 30 min on ice, washed to remove unbound toxin and chased for 2 h at 22ºC. Cleavage of NF-B p65 was analyzed by 
western blotting (chromogenic detection). (B) sbPL were incubated with 10 µg ml-1 AIP56, FITC-AIP56 or Alexa 488-AIP56, 
for 4 h at 22ºC. Mock-treated cells were used as control. Images shown are representative cytospin preparations stained 
with Antonow´s (Afonso et al, 1998; do Vale et al, 2002) for labelling neutrophils (brown) followed by hemacolor. Note the 
presence of several apoptotic cells in samples incubated with AIP56, FITC-AIP56 or Alexa 488-AIP56 and their absence in 
mock-treated cells. (C) Confocal microscopy of mBMDM incubated with FITC-AIP56 or Alexa 488-AIP56 resulted in similar 
observations.  Representative confocal images of mBMDM pulsed with FITC-AIP56 or Alexa 488-AIP56 (green) for 30 min 
on ice, washed and chased at 37ºC. At the indicated times, cells were fixed, actin was labeled with Alexa Fluor 594-
Phalloidin (red) and nuclei were counterstained with DAPI (blue). A merge of the different channels is shown. 
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To analyze AIP56 internalization, fluorescent labeled toxin was incubated with cells 
for 30 min on ice, unbound toxin was washed out and cells were then transferred and 
incubated for different time intervals at 22ºC or 37ºC for sbPL or mBMDM, respectively. 
Incubation of fluorescent labeled AIP56 with sbPL or mBMDM resulted in similar 
observations (Figure 4.6A). After 5 min incubation with sbPL or mBMDM, AIP56 was 
observed in vesicle-like structures (Figure 4.6A), suggesting that binding of the toxin to the  
 
 
Figure 4.6. AIP56 is rapidly endocytosed into vesicle-like structures (A) Representative confocal images of mBMDM 
and sbPL pulsed with 10 µg ml-1 Alexa 488-AIP56 (green) for 30 min on ice, washed and chased at the appropriate 
temperature for the indicated time-points. After fixation, F-actin was stained with Alexa 594-Phalloidin (red) and nuclei with 
DAPI (blue). A merge of the different channels is shown. Images shown are derived from one out of three independent 
experiments. (B) Shortly after incubation with mBMDM or sbPL, AIP56 localizes in a protease protected compartment. 
mBMDM or sbPL were pulsed with 5 µg ml-1  AIP56V5 or 10 µg ml-1 AIP56, respectively, washed to remove unbound toxin 
and shifted to 37ºC (mBMDM) or 22ºC (sbPL). At the indicated time-points, to remove extracellular toxin, cells were treated 
with pronase E (pronE) and the intracellular pool detected by western blotting (mBMDM: anti-V5 antibody, chromogenic 
detection; sbPL: anti-AIP56 rabbit serum, ECL detection). The blots shown are representative of three independent 
experiments. (C) Intracellular AIP56 decreases at longer chasing times in a proteosomal-independent way.  sbPL were 
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incubated with 20 µM of the proteosomal inhibitor MG132 for 1 h before incubation with 10 µg ml-1 AIP56Myc as described 
in (B). Intracellular AIP56 was detected by western blotting using an anti-c-Myc antibody (ECL detection). The activity of 
MG132 was confirmed by looking at its inhibitory effect upon the degradation of the AIP56-generated NF-B p65 cleavage 
fragment (These experiments were done in parallel with those shown in Figure 4.3). The graphs show quantification of the 
blots (three independent experiments). Loading correction was achieved by dividing the density of AIP56Myc band by the 
respective density of Ponceau S. The inverse regression models represent AIP56Myc as a function of time (AIP56Myc 
R2=0.635 and AIP56Myc+MG132 R2=0.643). 
 
 cell surface was followed by endocytosis. Over time, the AIP56-positive vesicles 
increased in size and were found to concentrate in a more perinuclear area, and from 30 
minutes onwards the AIP56-associated fluorescence gradually decreased (Figure 4.6A). 
Western blotting analysis confirmed the internalization of the toxin (Figure 4.6B). This 
analysis showed that in mBMDM, after a 30 min pulse on ice followed by a 5 min 
incubation at 37ºC, a significant proportion of the toxin had been internalized (Figure 
4.6B). Similar results were obtained in sbPL (Figure 4.6B), but in this case, the shorter 
time that we were able to analyze was 15 min, because in these cells endocytosis cannot 
be blocked by cooling as in mammalian cells (not shown) and they needed to be 
centrifuged for washing. A kinetic analysis of the entry in sbPL revealed a marked 
decrease of intracellular toxin after 60 min incubation (Figure 4.6C), not prevented by the 
proteosomal inhibitor MG132 (Figure 4.6C), suggesting that did not result from 
proteosomal degradation of the toxin.  
 
2.2. AIP56 intoxication in mBMDM involves interaction of the C-terminal region 
of the toxin with cell surface components 
Previous studies with sbPL showed that the entry of the toxin involves specific 
interaction of its C-terminal region with cell surface components (Silva et al, 2013). To 
investigate if the C-terminal region of AIP56 is also playing a role in the entry of the toxin 
in mBMDM, we performed a competition assay testing the ability of the C-terminal 
truncate AIP56286-497C298S (corresponding to the toxin’s B domain) (Silva et al, 2013) to 
inhibit the arrival of the toxin into the cytosol. The N-terminal truncate AIP561-285C262S 
corresponding to the toxin’s A domain (Silva et al, 2013) was used as a control. The 
competitors were allowed to incubate with cells for 15 min on ice to block the receptors at 
cell surface before the addition of AIP56. The cleavage of p65 was assessed after 2 h 
incubation and was used as a read-out for the presence of the toxin in the cytosolic 
compartment. Pre-incubation of the cells with the C-terminal truncate inhibited p65 
cleavage whereas no inhibition was observed when the N-terminal truncate was used as a 
competitor (Figure 4.7A), indicating that in mBMDM the C-terminal domain of AIP56 was 
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able to block the internalization of the full-length toxin. This suggests that, similarly to what 
has been reported for sbPL, the entry of AIP56 in mBMDM involves interaction of its C-
terminal domain with cell surface receptors. 
 
   
Figure 4.7. AIP56 C-terminal domain is involved in binding/entry into mBMDM and the N-terminal domain plays the 
catalytic role. (A) Intoxication of mBMDM by AIP56 is inhibited by the toxin’s B domain AIP56286-497C298S. Cells were 
incubated with 7 µM of AIP561-285C262S (AIP56Nterm) or AIP56286-497C298S (AIP56Cterm) for 15 min on ice, followed by further 
15 min incubation with an 800-fold lower concentration of recombinant AIP56 in the presence of the competitor. Cells were 
washed and incubated at 37ºC for 2 h. Cleavage of NF-B p65 was assessed by western blotting (chromogenic detection). 
The bar graph shows the quantification of the blots and combines the results of three independent experiments (mean ± 
SD). Loading correction was achieved by dividing the density of p65 by the respective density of Ponceau S. The results 
were divided by the same constant in order to set to 1 the mean of the control (mock-treated cells). The significance of 
differences was tested by one-way ANOVA. p-values for individual comparisons were calculated using Tukey's HSD 
multiple comparisons test and are indicated in the graph. (B) Delivery of AIP56 N-terminal domain into the cell’s cytosol 
reproduces the activity of the full length toxin. mBMDM were incubated for 2 h at 37ºC with 20 nM of LF11-263∙AIP561-261 
(LF∙AIP56Nterm) or LF11-263∙AIP56299-497 (LF∙AIP56Cterm) in the presence of 10 nM of PA and cleavage of NF-B p65 detected 
by western blotting (chromogenic detection). Mock treated cells and cells incubated with 0.5 µg ml−1 (8.75 nM) of AIP56 
were used as control. The blot shown is representative of three independent experiments. 
 
For finding out whether in mBMDM the N-terminal domain does not need the C-
terminal domain to exert its catalytic effect, a strategy to deliver the AIP56 N-terminal 
portion into the cell cytosol was delineated based on the Bacillus anthracis protective 
antigen (PA)/lethal factor (LF) delivering system, as already performed with great success 
in sbPL (Silva et al, 2013) and in the delivering of the catalytic domain of different toxins 
like diphtheria toxin, shiga toxin and Pseudomonas exotoxin into the cytosol (Arora & 
Leppla, 1993; Arora & Leppla, 1994; Milne et al, 1995). Because the first 263 N-terminal 
residues of LF were found to be sufficient for recognition and binding to the protective 
antigen (PA), the receptor binding subunit of LF (Collier, 2009), and able to cause cellular 
uptake of fused polypeptides (Arora & Leppla, 1993), chimeric proteins consisting of LF N-
terminal region (LF11-263) fused to AIP56’s N-terminal (LF11-263.AIP561-261) or C-terminal 
(LF11-263.AIP56299-497) domain were produced.  LF11-263.AIP56299-497 was used as control. 
.mBMDM were intoxicated with 20 nM of the chimeric proteins in the presence of 10 nM 
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PA. By western blotting analysis a significant decrease in p65 levels was observed in cells 
incubated with LF11-263.AIP561-261, reproducing the effect of AIP56 holotoxin, while no 
differences in p65 levels was observed in cells incubated with LF11-263.AIP56299-497 (Figure 
4.7B). This confirms that, like occurs in sbPL, in mBMDM AIP56 N-terminal domain plays 
the catalytic role and the C-terminal domain is involved in binding/entry into mBMDM. 
 
2.3. AIP56 endocytosis and toxicity require dynamin and clathrin  
To enter host cells, bacterial toxins are known to use clathrin-dependent and/or 
clathrin-independent endocytic mechanisms. Dynamin is a GTPase involved in endocytic 
membrane fission that is known to be involved in clathrin-dependent endocytosis, 
although it may also participate in clathrin-independent endocytosis pathways (Ferguson 
& De Camilli, 2012). To investigate if AIP56 endocytosis is dependent on clathrin and/or 
dynamin, we inhibited their functions using the specific cell-permeable inhibitors 
chlorpromazine (Wang et al, 1993) and dynasore (Kirchhausen et al, 2008), respectively. 
In vitro tests, using in vitro translated 35S-labeled sbp65Rel as substrate, confirmed 
that chlorpromazine and dynasore did not affect AIP56 metalloprotease activity (Figure 
4.8A). Phagocytosis assays confirmed that they were acting specifically (Figure 4.8B). 
Phagocytic uptake was not affected by dynasore or chlorpromazine, confirming that these 
inhibitors are not having a broad inhibitory effect upon all endocytic pathways. In contrast, 
phagocytosis was strongly inhibited by cytochalasin D, confirming disruption of actin 
function by the inhibitor.  
 
  
Figure 4.8. AIP56 metalloprotease activity is not abolished by inhibitors of the intracellular trafficking and 
endocytic pathway. (A) The inhibitors of intracellular trafficking and endocytosis used in this work do not inhibit AIP56 
activity in vitro. In vitro translated 35S-labeled sbp65Rel was incubated for 2 h at 22ºC with 100 nM (5.7 µg ml-1) AIP56 in the 
presence of the inhibitors at the concentration used for the ex vivo assays (see table 5 in Chapter III) in a final volume of 20 
µl. 35S-labeled sbp65Rel incubated with AIP56 in the absence of the inhibitors was used as control. The reaction was 
stopped by adding SDS-PAGE sample buffer and p65 cleavage assessed by autoradiography. The result shown is 
representative of two independent experiments. (B) Phagocytic uptake was strongly inhibited by cytochalasin D but was not 
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affected by dynasore or chlorpromazine. mBMDM were incubated with cytochalasin D (cyto D),  dynasore (dyn) or 
chlorpromazine (cpz) for 1 h at 37ºC or left untreated prior to phagocytosis assay. Listeria monocytogenes EGD (LmEGD) 
was added to the cells and incubated for 30 min at 37ºC. Extracellular bacteria were killed with gentamicin for 1 h at 37ºC, 
cells were washed, lysed and serial dilutions plated in BHI agar. Colony forming units (CFU) were determined after 24 h 
incubation and normalized to CFU in cells treated with bacteria in the absence of the inhibitors. Assays were performed in 
triplicate. The obtained values were divided by the same constant in order to set to 1 the mean of the control (LmEGD with 
no inhibitor) and are presented as means ± SD of four independent experiments. The significance of differences was tested 
by one-way ANOVA.  p-values for the comparisons to LmEGD with no inhibitor were calculated using Tukey's HSD multiple 
comparisons test and are indicated in the graph.  
 
To test the effect of chlorpromazine and dynasore in AIP56 endocytosis, we 
treated mBMDM with the inhibitors or left the cells untreated before pulsing with 
recombinant toxin for 30 min on ice. Cells were washed, transferred to 37ºC and after 2 
min chase, extracellular toxin was removed with pronase E. As shown in Figure 4.9A, 
endocytosed AIP56 was detected in control cells but not in cells pre-treated with 
chlorpromazine and dynasore. The inhibitory effect of the inhibitors upon AIP56 
endocytosis together with the observation that the AIP56-dependent cleavage of p65 was 
strongly inhibited by pre-treatment with chlorpromazine and was prevented by pre-
treatment with dynasore (Figure 4.9B) suggests that a significant pool of AIP56 is 
endocytosed through a clathrin- and dynamin-dependent pathway.  
 
 
Figure 4.9. AIP56 endocytosis and toxicity require clathrin and dynamin. (A) AIP56 endocytosis is prevented by 
chlorpromazine and dynasore. mBMDM were pre-treated with chlorpromazine (cpz) or dynasore (dyn), pulsed with AIP56V5 
in the presence of the inhibitors for 30 min on ice, washed and incubated at 37ºC in culture medium with the inhibitor. After 2 
min, surface-exposed toxin was removed with pronase E (pronE) and the intracellular pool was detected by western blotting 
(chromogenic detection). The result shown is representative of three independent experiments. (B) AIP56-mediated 
cleavage of NF-B p65 is inhibited by chlorpromazine and dynasore. mBMDM or sbPL were treated with chlorpromazine or 
dynasore, pulsed with AIP56 for 30 min on ice, washed and shifted to 37ºC (mBMDM) or 22ºC (sbPL) for 2 h, while 
maintaining the inhibitory conditions. Cleavage of NF-B p65 was assessed by western blotting (chromogenic detection). 
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The graphs show the quantification of the blots. Loading correction was achieved by dividing the density of p65 by the 
respective density of Ponceau S. The results used for each graph were divided by the same constant in order to set to 1 the 
mean of the control (mock-treated cells). Each graph combines the results of three independent experiments (mean ± SD). 
The significance of differences was tested by one-way ANOVA. p-values for individual comparisons were calculated using 
Tukey's HSD multiple comparisons test and are indicated in the graphs. 
 
2.4. Microtubules and actin dynamics are dispensable for intoxication by AIP56 
Functional actin dynamics are required for several endocytic processes, from clathrin-
dependent to clathrin-independent endocytosis (Doherty & McMahon, 2009). To 
determine if internalization of AIP56 depends on actin, we disrupted actin filaments with 
cytochalasin D and assessed whether the disruption inhibited endocytosis of the toxin and 
arrival of the toxin into the cytosol (assessed using AIP56-mediated p65 cleavage as a 
read-out). The efficacy of cytochalasin D treatment was confirmed by phagocytosis 
assays (Figure 4.8B) and by staining actin filaments with the F-actin probe Alexa Fluor-
594 Phalloidin (Figure 4.10A). Treatment with cytochalasin D did not inhibit AIP56 
endocytosis (Figure 4.10B) and did not significantly affect AIP56-dependent p65 cleavage 
(Figure 4.10C), indicating that AIP56 intoxication does not require functional actin 
dynamics.  
 
 
 
Figure 4.10. AIP56 intoxication is independent on actin filaments and microtubules. (A) Effect of cytochalasin D 
treatment on actin filaments. Cells were pre-treated with cytochalasin D (cyto D) and then processed for fluorescence 
microscopy to detect actin filaments using the F-actin probe Alexa Fluor-594 Phalloidin (red). Nuclei were counterstained 
with DAPI (blue). A merge of the different channels is shown. Images shown are derived from one out of three experiments. 
(B) AIP56 endocytosis is not inhibited by cytochalasin D or nocodazole. mBMDM were treated with cytochalasin D or 
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nocodazole (noco) before incubation with 5 µg ml-1 AIP56 in the presence of the inhibitors for 30 min on ice, washed and 
incubated at 37ºC in culture medium containing the inhibitors. After 5 min, surface-exposed cell-associated toxin was 
removed with pronase E (pronE) and the intracellular pool was detected by western blotting using an anti-V5 antibody 
(chromogenic detection). (C) The arrival of AIP56 into the cytosol is not prevented by cytochalasin D. sbPL or mBMDM were 
treated with cytochalasin D at the appropriate temperature prior to incubation with AIP56 for 30 min on ice in the presence 
of the inhibitor. Cells were washed and shifted to 22ºC (sbPL) or 37ºC (mBMDM) for 2 h while maintaining the inhibitory 
conditions. Cleavage of NF-B p65 was assessed by western blotting (chromogenic detection). The blots shown are 
representative of three independent experiments. 
 
The involvement of microtubules in AIP56 uptake was investigated using the 
microtubule depolymerizing agents nocodazole (Vasquez et al, 1997) and colcemid (Yang 
et al, 2010) and also the microtubule stabilizing agent taxol (Schiff et al, 1979). The effect 
of these compounds on microtubules was confirmed by immunofluorescence using an 
anti-α-tubulin antibody. As shown in Figure 4.11A, in cells treated with PBS microtubules 
radiate from the cell center to the cell periphery while in cells treated with nocodazole or 
colcemid a dramatic decrease in the number of microtubules per cell was noticed. In cells 
treated with taxol, an increase in tubulin polymerization was observed (Figure 4.11A). The 
effect of nocodazole was also confirmed by testing its effect in the delivery of the AIP56 
catalytic domain using the PA+LF delivery system. It is known that cytoplasmic release of 
anthrax lethal factor (LF) occurs preferentially from late endosomes in a microtubule-
dependent way and that depolymerization of microtubules with nocodazole delays LF 
toxicity (Abrami et al, 2004). It is also known that AIP56 catalytic domain can be delivered 
into the cytosol using the PA+LF system (Silva et al, 2013). Therefore, to confirm 
functional disruption of microtubules by nocodazole in mBMDM, we tested the effect of the 
inhibitor upon delivery of AIP56 catalytic domain by PA+LF. This was used as a control in 
AIP56-intoxication assays performed in the presence of nocodazole. As shown in Figure 
4.11B, disruption of microtubules with nocodazole delayed the delivery of the AIP56 
catalytic domain using the PA+LF delivery system (LF11-263.AIP561-261) but did not affect 
AIP56-dependent p65 cleavage. Accordingly, when mBMDM or sbPL were pre-treated 
with colcemid or taxol, which also interfere with microtubules dynamics, no differences in 
AIP56-dependent p65 cleavage was observed when compared to cells only treated with 
the toxin (Figure 4.11C). These results, together with the fact that nocodazole does not 
inhibit AIP56 endocytosis (Figure 4.10B), strongly suggest that AIP56 exploits a 
microtubule-independent intoxication pathway.  
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Figure 4.11. AIP56 intoxication is independent on microtubules. (A) Effect of nocodazole, colcemid and taxol on 
microtubules. Cells were treated with nocodazole (noco), colcemid (colc) or taxol and microtubules were visualized after 
staining with an anti-α-tubulin antibody (green). Untreated cells were used as control. Nuclei were counterstained with DAPI 
(blue). Images shown are derived from one out of three experiments. (B) Nocodazole does not affect AIP56 intoxication but 
delays the delivery of the AIP56 catalytic domain into the cytosol through the PA+LF delivery system. mBMDM were left 
untreated or treated with nocodazole before incubation with 5 µg ml-1 (89 nM) AIP56 or 10 nM PA + 20 nM LF11-263.AIP561-261 
(PA+LF.AIP56Nterm)  for 30 min on ice, washed and incubated in culture medium with or without the inhibitor. At the indicated 
time-points, cells were washed and processed for western blotting (chromogenic detection) for assessing NF-B p65 
cleavage. The experiment was repeated six times. Quadratic regression models were estimated of intact p65 as function of 
time. In the case of PA+LF.AIP56, R2 for the two models (-noco and +noco) was, respectively, 0.786 and 0.638; for AIP56, 
R2 for the two regression models (-noco and +noco) was, respectively, 0.863 and 0.874. (C) The arrival of AIP56 into the 
cytosol is not prevented by compounds that interfere with microtubules dynamics. sbPL or mBMDM were treated with 
nocodazole, colcemid or taxol at the appropriate temperature prior to incubation with AIP56 for 30 min on ice in the 
presence of the inhibitor. Cells were washed, shifted to 22ºC (sbPL) or 37ºC (mBMDM) and incubated for 2 h in culture 
medium while maintaining the inhibitory conditions. Cleavage of NF-B p65 was assessed by western blotting (chromogenic 
detection). The blots shown are representative of three independent experiments.  
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3. AIP56 intracellular pathway 
3.1. Upon endocytosis, AIP56 localizes in early endosomes and then is routed to 
the recycling endocytic compartment 
To further characterize the intracellular trafficking of AIP56, cells were pulsed with 
Alexa 488-AIP56 for 30 min on ice, washed to remove unbound toxin and transferred to 
37ºC. At different chase times, cells were processed for immunofluorescence to assess 
the co-localization of the toxin with established markers of intracellular compartments 
(Figure 4.12). Co-localization experiments are only reported for mBMDM, because most of 
the commercially available antibodies and probes are not validated or do not work on fish 
cells. After 2 min chase, Alexa 488-AIP56 was observed in peripheral endocytic vesicles 
negative for all the markers tested, but shortly after (5 min chase), part of the toxin-
containing vesicles were positive for the early endosome marker EEA-1 (Figure 4.12). The 
co-localization with EEA-1 reached a maximum at 15/20 min and afterwards markedly 
decreased, being minimal at 60 min (Figure 4.12). These results indicate that after 
endocytosis, AIP56 localizes in early endosomes, where it remains for 20-30 min. In a 
more detailed analysis of cells immunostained for EEA-1 (Figure 4.12B), we can observe 
that AIP56 starts by appearing in the lumen of EEA1 positive vesicles to then, after 15 to 
20 min, appear co-localizing with EEA1 in the cytosolic endosomal membrane, in vesicles 
“donuts-like”. To define the compartment where AIP56 was being delivered after leaving 
early endosomes, we looked for co-localization of the toxin with the late 
endosome/lysosome marker LAMP-1, the Golgi apparatus marker GM130 or the 
endoplasmic reticulum marker GRP78 Bip. Alexa 647-Transferrin was used as a marker 
of the recycling route (Figure 4.12 A). It is of note that, in macrophages (Casbon et al, 
2009; Cox et al, 2000; Halaas et al, 2010; Marcil et al, 2008; Stanley et al, 2014; 
Wainszelbaum et al, 2006) similarly to what occurs in other cells (Maxfield & McGraw, 
2004), transferrin is recycled back to the cell surface using two kinetically distinguishable 
mechanisms of recycling: fast and slow recycling. This supports the use of transferrin as a 
marker for the recycling pathway in macrophages and, in particular, in mBMDM. Co-
localization of Alexa 488-AIP56 with Alexa 647-Transferrin was evident at 5 min and was 
maintained during the remaining chase (Figure 4.12), suggesting that after leaving early 
endosomes, the toxin was delivered to the recycling endocytic compartment. In 
agreement with this hypothesis, Alexa 488-AIP56 was never observed to co-localize with 
LAMP-1 (Figure 4.12A) or markers of Golgi apparatus and endoplasmic reticulum (Fig. 
4.12A).  
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Figure 4.12. Shortly after endocytosis AIP56 localizes in early endosomes and then is routed to the recycling 
compartment. (A) Representative confocal images of mBMDM pulsed with Alexa 488-AIP56 (green) for 30 min on ice, 
washed and chased at 37ºC. At the times shown, the cells were fixed and processed for immunofluorescence. Early 
endosomes were stained with an anti-EEA1 antibody, LE/lysosomes were labelled with anti-LAMP-1, Golgi apparatus with 
anti-GM130, the endoplasmic reticulum with anti-GRP78 Bip and the entire recycling pathway with a continuous incubation 
with Alexa 647-Transferrin (TF). Nuclei (blue) were counterstained with DAPI. A merge of the different channels is shown. 
Insets are magnified views of boxed areas. (B) Quantification of Alexa 488-AIP56 colocalization with EEA1 and TF. For 
each marker, the percentage of colocalization was determined for several cells (n≥15) obtained from at least three 
independent experiments.  Each point in the plot corresponds to the average of an independent experiment. Linear 
regression models were developed for each of the marker. In the case of TF the model represents TF concentration as a 
function of the logarithm of time (R2=0.71) whereas for EEA1 represents the logarithm of EEA1 as a function of the 
logarithm of time (R2=0.91). For the remaining components the observed colocalization and its variation with time was 
negligible so that the best linear model was an almost horizontal line (not shown). (C) Details of confocal images from cells 
immunostained for EEA-1. mBMDM were treated with FITC-AIP56 (green) as described in (A) and immunostained for EEA1 
(red). Nuclei (blue) were counterstained with DAPI. A merge of the different channels is shown.   
 
 
3.2.  Shortly after endocytosis a pool of AIP56 is recycled back to the 
extracellular medium through a mechanism requiring PI3K activity but 
independent on endosome acidification. 
The observation that AIP56 was delivered to the recycling endocytic compartment 
following endocytosis, suggested that the toxin was being recycled back to the 
extracellular medium. To investigate this hypothesis, we allowed mBMDM to bind AIP56 
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and internalize it for 5 min (pulse), removed the extracellular and surface-exposed cell-
associated toxin with pronase E, chased the cells at 37ºC and analyzed the presence of 
the toxin inside cells and in the extracellular medium at different chasing times. The 
absence of AIP56 in the last wash after pronase E treatment (Figure 4.13A, lane 5) 
confirmed that the extracellular AIP56 was effectively removed before chasing. After 2 min 
chase, AIP56 was detected in the extracellular medium (Figure 4.13A, lane 7). The 
amount of extracellular AIP56 increased along the kinetic (Figure 4.13A, lanes 7-10) and 
was paralleled by a decrease in the amount of cell-associated toxin (Figure 4.13A, lanes 
12-15), indicating that during chase, intracellular AIP56 was being recycled to the 
extracellular medium. The cytosolic enzyme GAPDH was only detected in cell lysates 
(Figure 4.13), confirming that the AIP56 detected in the supernatant did not result from 
cell lysis and consequent leakage of intracellular proteins.  
Since phosphoinositide 3-kinase (PI3K), an evolutionarily conserved enzyme complex 
which phosphorylates phosphatidylinositol lipid substrates into 3-phosphoinositides 
(Foster et al, 2003; Vanhaesebroeck et al, 2010), has been shown to play a key role in 
regulating the recycling pathway (Carpentier et al, 2013; Hunyady et al, 2002; Lindmo & 
Stenmark, 2006; Naughtin et al, 2010; Raiborg et al, 2013) we analyzed the involvement 
of  PI3K in  AIP56 recycling. For this, we performed recycling assays in the presence of 
LY294002, a reversible pan-inhibitor of PI3K activity (Knight et al, 2004; Vlahos et al, 
1994). The effect of LY294002 upon PI3K activity was controlled by confirming LY294002-
induced inhibition of the phosphorylation of Akt, a downstream target of PI3K (Laird et al, 
2009) (Figure 4.14A). As shown in Figure 4.13B, in the presence of LY294002 recycling of 
AIP56 was strongly inhibited (compare lanes 6 and 7 with lanes 10 and 11, respectively) 
and an increase in cell-associated toxin was observed (compare lanes 12 and 13 with 
lanes 14 and 15, respectively), suggesting that recycling of AIP56 is dependent on PI3K 
activity. Because PI3K is involved in a wide range of cellular processes (Foster et al, 
2003) including regulation of the endocytic pathway we also analyzed the effect of this 
inhibitor in AIP56 toxicity. As shown in Figure 4.13B, no differences in AIP56-dependent 
p65 cleavage was observed in cells treated with LY294002 when compared to those 
incubated with the toxin in the absence of the inhibitor, indicating that the AIP56 
intoxication pathway is independent of PI3K activity. 
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Figure 4.13. After endocytosis AIP56 is recycled back to the extracellular medium by a mechanism requiring PI3K 
activity but independent on endosomal acidification. (A) mBMDM were left untreated or incubated with 10 µg ml-1 
AIP56V5 on ice for 30 min followed by 5 min incubation at 37ºC (pulse). Cells were washed, extracellular toxin was removed 
with pronase E (pronE), and cells were washed again and chased at 37ºC for different time intervals. Cell-associated (pellet) 
and recycled (supernatant) AIP56V5 was detected by western blotting (anti-V5 antibody; chromogenic detection). To control 
the efficacy of pronase E treatment, we analyzed the presence of the toxin in the last wash before pronase E treatment 
(wash BP) and in the last wash after pronase E treatment (wash AP). Samples (washes, supernatants and pellets) from 12 
wells were pooled and the equivalents to 12 wells for washes/supernatants or 4 wells for pellets were loaded in the gels. 
GAPDH was used as a cytosolic marker. The graphs show the quantification of the recycled or cell associated AIP56V5 
relative to the total internalized protein (lane 3) and combines results from three independent experiments (represented by 
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different symbols). The logarithmic regression model represents the percentage of recycled or cell associated AIP56V5 as a 
function of time (recycled R2=0.451, cell-associated R2=0.679). (B) LY294002 inhibits the recycling of AIP56 into the 
extracellular medium but not it´s toxicity. (I) mBMDM were left untreated or treated with LY294002 (LY) before performing 
the recycling or toxicity assays in the presence of the inhibitor. The recycling protocol was the same as described in (A). The 
graph shows the quantification of the blots and combines results from four independent experiments (the middle line in each 
box corresponds to the median and the lower and upper side of the boxes to the first and third quartiles; whiskers represent 
the smallest and largest observed values). Values correspond to percentage of recycled AIP56V5 relative to the total 
internalized protein (lane 3). Statistical analysis involved performing two-way ANOVA (main effect of inhibitor p<0.001, main 
effect of time p=0.073, inhibitor and time interaction p=0.059). (II) Toxicity (cleavage of NF-kB) was assessed and quantified 
as described in Figure 4.9B. The significance of differences was tested by one-way ANOVA (three independent 
experiments; mean ± SD). p-values for individual comparisons were calculated using Tukey's HSD multiple comparisons 
test and are indicated in the graph. (C) Recycling of AIP56 into the extracellular medium is not inhibited by concanamycin A. 
mBMDM were treated with concanamycin A (conc A) or left untreated before performing the recycling assay as described in 
A, but in the presence of concanamycin A. The graph shows the quantification of the blots and combines results from three 
independent experiments (the middle line in each box corresponds to the median and the lower and upper side of the boxes 
to the first and third quartiles; whiskers represent the smallest and largest observed values). Values correspond to 
percentage of recycled AIP56V5 relative to the total internalized protein (lane 3). Statistical analysis involved performing 
two-way ANOVA (main effect of inhibitor p=0.180, main effect of time p=0.784, inhibitor and time interaction p=0.942). 
 
We also investigated if recycling of AIP56 was dependent on endosome 
acidification because it is reported that the exposure of ligand-receptor complexes 
internalized by receptor-mediated endocytosis to low endosomal pH is required for the 
efficient sorting of several cargos and recycling of receptors (Hunyady et al, 2002; Jovic et 
al, 2010). The recycling experiment was repeated in the presence of concanamycin A, an 
inhibitor of the endosomal vacuolar ATPase pump responsible for endosome acidification 
(Huss & Wieczorek, 2009). The efficacy of concanamycin A in inhibiting the vacuolar 
ATPase pump was confirmed using the fluorophore acridine orange. Acridine orange is a 
weak base that becomes protonated and accumulates in acidic endosomes exhibiting a 
concentration-dependent shift from green (low concentration) to red (high concentration) 
fluorescence (Zelenin, 1993). Cells were visualized by fluorescence microscopy and as 
shown in Figure 4.14B in the absence of concanamycin A, acidic vesicles appeared 
orange because acridine orange was trapped within the endosomes and its concentration 
increased, while in the presence of the inhibitor no red/orange staining was detected, 
confirming the inhibitory effect of concanamycin A. As shown in Figure 4.13C, recycling of 
AIP56V5 was not inhibited by concanamycin A (compare lanes 6 and 7 with lanes 10 and 
11, respectively), suggesting that it does not require low endosomal pH for efficient 
sorting.  
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Figure 4.14. Control of the activity of LY294002 and concanamycin A. (A) LY294002 inhibits PI3K activity in mBMDM. 
Cells were treated for 1 h at 37ºC with 10 µM LY294002 or left untreated before incubation with 100 ng/ml bacterial LPS 
(known to stimulate the phosphorylation of Akt, a downstream target of PI3K (Laird et al, 2009)) or with 5 ug ml-1 AIP56V5 
(used also as a stimulus). After incubation for 10 min at 37ºC, cells were washed and total and phosporylated Akt (P-Akt) 
analyzed by western-blotting (chromogenic detection). Note that in the presence of LY294002 no P-Akt is observed, 
confirming that LY294002 is inhibiting PI3K activity. The blot shown is representative of three independent experiments. (B) 
Concanamycin A inhibits the vacuolar ATPase pump in sbPL and mBMDM. Cells were incubated with 10 nM concanamycin 
A (concA) or vehicle (DMSO) before incubation for 15 min at 22ºC (sbPL) or 37ºC (mBMDM) with 0.5 µg ml-1 acridine 
orange (AO) in the presence of the inhibitor. Cells were washed and processed for fluorescence microscopy. Nuclei were 
counterstained with DAPI. Images shown correspond to the overlay of the green and red channels and are representative of 
two independent experiments. 
 
4. Translocation of AIP56 into the cytosol 
4.1. Endosome acidification is required for arrival of AIP56 into the cytosol  
The indication that following endocytosis, AIP56 entered early endosomes and that 
after 20/30 min trafficked into the endocytic recycling compartment suggests that in order 
to  reach  its cytosolic  target,  this toxin translocates  from early or  recycling  endosomes. 
AB toxins that translocate from endosomes (e.g., diphtheria, tetanus and botulinum toxins) 
are inhibited by agents that prevent acidification of endosomes/lysosomes (Falnes & 
Sandvig, 2000; Montecucco & Papini, 1995; Sandvig & van Deurs, 2005), because the  
trigger for translocation is the low endosomal pH. To clarify the mechanism involved in the 
translocation of AIP56 into the cytosol, several compounds known to inhibit endosome 
acidification were tested for their ability to inhibit AIP56 trafficking and toxicity. Those 
included ammonium chloride and chloroquine, known to diffuse into the 
endosomes/lysosomes and become protonated with a subsequent increase of the pH in 
the vesicles (Ohkuma & Poole, 1978); monensin and nigericin, acidic ionophores that 
have the same effect of ammonium chloride and chloroquine (Ohkuma & Poole, 1978) 
and  also  bafilomycin  A1  and  concanamycin A,   potent  inhibitors  of  the  endosomal  
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Figure 4.15. Endosome acidification is required for AIP56-dependent cleavage of p65 and AIP56-associated 
apoptosis. (A) Compounds that inhibit endosome acidification prevent AIP56-dependent cleavage of p65. sbPL were 
treated with the indicated inhibitor before incubation with 10 µg ml-1 AIP56 for 30 min on ice. Cells were washed, shifted to 
22ºC and incubated for 2 h while maintaining the inhibitory conditions. Mock treated cells, cells treated with AIP56 in the 
absence of the inhibitor and cells treated only with the inhibitor were used as controls. Cleavage of p65 was assessed by 
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western blotting (chromogenic detection). To control the protein loading, the membrane was stained with Ponceau S 
(bottom panels). Numbers on the left indicate the position of the molecular weight markers, in kDa. The blot shown is 
representative of three independent experiments. (B) Compounds that inhibit endosome acidification inhibit AIP56-induced 
apoptosis. Cells were treated as described in A and the percentage of apoptotic cells determined after 4 h incubation by 
morphological analysis of cytospin preparations stained with hemacolor. Pictures were randomly taken and the percentage 
of cells with apoptotic morphology determined by counting a minimum of 300 cells in a blinded fashion. Results are 
expressed as the percentage of cells with apoptotic morphology (mean ± SD, n=4) relative to the percentage of apoptotic 
cells in samples treated only with AIP56. 
 
vacuolar ATPase pump that block the acidification of early and late endosomes as well as 
lysosomes (Huss & Wieczorek, 2009). These compounds did not affect the in vitro 
catalytic activity of AIP56 (Figure 4.8A), and had almost no effect on cell viability at the 
doses and incubation times employed (not shown). When sbPL were treated with each 
inhibitor before incubation with AIP56, the cleavage of p65 (Figure 4.15A) and the AIP56-
associated apoptosis (Figure 4.15B) were inhibited. 
 
 
 
Figure 4.16. AIP56 translocation into the cytosol is dependent on endosome acidification. Concanamycin A (concA) 
and bafilomycin A1 (bafA1) prevent the AIP56-dependent cleavage of p65 but do not inhibit AIP56 endocytosis. (A) sbPL or 
mBMDM were treated with the indicated inhibitor before incubation with 10 µg ml-1 (sbPL) or 5 µg ml-1 (mBMDM) AIP56 in 
the presence of the inhibitor for 30 min on ice. Cells were washed, shifted to 22ºC (sbPL) or 37ºC (mBMDM) and incubated 
for 2 h while maintaining the inhibitory conditions. Mock treated cells, cells treated with AIP56 in the absence of the inhibitor 
and cells treated only with the inhibitor were used as control. Cleavage of p65 was assessed by western blotting 
(chromogenic detection). The graphs show quantification of the blots and combine the results of three independent 
experiments (mean ± SD). Loading correction was achieved by dividing the density of p65 by the respective density of 
Ponceau S. The results used for each graph were divided by the same constant in order to set to 1 the mean of the control 
(mock-treated cells). The significance of differences was tested by one-way ANOVA. p-values for individual comparisons 
were calculated using the Tukeys´s HSD multiple comparisons and are indicated in the graphs. (B) mBMDM were left 
untreated or treated with concanamycin A or bafilomycin A1 at 37ºC before incubation with 5 µg ml-1 AIP56V5 in the 
presence of the inhibitors for 30 min on ice (pulse), washed and incubated at 37ºC in culture medium containing the 
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inhibitor. After 5 min, surface-exposed cell-associated toxin was removed with pronase E (pronE) and the endocytosed pool 
detected by western blotting using an anti-V5 antibody (chromogenic detection). To control the protein loading, the 
membrane was stained with Ponceau S (bottom panels). The blot shown is representative of three independent 
experiments.  
 
The protective effect of concanamycin A and bafilomycin A1, the two most potent 
inhibitors of endosome acidification, were also tested in mBMDM. By western blotting 
analysis, we confirmed that, similarly to what was observed in sbPL, concanamycin A and 
bafilomycin A1 inhibited AIP56-dependent p65 cleavage in mBMDM (Figure 4.16A). 
Pharmacological inhibitors can act at the cell membrane or at different steps of the 
intracellular trafficking pathways. To exclude that concanamycin A and bafilomycin A1 
were blocking AIP56 toxicity by interfering with the initial steps of AIP56 uptake at the cell 
membrane, mBMDM were treated with the inhibitors or left untreated (control) before 
pulsing for 30 min on ice with AIP56V5. The cells were washed and after 5 min chase at 
37ºC, surface-exposed toxin was removed with pronase E and the intracellular pool of 
AIP56 detected by western blotting. As shown in Figure 4.16B neither inhibitor affected 
AIP56 endocytosis, confirming that they are blocking an intracellular step of AIP56 
trafficking.  
 
4.2. Time-course of AIP56 translocation 
To analyze the time of AIP56 arrival to its cytosolic substrate we performed kinetic 
studies of the p65 cleavage. Cells were incubated with AIP56 and at the times indicated 
(Figure 4.17A) samples were collected for western blotting analysis. After 60 min 
incubation with AIP56, cleavage of NF-B p65 (cl-p65) was detected, confirming that by 
that time, AIP56 had arrived into the cytosol (Figure 4.17A).    
To complement the kinetic experiments and to gain insight into the time-course of 
AIP56 translocation, we took advantage of the inhibitory effect of concanamycin A on 
AIP56 toxicity. Cells were incubated with AIP56 for 30 min on ice, washed to remove 
unbound toxin and transferred to 37ºC (mBMDM) or 22ºC (sbPL). At the times indicated 
(Figure 4.17B) concanamycin A was added and after 2 h incubation p65 cleavage was 
analyzed to assess the arrival of AIP56 into the cytosol. As shown in Figure 4.17B 
concanamycin A markedly inhibited AIP56-dependent p65 cleavage when added up to 15 
min following AIP56 treatment. However, addition of the inhibitor 30 min after toxin 
treatment resulted only in partial inhibition of p65 cleavage and afterwards, the addition of 
concanamycin A had no effect on p65 degradation. These results were further supported 
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by quantifying AIP56-associated apoptosis in sbPL (Figure 4.17C). Addition of 
concanamycin A up to 15 min following AIP56 treatment resulted in a significant decrease   
in the percentage of cells with apoptotic morphology (Figure 4.17C), while addition of the 
inhibitor 30 min after incubation with AIP56 had only a minimal inhibitory effect on the 
AIP56-induced apoptosis (Figure 4.17C). When concanamycin A was added 45 min after 
treatment with the toxin, no protective effect was observed (Figure 4.17C).  Altogether, 
these results indicate that after 15-30 min incubation some AIP56 is no longer susceptible 
to the effect of concanamycin A, suggesting that it was already translocated into the 
cytosol to exert its toxic effect. Since by confocal microscopy of intoxicated mBMDM, 
AIP56 was found to be localized in EEA-1 positive vesicles up to 20/30 min incubation, 
these observations are consistent with the hypothesis that the toxin reaches the cytosol by 
translocating from early endosomes.  
 
 
 
Figure 4.17. Time-course of AIP56 translocation. (A) Kinetic analysis of AIP56-induced NF-B p65 cleavage. mBMDM or 
sbPL were left untreated or incubated with 5 or 10 µg ml-1 AIP56, respectively, for 30 min on ice, washed and transferred to 
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37ºC (mBMDM) or 22ºC (sbPL).  At the indicated time-points, cells were washed and cleavage of p65 analysed by western 
blotting (chromogenic detection). The blots shown are representative of three independent experiments. (B) mBMDM or 
sbPL were left untreated or incubated with 5 or 10 µg ml-1 AIP56, respectively, for 30 min on ice, washed and transferred to 
37ºC (mBMDM) or 22ºC (sbPL) .  Concanamycin A (concA) was added at the indicated times and after 2 h, cleavage of p65 
was assessed by western blotting (chromogenic detection). The bar graphs show the results of the quantification of the 
blots (intact NF-kB p65 relative to cells treated with concA at time 0, mean ± SD, n=3). (C) sbPL were incubated as 
described in B and the percentage of apoptotic cells determined after 4 h incubation  by morphological analysis of cytospin 
preparations stained with hemacolor. Pictures were randomly taken and the percentage of cells with apoptotic morphology 
determined by counting a minimum of 300 cells in a blinded fashion. Results are expressed as the percentage of cells with 
apoptotic morphology (mean ± SD, four independent experiments) relative to the percentage of apoptotic cells in samples 
treated only with AIP56. 
 
4.3. At acidic pH, AIP56 undergoes reversible conformational changes and 
interacts with artificial lipid bilayer membranes  
Considering that toxins that translocate from endosomes undergo conformational 
rearrangements at endosomal pH (Qa'Dan et al, 2000), pH-induced structural changes in 
AIP56 were monitored analyzing TNS fluorescence. TNS is a commercial probe that is 
non-fluorescent in water and becomes fluorescent when bound to hydrophobic regions of 
a protein (Sachdev et al, 1973). Recombinant toxin was incubated with TNS at different 
pH values for 15 min and fluorescence analyzed. As shown in Figure 4.18A, while TNS 
fluorescence at pH 6.0 and above was not higher than background levels, at pH 5.5 
fluorescence markedly increased. The increase continued at pH 5.0, 4.5 and 4.0 and was 
found to be reversible, since returning the toxin that had been incubated at pH 4.0 to pH 
7.0 resulted in a strong decrease in fluorescence intensity (Figure 4.18B). These results 
indicate that AIP56 exhibits a reversible increase in hydrophobicity when exposed to an 
acidic (pH 5.5-4.0) environment. Because TNS is an “external” probe of protein 
hydrophobicity, the intrinsic fluorescence of tryptophan residues was also analyzed. 
Changes in tryptophan fluorescence can be used to detect protein conformational 
alterations because the fluorescence is quenched in presence of an aqueous solvent. As 
shown in Figure 4.18C, tryptophan fluorescence from AIP56 decreases as pH declines, 
suggesting that under acidic conditions tryptophan-containing domains move into more 
aqueous environments or that hydrophobic pockets move away from tryptophans.  
Following the observation that AIP56 undergoes pH-induced conformational changes, 
we used black lipid bilayers (Benz et al, 1978) to determine whether the toxin is able to 
interact with lipid membranes and if the observed pH-induced conformational changes 
play a role in the interaction. When tested at neutral pH values (pH 7.0-7.4) recombinant 
AIP56 failed to exhibit membrane activity in black lipid membranes. However, acidification 
of  the  aqueous  phase  at  the side of the cis-compartment triggered membrane activity 
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Figure 4.18. Under acidic conditions AIP56 undergoes reversible conformational changes and interacts with lipid 
bilayer membranes. (A) TNS analysis of pH-induced hydrophobic transitions in AIP56Myc. The toxin was incubated with 
TNS at the indicated pH values, and fluorescence analyzed. (B) TNS fluorescence analysis following a pH shift. AIP56Myc 
was incubated with TNS at pH 4.0, and fluorescence analyzed as described in (A); the pH was then adjusted to 7.0 and the 
TNS emission spectrum was recorded again. (C) Intrinsic tryptophan fluorescence of AIP56Myc incubated at pH 7.5 or pH 
4.0. In experiments A, B and C, fluorescence intensities were determined by averaging two readings and background 
fluorescence (TNS + buffer alone for TNS analysis or buffer alone for tryptophan) subtracted to the fluorescence of each 
experimental sample. Each spectrum represents the average of four independent experiments. (D) Current recording of a 
diphytanoyl phosphatidylcholine/n-decane membrane in the presence of recombinant AIP56. The applied membrane 
potential was 50 mV.  Initial experimental conditions consisted of 150 mM KCl, 2 mM CaCl2, 1 mM DTT, 10 mM HEPES pH 
7.4. Addition of recombinant AIP56 mixed 1:1 with cholesterol suspension in water to the cis compartment of the chamber 
(left-side arrow) had no effect on membrane conductivity. Acidification of the aqueous at the cis-compartment by addition of 
10 mM CH3COOK pH 4.6 (right-side arrow) triggered membrane activity. The experiment was repeated three times. (E) 
Membranes activity could also be triggered by a 150 mV voltage-pulse. Current recording of a diphytanoyl 
phosphatidylcholine/n-decane membrane in the presence of recombinant AIP56 mixed 1:1 with cholesterol suspension in 
water. Measurements were performed in 150 mM KCl, 2 mM CaCl2, 10 mM MES pH 6.0 and under these conditions, 
membrane activity was triggered by a 150mV pulse (left-side of panel E, arrow), which finally resulted in membrane rupture. 
A very stable signal could be observed when only 50 mV were applied to a diphytanoyl phosphatidylcholine/n-decane 
membrane in the presence of recombinant AIP56 mixed 1:1 with cholesterol suspension in water (right-side of panel E). The 
experiment was repeated three times. (F) Mutations in the metalloprotease signature do not impair the interaction of AIP56 
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with lipid bilayer membranes. Current recording of a diphytanoyl phosphatidylcholine/n-decane membrane in the presence 
of AIP56AAIVAA mixed 1:1 with cholesterol suspension in water. Measurements were performed in 150 mM KCl, 2 mM CaCl2, 
10 mM MES pH 6.0. Membrane activity was triggered under these conditions by a 150 mV pulse (left-side arrow) and 
stabilized by lowering the applied voltage to 50 mV (right-side arrow). The experiment was repeated twice. 
 
(Figure 4.18D). Accordingly, when recombinant AIP56 was added to the cis chamber at 
acidic pH (6.5 to 4.5) membrane activity was also triggered after a 150 mV voltage-pulse 
(Figure 4.18E) leading to an undefined but step-wise increase in membrane-conductivity 
(left side of Figure 4.18E), which was followed by membrane rupture. A very stable signal 
was observed when voltage was kept to 50 mV (right side of Figure 4.18E). The catalytic 
mutant AIP56AAIVAA behaved similar to AIP56 (Figure 4.18F), indicating that mutations in 
the metalloprotease signature did not impair AIP56’s membrane activity. The observed 
current fluctuations were irregular and inhomogeneous, indicating that interaction of AIP56 
with bilayer membranes does not lead to the formation of regular channels comparable to 
the ones formed by other AB toxins such as anthrax toxins (Finkelstein, 1994; Schmid et 
al, 1994) or Clostridium botulinum C2 (Finkelstein, 1994; Schmid et al, 1994). The current 
fluctuations induced by AIP56 are similar to the ones reported to occur with the C. 
botulinum and C. limosum C3 toxins (Fahrer et al, 2009) as well as with the C. difficile 
TcdB and TcdA toxins (Barth et al, 2000; Giesemann et al, 2006), and may result from 
formation of transient channels.  
 
4.4. Extracellular acidification triggers translocation of cell surface-bound AIP56 
into the cytosol   
The observation that inhibitors which prevent endosome acidification inhibited 
AIP56 toxicity, that AIP56 undergoes pH-induced conformational changes and is able to 
interact with black lipid bilayers at low pH prompted us to test if a low-pH pulse could drive 
the translocation of plasma membrane-bound AIP56 into the cytosol, similarly to what has 
been reported for several other bacterial toxins that translocate from endosomes through 
a pH-dependent mechanism (Draper & Simon, 1980; Sandvig & Olsnes, 1980). 
Concanamycin A was used to block endosomal toxin translocation and the cleavage of 
p65 used as a read-out for the arrival of AIP56 into the cytosol. mBMDM were incubated 
with recombinant AIP56 for 30 min on ice to allow toxin binding and then subjected to a 
pulse at pH 5.5 or 5.0 (pH 7.0 as control) at 37ºC. Afterwards, cells were incubated in 
supplemented culture medium at pH 7.4 for 2 h at 37ºC, washed and analyzed by western 
blotting for detection of p65 cleavage. In the absence of an acidic-pulse, concanamycin A 
inhibited AIP56 endosomal translocation and the concomitant cleavage of p65 (Figure 
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4.19). However, the inhibitory effect of concanamycin A on AIP56 toxicity was abolished 
when mBMDM with surface-bound toxin were exposed to pH 5.0 or 5.5 (Figure 4.19), 
indicating that an acidic pulse is sufficient to induce AIP56 translocation across the 
plasma membrane of targeted cells. Similar results were obtained when sbPL were used 
(not shown). 
 
          
 
Figure 4.19. An acidic pulse can drive translocation of AIP56 across the cell membrane. mBMDM treated with 
concanamycin A (concA) (that was maintained during the entire assay to inhibit endosomal toxin translocation) or left 
untreated were incubated on ice with recombinant AIP56. After 30 min, medium was removed and cells incubated for 1 h at 
37ºC with buffers at the indicated pH values followed by incubation in culture medium at pH 7.4 for 2 h. Cleavage of p65 
was assessed by western blotting (chromogenic detection). The graph shows the quantification of the blots (mean ± SD; 
three independent experiments). Loading correction was achieved by dividing the density of p65 band by the respective 
density of Ponceau S. The results were divided by the same constant in order to set to 1 the mean of the control (mock-
treated cells, pH 7.0). For each pH, significance of differences was assessed by one-way ANOVA. p-values for the 
comparisons with cells treated only with toxin were calculated using Tukey's HSD multiple comparisons test and are 
indicated in the graph. 
comparisons with cells treated only with toxin were calculated using Tukey's HSD multiple comparisons test and are 
indicated in the graph. 
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1. AIP56 cleaves NF-B p65 and induces apoptosis in mBMDM 
The nuclear factor-B (NF-B) comprises a family of transcription factors, master 
regulators of inflammatory and antiapoptotic responses (Gilmore & Wolenski, 2012; 
Wolenski et al, 2013). NF-B is evolutionary conserved from simple organisms as the 
demosponge Amphimedon queenslandica (Gauthier & Degnan, 2008; Meyer et al, 2009; 
Shinzato et al, 2011; Wolenski et al, 2013) to the fly Drosophila melanogaster (Gilmore & 
Wolenski, 2012; Wang et al, 2006), fish species (Correa et al, 2004; Kong et al, 2011; 
Schlezinger et al, 2000; Tacchi et al, 2011; Wang et al, 2009), and humans (Gilmore & 
Wolenski, 2012; Wang et al, 2006), suggesting that the proteins involved and their 
mechanisms of action are also evolutionary conserved, highlighting their pivotal role in 
biological responses. In mammals, it has been shown that the NF-B family is composed 
by five elements, RelA/p65, RelB, c-Rel, p50 (NF-B1), and p52 (NF-B2), that can form 
different combinations of homo- or hetero-dimers, contributing to the transcriptional 
selectivity of the NF-B response (Oeckinghaus & Ghosh, 2009; Smale, 2012). The most 
abundant heterodimer of the NF-B family is p50/p65, often used synonymously for NF-
B. Under normal physiological conditions, NF-B is retained inactive in the cytoplasm by 
forming a complex with the inhibitors of kappa B (IB) proteins. Different stimuli, including 
bacterial and viral products and cytokines acting via cellular receptors such as Toll-like 
receptors (TLRs), Interleukin-1 receptor (IL-1R) and TNF receptors (TNFRs), can trigger a 
signaling cascade that results in phosphorylation and degradation of the inhibitory IB 
proteins and activation and transport of the NF-B complexes to the nucleus, culminating 
in the up-regulation of inflammatory and anti-apoptotic genes (Rahman & McFadden, 
2011). 
To counteract the crucial role of NF-B in immunity, many successful pathogens have 
evolved a variety of mechanisms to subvert NF-B signaling (Rahman & McFadden, 
2011). Indeed, it has been shown that several pathogenic bacteria interfere with NF-B 
signaling by targeting different intermediates of the NF-B activation cascade (Baruch et 
al, 2010; Bhattacharjee et al, 2006; Christian et al, 2010; Muhlen et al, 2011; Ruckdeschel 
et al, 2001; Yen et al, 2010; Zheng et al, 2011), usually by injecting protein effectors 
directly into the cell´s cytosol through type III or type IV secretion systems (see reviews by 
Bhavsar et al, 2007; Neish & Naumann, 2011; Rahman & McFadden, 2011). Interestingly, 
AIP56 is the only described AB-type toxin targeting NF-B. Previous studies showed that 
AIP56 cleaves sea bass NF-B p65 at an evolutionary conserved site, the Cys39-Glu40 
peptide bond (Silva et al, 2013). Interestingly, Cys38 of human p65 (corresponding to sea 
bass Cys39) has been shown to play a key role in NF-B binding to DNA (Kelleher et al, 
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2007) and in regulation of the anti-apoptotic actions of NF-B (Sen et al, 2012). Moreover, 
it is known that abnormal activation of this transcription factor contributes to the 
pathophysiology of a variety of diseases, including inflammatory and autoimmune 
diseases and cancer (DiDonato et al, 2012; Li & Verma, 2002; Wong & Tergaonkar, 
2009), and Cys38 of human p65 has been described to be the target of several NF-B 
inhibitors with reported anti-inflammatory and/or anticancer properties (Garcia-Pineres et 
al, 2001; Ha et al, 2009; Han et al, 2005; Harikumar et al, 2009; Liang et al, 2006; Sandur 
et al, 2006; Watanabe et al, 2008).  
The lack of appropriate and established tools for studying intracellular trafficking in fish 
cells prompted us to search for mammalian cells susceptible to AIP56. During this search, 
we have found that although mammals are not susceptible to infection by Photobacterium 
damselae piscicida, likely due to temperature and salt-restricting conditions, AIP56 is able 
to enter and cleave cytosolic NF-B p65 in different mammalian cells. We also found that 
the extent of p65 depletion and the occurrence of death upon incubation with AIP56 
depend on the cell type: while in the mammalian cell lines tested p65 was not depleted 
and the cells did not die upon exposure to AIP56, in mBMDM p65 depletion and apoptosis 
were observed following incubation with the toxin. The different cellular fates upon AIP56 
intoxication may be related to the existence of different NF-B regulatory mechanisms in 
different cell-types. Alternatively, and similarly to what has been described for diphtheria 
toxin, in resistant cells AIP56 may be internalized through a non-specific endocytic 
mechanism that does not allow efficient intoxication. Indeed, studies on diphtheria toxin 
(DT) demonstrated that sensitivity of the cells to DT-toxicity is related to the presence of 
DT-specific cell surface-expressed receptor (Almond & Eidels, 1995; Middlebrook et al, 
1978; Morris & Saelinger, 1983). While in sensitive cells, DT enters by receptor-mediated 
endocytosis through a clathrin-dependent mechanism, in resistant cells the toxin is mainly 
endocytosed through non-clathrin-coated regions of the plasma membrane, independently 
of the receptor. This mechanism of endocytosis allows the internalization of the toxin but 
not its toxicity suggesting that receptor-mediated endocytosis is required for efficient 
intoxication. The identification of AIP56 cell membrane receptor and the understanding of 
the entry mechanisms in different cell-types could help clarifying the toxin specificity. The 
observation that, similarly to sea bass macrophages (Silva et al, 2013), mBMDM undergo 
p65 depletion and apoptosis in response to AIP56 supported the use of these cells as an 
alternative model to study several details of AIP56 intoxication that could not be properly 
addressed using sbPL. 
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It is well known that NF-B, and in particular its p65 subunit, is responsible for 
preventing apoptosis (Beg & Baltimore, 1996; Beg et al, 1995; Sen et al, 2012). However, 
apoptosis of eukaryotic cells is an active and complex process of cell suicide (Fuchs & 
Steller, 2011; Hacker, 2000; Ren & Savill, 1998) and inactivation of NF-B alone may not 
explain its occurrence (Baichwal & Baeuerle, 1997; Liu et al, 1996; Natoli et al, 1998; 
Wang et al, 1996). Nevertheless, it is well established that cells with inactivated NF-B are 
more susceptible to apoptosis in response to different stimulus including the inflammatory 
cytokine Tumor Necrosis Factor Alpha  (TNF-α) and Toll-Like Receptors (TLRs) ligands 
(Beg & Baltimore, 1996; Hsu et al, 2004; Wang et al, 1996). Until now, it is not clear 
whether AIP56-mediated p65 cleavage/depletion per se is responsible for inducing 
apoptosis, in resemblance to what has been suggested for the macrophage apoptosis 
induced by the Vibrio parahaemolyticus type III secreted effector VP1686 (Bhattacharjee 
et al, 2006), or if it requires an additional  stimulus, similarly to what has been described 
for the macrophage apoptosis induced by Yersinia outer protein (Yop) P in Yersinia 
enterocolitica, or its homologue YopJ in Yersinia pseudotuberculosis and Yersinia pestis 
(Cornelis et al, 1998; Orth, 2002), which have been shown to require stimulation of TLR4 
(Haase et al, 2003; Ruckdeschel et al, 2001; Zhang & Bliska, 2003). Our results suggest 
that TNF-α and TLR4 signaling are dispensable for AIP56 toxicity. However, similarly to 
what was observed in studies of Yersinia YopP (Haase et al, 2003; Ruckdeschel et al, 
2001; Zhang & Bliska, 2003), the apoptotic response triggered by AIP56 is delayed in the 
absence of TLR4. This suggests that although AIP56 toxicity is independent of TLR4 
signaling, the toxin can take advantage of LPS to potentiate its intoxication mechanism, 
i.e. TLR4 signaling critically accelerates the onset of AIP56-induced apoptosis that 
otherwise occurs with a delayed kinetic. This result, points to the existence of a secondary 
stimulus that synergizes with the NF-B inhibitory action of AIP56 to speed up apoptosis. 
Curiously, although TLR4 is known as a key component of the innate immune response 
against Gram-negative bacteria it is not always beneficial to the host. It has been 
demonstrated that bacteria and toxins can subvert TLR4 for their own benefit: TLR4 can 
facilitate the translocation of uropathogenic E. coli across renal collecting duct cells 
(Chassin et al, 2008); pertussis toxin from Bordetella pertussis uses TLR4 as a receptor 
and is largely dependent on TLR4 to induce intracellular signaling events (Kerfoot et al, 
2004); TLR4 facilitates the binding of Shiga toxin to its receptor Gb3 enhancing its 
cytotoxicity (Torgersen et al, 2010); absence of TLR4 protects against anthrax lethal toxin-
induced cardiac contractile dysfunction (Kandadi et al, 2012); and Yersinia YopP exploits 
TLR4 signaling to trigger apoptosis in macrophages (Ruckdeschel et al, 2001). 
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2. AIP56 undergoes receptor mediated endocytosis in a clathrin-dependent 
mechanism 
Similar to diphtheria toxin, CNF1, botulinum and tetanus neurotoxins (Collier, 2001; 
Tana et al, 2013; Turton et al, 2002), AIP56 is a single-chain AB toxin that reaches the 
cytosolic compartment to exert its activity (Silva et al, 2013).  Although this implies that the 
toxin must be able to enter the cells and reach the cytosolic compartment, the entry 
mechanism and trafficking pathways used by AIP56 were never investigated. Here, using 
sea bass peritoneal leukocytes (sbPL) and mouse bone marrow derived macrophages 
(mBMDM), we show that shortly after incubation with cells, AIP56 localizes in intracellular 
vesicular compartments initially scattered near the cell membrane but that over time 
concentrate in the perinuclear area, suggesting that binding of AIP56 to still unidentified 
cell-surface receptor(s) is followed by endocytosis into a vesicular/endosomal 
compartment from where it must escape to reach the cytosol. 
Different bacterial AB toxins have distinct mechanism of internalization, but are usually 
internalized by receptor-mediated endocytosis before translocation into the cytosol 
(Falnes & Sandvig, 2000; Sandvig & van Deurs, 1996; Sandvig & van Deurs, 1999; 
Sandvig & van Deurs, 2005; Watson & Spooner, 2006). In the case of AIP56, similarly to 
what has been recently reported in sbPL (Silva et al, 2013), the binding to mBMDM occurs 
by interaction of the C-terminal region (the B domain) of the toxin with the host cell 
surface, suggesting that the toxin recognizes a conserved receptor and is endocytosed by 
receptor mediated endocytosis.  
After binding to the cell surface receptor, bacterial AB toxins can be endocytosed by 
different mechanisms and can use exclusively one or more endocytic pathways (Falnes & 
Sandvig, 2000; Sandvig et al, 1993). While diphtheria toxin (Lemichez et al, 1997; 
Skretting et al, 1999), clostridial glucosylating toxins (CGTs), and anthrax toxin (Abrami et 
al, 2010; Abrami et al, 2003) are thought to predominantly use clathrin-dependent 
endocytosis, several protein toxins like cholera (Torgersen et al, 2001) and Shiga toxins 
(Sandvig et al, 2009; Sandvig et al, 2002) can be internalized either by clathrin-dependent 
or independent mechanisms. Our results indicate that following receptor binding, AIP56 
endocytosis mainly occurs through a clathrin-dependent mechanism, since inhibition of 
clathrin-coated pits formation blocked AIP56 internalization. In agreement with this, 
inhibition of the large GTPase dynamin, known to play an important role in clathrin-
mediated endocytosis by participating in the constriction and subsequent budding of 
coated pits (Damke et al, 1994; Ferguson & De Camilli, 2012; Praefcke & McMahon, 
2004; Schmid et al, 1998), also blocked AIP56 entry. Clathrin-dependent endocytosis 
includes several internalization pathways, all relying on the use of the coat protein clathrin, 
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but differing in what concerns the requirement for other proteins, including actin 
(McMahon & Boucrot, 2011). Findings of the present study indicate that the actin 
cytoskeleton is not involved in AIP56 endocytosis, since depolymerization of F-actin by 
cytochalasin D (Sampath & Pollard, 1991) did not affect entry nor p65 cleavage by the 
toxin. This is similar to what has been reported for transferrin, a classical marker of 
clathrin-mediated endocytosis, that in several cell types has been shown to enter through 
a pathway independent of actin (Fujimoto et al, 2000), and also for diphtheria toxin, known 
to enter cells via a clathrin-dependent mechanism that is actin-independent (Abrami et al, 
2010; Moya et al, 1985).  
Altogether, these data suggest that AIP56 is endocytosed by a dynamin-dependent 
process mainly governed by clathrin that, as in the case of transferrin (Fujimoto et al, 
2000) and diphtheria toxin (Abrami et al, 2010; Moya et al, 1985), does not involve actin. 
Since pharmacological inhibitors are not absolutely specific (Dutta & Donaldson, 2012; 
Ivanov, 2008) it would be interesting to complement our results with approaches involving 
protein depletion or overexpression of dominant-negative mutants that impair clathrin-
dependent endocytosis. 
 
3. AIP56 is a “short-trip” toxin that follows the endocytic recycling route 
After receptor-mediated endocytosis, AB toxins end up in early endosomes, the 
central sorting and routing station in cells, and, in what concerns the cytosolic entry, fall in 
two main groups: some enter from early/late endosomes in response to low pH, whereas 
others are transported all the way to the Golgi apparatus and from there to the 
endoplasmic reticulum (ER) from where they translocate into the cytosol.  
It was classically thought that molecules internalized via clathrin-dependent 
endocytosis are either recycled back to the plasma membrane or degraded via the 
lysosomal pathway (McMahon & Boucrot, 2011). However, there are toxins like Shiga and 
cholera toxins that upon internalization via clathrin-coated pits traffic retrogradely to the 
Golgi apparatus (Sandvig et al, 2002). In this study, we used confocal microscopy to 
dissect the intracellular route followed by AIP56. We found that within 5 minutes after 
endocytosis, AIP56 localizes in early endosomes (positive for EEA-1 and Alexa 647-
Transferrin), where it remains for 15-20 min and then is routed to the recycling endocytic 
compartment (identified by labeling with Alexa 647-Transferrin). Using a recycling assay in 
which we allowed cells to internalize AIP56, removed extracellular and surface-associated 
toxin and then monitored the appearance of recycled toxin in the extracellular medium, we 
were able to demonstrate that part of the endocytosed AIP56 is rapidly recycled back to 
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the extracellular compartment. Recycled toxin is already detected at 2 min chase 
(following a pulse of 30 min on ice + 5 min 37ºC) and its amount increases over time, 
while decreasing the amount of cell-associated toxin. The fact that the decrease in 
intracellular AIP56 is not inhibited by the proteasomal inhibitor MG132 and that no co-
localization of AIP56 with LAMP-1 was ever detected, suggests that the decrease of cell-
associated AIP56 during intoxication does not result from proteosomal or lysosomal 
degradation, but mainly from recycling of the endocytosed toxin back into the extracellular 
medium. Consistent with this interpretation is the observation that PI3K, which has been 
described to play a key role in the endocytic recycling of several molecules, including 
transferrin (Spiro et al, 1996; van Dam et al, 2002) and AT1 angiotensin receptor 
(Hunyady et al, 2002), is required for the appearance of recycled AIP56 in the 
extracellular compartment. 
For several recycled proteins, including transferrin receptor, two alternative recycling 
pathways have been described: a fast direct route from early endosomes or earlier 
compartments to the plasma membrane and a slower route involving the transport of 
cargo proteins to the endocytic recycling compartment (ERC) before transport to the 
plasma membrane (Grant & Donaldson, 2009; Maxfield & McGraw, 2004). The detection 
of recycled AIP56 after 2 min chase suggests that part of the toxin follows the fast 
recycling route while the observed co-localization with Alexa 647-Transferrin in a 
perinuclear compartment suggests that a pool of the toxin is recycled from the ERC. 
Based on the observation that AIP56 recycling requires PI3K activity, we speculate that 
the fast recycling route is playing a major role, since it is known that PI3K is mainly 
involved in the fast recycling (Hunyady et al, 2002; Naughtin et al, 2010; van Dam et al, 
2002) with very few evidences of its involvement in slow recycling (Gillooly et al, 2000). 
The efficient sorting and recycling of several cargos/receptors internalized by receptor-
mediated endocytosis, requires exposure of ligand-receptor complexes to low endosomal 
pH (Jovic et al, 2010; Mellman, 1996; Mukherjee et al, 1997). Frequently, this leads to the 
dissociation of the ligands from the receptors (Jovic et al, 2010). The membrane-bound 
components (e.g. the receptors) are recycled back to the plasma membrane while the 
released ligands concentrate in the vesicular parts of the early endosomes and are then 
routed through a microtubule-dependent maturation process to late 
endosomes/lysosomes (Maxfield & McGraw, 2004; Mellman, 1996; Mukherjee et al, 
1997). Several ligands, including transferrin (TF), move between the plasma membrane 
and sorting/recycling endosomal compartments remaining bound to their receptor and 
thus avoiding transport to lysosomes (Gibson et al, 1998; Sonnichsen et al, 2000; van 
Dam & Stoorvogel, 2002; van Dam et al, 2002). Iron-loaded transferrin (holo-TF) binds to 
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the transferrin receptor at cell surface and is endocytosed by clathrin-dependent 
endocytosis into early endosomes where the acidic pH facilitates the dissociation of the 
two atoms of Fe3+ from TF. The iron-free TF (apotransferrin), remaining bound to the 
receptor, is recycled back to the plasma membrane where, at neutral pH, apotransferrin 
dissociates leaving the transferrin receptor free to bind more TF (Dautry-Varsat et al, 
1983; Klausner et al, 1983a; Klausner et al, 1983b; Mayle et al, 2012; Rao et al, 1983). 
Due to the requirement of acidic endosomal pH for iron release from apotransferrin, 
inhibitors that raise the acidic pH to neutrality, like the V-ATPase inhibitors concanamycin 
A and bafilomycin A1, reduce the release of recycling transferrin (Baravalle et al, 2005; 
Johnson et al, 1993; van Weert et al, 1995). In the case of AIP56, our results suggest that 
endosomal acidification is dispensable for the recycling and release of the toxin, since the 
appearance of recycled toxin into the extracellular medium was not affected by inhibition 
of the vacuolar ATPase pump with concanamycin A.  
Although the release of endocytosed toxins back into the extracellular medium has 
been previously described for the plant toxin ricin (McIntosh et al, 1990; McIntosh et al, 
1984; Sandvig & Olsnes, 1979) and for anthrax toxin (Abrami et al, 2013), and is likely to 
contribute to toxicity, none of those toxins have been reported to follow the endocytic 
recycling route (Abrami et al, 2013; Moisenovich et al, 2004). The release of endocytosed 
ricin seems to occur through a mechanism involving exocytosis of multivesicular bodies 
(McIntosh et al, 1990) allowing intoxication of bystander cell populations (McIntosh et al, 
1984).  In the case of anthrax, it has been demonstrated that the toxin is delivered into the 
extracellular medium in exosomes, contributing to prolonged toxicity and to transmission 
of the toxin to distant cells (Abrami et al, 2013). During this work, several attempts were 
made to detect activity of recycled AIP56. These consisted in large-scale recycling assays 
in which we recovered 48 ml of extracellular medium containing recycled AIP56 from eight 
24-well plates and tried to concentrate the recycled toxin either using centrifugal devices 
or an immunoprecipitation protocol. However, we were unable to detect recycled toxin 
activity. This was likely due to significant losses of toxin during the procedures, since 
western blotting analysis of the concentrates revealed that the amount of AIP56 recovered 
was much less than expected and insufficient to perform activity tests. Therefore, the 
relevance of the putative recycling pathway and of recycled AIP56 for pathogenesis 
remains to be investigated. Nevertheless, we hypothesize that this mechanism may be 
relevant in vivo, especially during initial steps of infection, when the concentration of 
circulating toxin is still low. 
Although monitoring the intracellular localization of fluorescence labeled AIP56 by 
microscopy allowed imaging of some details of its intracellular trafficking, the low 
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sensitivity restrains its usefulness to detect translocation of the toxin into the cytosol. 
However, several biochemical findings indicate that endosome acidification and low pH-
triggered conformational changes are involved in AIP56 translocation: (1) the arrival of 
AIP56 into the cytosol requires endosome acidification, since AIP56-dependent p65 
cleavage was prevented by inhibitors of the vacuolar ATPase pump (Huss & Wieczorek, 
2009); (2) at pH 5.5 or lower AIP56 becomes more hydrophobic and is able to interact 
with artificial lipid bilayer membranes; (3) a low pH pulse promotes translocation of cell 
surface-bound AIP56 across the cytoplasmic membrane into the cytosol, similarly to what 
has been reported for several toxins that translocate from endosomes through a pH-
dependent mechanism (Barth et al, 2000; Draper & Simon, 1980; Sandvig & Olsnes, 
1980). Following endocytosis, AIP56 reaches early endosomes and then follows the 
recycling route leading to the hypothesis that translocation into the cytosol would occur 
from early and/or recycling endosomes. Since early endosomes are the first acidic 
compartment encountered by the toxin upon endocytosis, it is likely that at least the 
beginning of the translocation process occurs in early endosomes. The fact that in less 
than 30 min, when most of the toxin is still located in EEA-1 positive vesicles, an amount 
of AIP56 sufficient to intoxicate the cells is already at the cytosolic compartment together 
with the fact that inhibition of PI3K activity does not inhibit AIP56 toxicity fully agrees with 
the hypothesis that early endosomes are the first organelle along the recycling route from 
where the toxin translocates into the cytosol. The observation that microtubules 
depolymerization did not affect AIP56-mediated p65 cleavage is compatible with this 
interpretation and confirms that late endosomes/lysosomes are not involved in AIP56 
intoxication, as it is known that maturation of early endosomes into late endosomes is a 
microtubule dependent process (Huotari & Helenius, 2011).  
Altogether, the results herein presented show that AIP56 is a “short-trip” toxin that 
translocates from endosomes into cytosol in a pH-dependent manner. Additional studies 
are needed to further dissect the molecular mechanism underlying the different steps of 
AIP56 intracellular trafficking. 
 
4. Future perspectives 
In this study, we report that mBMDM are susceptible to AIP56 intoxication and, using 
both sbPL and mBMDM, define key steps involved in the entry and intracellular trafficking 
of the toxin. This opens new questions concerning AIP56 intoxication mechanisms that 
must be addressed in the future.  
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Our data clearly show that the extent of p65 depletion and the occurrence of death 
upon incubation with AIP56 is cell-type specific although the reasons for this specificity 
remain to be disclosed. The identification of AIP56 cell membrane receptor together with a 
more complete screening of AIP56 toxicity in different cell-types may contribute to clarify 
this question. 
One of the aspects that urges to clarify is whether AIP56 needs to be processed in 
order to exert toxicity, like occurs in most bacterial AB toxins secreted as single 
polypeptides, or if unprocessed toxin may be translocated into cytosol, as described for 
Pseudomonas exotoxin A (Alami et al, 1998; Morlon-Guyot et al, 2009). For several 
bacterial AB toxins secreted as single polypeptides, proteolytic nicking and integrity of the 
disulfide bond linking the two domains are essential for toxicity (Knust et al, 2009; 
Krieglstein et al, 1991; Papini et al, 1993; Pirazzini et al, 2011; Rupnik et al, 2005; 
Sandvig & Olsnes, 1981; Schiavo et al, 1990). In the case of AIP56, several evidences 
suggest that proteolytic nicking and integrity of the disulfide bridge are not mandatory for 
intoxication (Silva et al, 2013). Indeed, there is no evidence of proteolytically processed 
AIP56 in the Phdp culture supernatant or in the serum of infected fish (do Vale et al, 
2005), and despite several attempts we were unable to detect proteolytic processing of 
the toxin upon its interaction with host cells (not shown). Moreover, AIP56 does not 
requires proteolytic activation or reduction to display enzymatic activity in vitro, and 
disruption of the disulfide bridge linking the two structural domains by alkylation (Silva et 
al, 2013) or mutation (not shown) does not inhibit AIP56 toxicity. 
Another issue that must be clarified is whether eukaryotic co-factors are involved in 
AIP56 translocation. It is becoming clear that the translocation of several bacterial AB 
toxins into the cell cytosol is facilitated by specific interactions with common cellular 
components. Indeed, it has been demonstrated that COPI complex and the cytoplasmic 
chaperone Hsp90 are key regulators in the translocation and refolding of the catalytic 
domain of several bacterial toxins. COPI complex has been shown to play a crucial role in 
the translocation of the catalytic domain of diphtheria (Murphy, 2011) and anthrax 
(Tamayo et al, 2008) toxins. The Hsp90 has been shown to play a role in the translocation 
from endosomes and in the cytosolic refolding of diphtheria toxin (Murphy, 2011), the 
anthrax related fusion protein LFnDTA (Dmochewitz et al, 2010), the Clostridium 
botulinum C2 toxin (Barth, 2011; Haug et al, 2003), the family of binary actin-ADP-
ribosylating toxins (Kaiser et al, 2011) and in the translocation of the A1 subunit of cholera 
toxin  from  the  endoplasmic reticulum  to  the  cytosol (Taylor et al, 2010). These 
evidences lead to the hypothesis that divergent toxins probably follow a common 
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mechanism in the initial steps of catalytic domain translocation and should be taken into 
account when exploring the molecular details of AIP56 translocation.  
One of the most interesting findings reported in this thesis is the occurrence of AIP56 
recycling. This contrasts to what has been reported for other “short-trip” AB toxins which, 
in the absence of translocation are degraded in lysosomes. AIP56 is, therefore, the first 
AB toxin reported to follow the endocytic recycling pathway, adding a novel route to the 
trafficking of AB toxins. Future studies are needed to define the importance of AIP56 
recycling for Phdp pathogenesis as well as to disclose the molecular mechanisms 
involved in the recycling of the toxin.  Our data suggest that fast recycling is playing a 
major role in the recycling of AIP56. This could be confirmed by investigating the 
involvement of molecules, rather than PI3K, specifically associated to fast or slow-
recycling routes. For instance, it is well recognized that Rab4 and Rab11 play key roles in 
the regulation of the recycling pathway with Rab4 associated to the fast recycling route 
and Rab11 associated to the slow recycling (Grant & Donaldson, 2009; Maxfield & 
McGraw, 2004). It would be interesting to evaluate the involvement of such Rab GTPases 
in AIP56 recycling. Another question that remains to be investigated is how AIP56 is 
efficiently sorted and recycled back to the extracellular medium. For several 
cargos/receptors internalized by receptor-mediated endocytosis the efficiency of recycling 
is dependent on low endosomal pH. Usually, under acidic endosomal pH, the ligands 
dissociate from the receptors (Jovic et al, 2010; Mellman, 1996; Mukherjee et al, 1997) 
and the membrane-bound components (e.g. the receptors) are recycled back to the 
plasma membrane while the released ligands are routed to late endosomes/lysosomes 
(Maxfield & McGraw, 2004; Mellman, 1996; Mukherjee et al, 1997). In the case of 
transferrin, after receptor-mediated endocytosis the endosomal acidic pH facilitates the 
release of Fe3+ but the iron-free transferrin remains bound to the receptor to avoid 
lysosomal degradation and to be efficiently recycled back to the cell surface where the 
neutral pH leads to dissociation of transferrin receptor from TF. In contrast, the recycling 
of AIP56 is independent on endosomal acidification. The mechanism/molecules 
contributing for AIP56 recycling need to be further investigated. The identification of the 
eukaryotic cell surface receptor recognized by the toxin will likely contribute to disclose 
this issue. 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER VI 
CONCLUDING REMARKS 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER VI- CONCLUDING REMARKS 
111 
 
AIP56 is a plasmid-encoded protein secreted by Photobacterium damselae piscicida 
(Phdp), a Gram-negative bacterium that causes septicemic infections in several warm 
water fish species worldwide. In Phdp infections, the toxin is systemically distributed and 
induces apoptosis of the host macrophages and neutrophils (do Vale et al, 2007a; do Vale 
et al, 2003; do Vale et al, 2005). The inefficient clearing of the apoptosing cells due to 
phagocyte depletion culminates in a post-apoptotic secondary necrotic process with lysis 
of the apoptosing cells. This leads to the impairment of host immune defenses and 
contributes to the formation of the necrotic lesions observed in the diseased animals (do 
Vale et al, 2007a; do Vale et al, 2007b). Recent data from our laboratory demonstrated 
that AIP56 is an AB-type toxin that depletes the NF-B p65 of the host cells (Silva et al, 
2013), an observation that likely explains the apoptogenic activity of the toxin.  
Until the beginning of this work, very little was known about the interaction of AIP56 
with different cells and about the cell entry and intracellular trafficking mechanisms used 
by the toxin to reach its target. With this study, we demonstrated that although Phdp is not 
able to infect mammals, AIP56 enters and cleaves NF-B p65 not only in fish leukocytes 
but also in mammalian cells. Additionally, our results disclosed important aspects of AIP56 
trafficking showing that these are conserved between fish and mammals. 
The findings reported here revealed that AIP56 is a “short-trip” toxin that follows two 
intracellular pathways that are at least partially independent: the intoxication pathway (that 
requires acidification of the endosomes and involves conformational changes in the toxin 
molecule but is independent on PI3K activity) and the recycling pathway (independent on 
endosome acidification but requiring PI3K activity). The evidences supporting that a 
significant pool of endocytosed AIP56 follows the recycling pathway and is released into 
the extracellular medium suggest a novel intracellular route amongst the ones already 
established for bacterial AB toxins. Additional studies are required to define the relevance 
of the AIP56 recycling for Phdp pathogenesis, but we anticipate that it may be particularly 
important during initial phases of infection, when the amount of secreted toxin is still 
limited.  
Studies of toxin trafficking contributed to reveal detailed mechanisms of fundamental 
transport steps in cells, adding to the basic knowledge in cell biology. Furthermore, 
learning how toxins invade cells may help to find steps in which we can interfere with to 
prevent disease, leading to advances in medicine and physiology. In this context, 
disclosing the details of the intoxication mechanism used by AIP56 may contribute to find 
alternative strategies to prevent or treat Phdp infections. Additionally, it may expand the 
knowledge on the biology of AIP56-like toxins. Indeed, since we first described AIP56, a 
growing number of AIP56 full-length homologues, likely possessing key pathological roles 
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during infection, have been reported (up to now mainly in marine Vibrio species, but also 
in Arsenophonus nasoniae). None of them has been characterized so far and, therefore, 
studies on AIP56 will not only add to the understanding of Phdp pathogenesis, but will 
also contribute to shed light on the pathogenesis of infections caused by bacteria 
producing AIP56-like toxins.  
Apart from the intrinsic biologic interest of AIP56, the AB-type structure of the toxin 
makes it suitable to modifications that can redirect its potent cytotoxicity from disease to a 
therapeutic function. However, the use of a toxin as a therapeutic must be grounded on a 
solid knowledge of its intoxication mechanism. In this context, the data presented in this 
study may contribute to the use of AIP56 as a biotechnological/therapeutic tool in 
situations associated to uncontrolled activation of NF-B, such as inflammatory diseases 
and cancers. 
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